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Abstract 
Perineuronal nets (PNNs) are an important pericellular matrix structure that form 
around the soma and dendrites of sub-populations of neurons in the mature central 
nervous system (CNS). They have been implicated in regulating synaptic plasticity, 
increasing synaptic stability, neuroprotection and memory formation. They are 
composed of hyaluronan (HA), chondroitin sulfate proteoglycans (CSPGs), Haplns 
and tenascin-R, that can assemble in many different potential configurations to form 
morphologically distinct PNNs. Currently there is a proposed model for the assembly 
of this extracellular matrix structure, but the detailed mechanism for the stabilisation 
of the morphologies of PNNs is not yet known. The aim of this thesis project is to 
characterise the biochemical heterogeneity of PNNs and understand how PNN 
molecules assemble to form a pericellular coat with distinct morphologies, while 
ascertaining the biomechanical contribution of each molecule to the pericellular coat.  
Using Western blotting, regional variations in the molecular composition of PNN-
associated molecules were observed that may present an opportunity to modulate 
PNNs region specifically in the future. Different splice variants and levels of 
glycosylation of CSPGs were profiled in different CNS regions. To analyse the 
assembly of PNNs in real-time and measure the biomechanical properties of the film, 
an in vitro methodology was established using quartz crystal microbalance with 
dissipation monitoring (QCM-D). The PNN film was modelled using a tethered film of 
HA, to which HA and proteoglycan link protein 1 (Hapln1) and aggrecan (Acan) were 
sequentially added. Hapln1 bound to HA films stably, while binding of Acan was 
reversible, though could be stabilised by sequentially adding Acan to Hapln1-
presenting HA films. While the density of HA films influenced the interaction of Acan, 
increasing the density of pre-bound Hapln1 did not. Furthermore, Hapln1 addition 
caused a rigidification of HA films, while Acan addition caused a softening effect, 
highlighting the important role of Hapln1 in stabilising the PNN matrix and a potential 
mechanism for regulating the biomechanical properties of PNNs. As cells in the CNS 
can mechanosense, understanding these mechanisms may offer new therapeutic 
avenues for targeting neurological diseases correlated with changes to PNNs. 
In addition, a new methodology for sizing surface-anchored GAG chains was 
established using QCM-D by utilising the relationship between the ratio of ∆𝐷/−∆𝑓 
and GAG size. This methodology highlights the effect of HA size on the 
biomechanical properties of the PNN film and presents a potential future 
methodology for the characterisation of PNN HA size. Mechanisms for 
biomechanically manipulating PNN films by increasing HA size and varying the 
density of Hapln1 and HA suggest PNNs may partially function via a biomechanical 
signalling mechanism in addition to already established mechanisms.   
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Chapter 1: Introduction 
1.1 Overview 
Perineuronal nets (PNNs) were first described as a reticular structure on the 
surface of neurons in 1898 (Golgi, 1898). PNNs are found surrounding the 
soma and dendrites of subpopulations of neurons in the central nervous 
system (CNS) (Kwok et al., 2011; Wang and Fawcett, 2012). Importantly, they 
form a condensed ‘net-like’ layer around the outside of neurons, therefore are 
considered an extracellular matrix (ECM) structure. Though the structure was 
first described over a century ago, how the structure spontaneously self-
organises and the mechanisms by which PNNs exert changes to biological 
processes remain poorly understood. Although the mechanisms remain 
unclear, the importance of PNNs to biological processes is evident, as when 
enzymatically removed, clear changes at both the cellular and behavioural 
level have been observed that will be discussed in section 1.2 (Celio et al., 
1998; Kwok et al., 2011; Wang and Fawcett, 2012; Sorg et al., 2016).  
PNNs have been observed in the CNS of several mammals including, mice, 
rats, Chilean fat-tailed mouse opossums, cows, hamsters,  macaques, and 
humans (Kalb and Hockfield, 1988; Asher et al., 1995; Carulli et al., 2006; 
Deepa et al., 2006; Brückner et al., 2006; Galtrey et al., 2008; Carulli et al., 
2010; Mueller et al., 2016; Enwright et al., 2016). There is also some evidence 
suggesting fish may also have PNNs (Genade and Lang, 2013). It may be that 
PNNs are a conserved pericellular structure that are common in the CNS of 
most animals. However, the PNN structure is specific to the CNS, as PNNs 
have not been observed in the peripheral nervous system. 
The molecular components of PNNs aggregate spontaneously in an activity 
dependent manner (Dityatev et al., 2007; Reimers et al., 2007; McRae et al., 
2007). Briefly, PNNs are formed of hyaluronan (HA) that is synthesised on the 
cell surface by hyaluronan synthase (HAS) molecules. Chondroitin sulfate 
proteoglycans (CSPGs) then interact with HA via their N-terminal globular 
domain (G1) (Carulli et al., 2006; Kwok et al., 2010; Kwok et al., 2011). The 
interaction of CSPGs with HA is strengthened through the interaction with 
Haplns (Binette et al., 1994; Matsumoto et al., 2003; Shi et al., 2004). The 
trimeric structure of tenascin-R (Tn-R) has been hypothesised to cross-link 
the CSPGs via their C-terminal domain (Lundell et al., 2004).  A model for the 
structure of PNNs has been hypothesised demonstrating how the components 
may self-organise to form the supra-molecular PNN structure (Figure 1; Kwok 
et al., 2011). The structure will be described in greater detail in section 1.5.  
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Figure 1. Schematic representation of the PNN structure. 
It demonstrates HAS anchoring HA to the cell membrane. CSPGs (aggrecan, brevican, 
neurocan and brevican) then interact with HA via their N-terminus in the presence of 
link protein. The C-terminus of CSPGs are then crosslinked by tenascin-R. In this 
schematic the molecules are not drawn to scale. The figure is courtesy of: Kwok et al 
(2011). 
 
Parvalbumin-expressing GABAergic interneurons, many of which express the 
fast reactivating voltage-gated potassium channel subtype Kv3.1b, are the 
most well characterised cell type found to be ensheathed by PNNs (Chang et 
al., 2010; Kwok et al., 2011; de Winter et al., 2016). However, PNNs 
surrounding: pyramidal neurons in the hippocampus and parietal cortex; 
motor neurons in the spinal cord and neurons in the medial nucleus of the 
trapezoid body, have also been observed (Takahashi-Iwanaga et al., 1998; 
Härtig et al., 2001; Wegner et al., 2003; Carstens et al., 2016; Irvine and Kwok, 
2018). Furthermore, PNNs have been observed throughout the CNS including 
the regions of the visual cortex, barrel cortex, substantia nigra, deep cerebellar 
nuclei, spinal cord and hippocampus (Pizzorusso, 2002; Carulli et al., 2006; 
McRae et al., 2007; Brückner et al., 2008; Galtrey et al., 2008). PNNs are 
found throughout the CNS surrounding multiple neuronal cell types. To date 
a systematic analysis investigating the exact populations of neurons PNNs 
surround in the CNS regions has not been undertaken, so it is plausible that 
PNNs may also surround other cell types that have yet to be characterised 
(this is addressed in objective 1 in section 1.6).  
Although PNNs are often considered to be a singular structure, this may be 
an over-simplification as recent evidence has suggested that the structures 
may be more heterogeneous than first predicted (Brückner et al., 2006; 
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Yamada and Jinno, 2017; Richter et al., 2018). What remains unclear is how 
the different PNN phenotypes are established (this is also addressed in 
objective 1 in section 1.6). In this introduction the functional importance of 
PNNs will first be described, alongside a description of the biological concepts 
of synaptic plasticity. The reasoning for why a biomechanical signalling 
mechanism is being proposed for PNNs will then be provided through the 
evidence of cellular mechanosensing in the nervous system. A description of 
the PNN components will then be provided, followed by a section explaining 
how these components could potentially combine to produce structurally 
heterogenous PNNs.  
1.2 Functional importance of PNNs 
PNNs have been implicated in numerous neurological diseases including 
epilepsy, schizophrenia and Alzheimer’s disease (Morawski et al., 2004; 
Pantazopoulos et al., 2010; Markus Morawski et al., 2012; McRae and Porter, 
2012; Pantazopoulos et al., 2015; Yang et al., 2015; Rankin-Gee et al., 2015; 
Enwright et al., 2016). A role in memory formation and addiction has also been 
suggested (Hylin et al., 2013; Romberg et al., 2013; Xue et al., 2014; Slaker 
et al., 2016; Banerjee et al., 2017; Carulli et al., 2020). Furthermore, a 
hypothesised mechanism for long term memory formation has been 
suggested, though there is currently no evidence to support this notion (Tsien, 
2013). It is important to note that most evidence that has suggested a 
functional role in neurological diseases is correlational, with little direct 
evidence implicating PNN modulation with a causal role in disease 
progression. The functional importance of PNNs has largely been inferred by 
experimentally modulating PNNs and measuring changes to neurological 
behaviour.  
 
1.2.1 Synaptic plasticity  
Synaptic plasticity is the ability of synaptic connections to strengthen or 
weaken, meaning that synaptic connections have the ability to establish or 
withdraw over time and adapt to changes in the environment. This mechanism 
has been proposed to play a central role in the brains ability to turn transient 
experiences into memories (Citri and Malenka, 2008). In this PhD thesis when 
referring to a reduction in synaptic plasticity it relates specifically to the 
limitation of plastic changes to synapses only. Therefore, reducing synaptic 
plasticity preserves existing connections and neuronal circuitry. It is also worth 
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highlighting that a synapse is made up of: a presynaptic axon terminal, the 
synaptic cleft, a post-synaptic terminal that is the dendrites or neuronal cell 
body. As PNNs surround the cell body and proximal dendrites of neurons in 
the CNS, they are ensheathing the post-synaptic terminal.  
 
1.2.2 Modulating PNNs 
Many studies looking to implicate PNNs in neurological functions have used 
the enzyme chondroitinase ABC (ChABC) to enzymatically remove PNNs 
from the CNS (Pizzorusso, 2002; Pizzorusso et al., 2006; Massey et al., 2006; 
Hrabětová et al., 2009; Pyka et al., 2011). ChABC digests chondroitin sulfate 
(CS), as well as HA in the experimental conditions used (Prabhakar et al., 
2005). It is important to note that preferential digestion of CS and HA can be 
achieved using ChABC by carefully manipulating the digestion conditions in 
vitro. As HA is an integral part of the PNN structure and has been implicated 
in tethering PNNs to the cell surfaces, the removal of HA enzymatically 
removes PNNs (Kwok et al., 2010). Furthermore, the CS chains present within 
PNNs, that are attached to the CSPG core proteins will also be enzymatically 
cleaved using ChABC (Deepa et al., 2006). Using ChABC in the CNS has 
resulted in a variety of behavioural phenotypes, including the restoration of 
juvenile levels of synaptic plasticity in the adult visual cortex (Pizzorusso, 
2002; Pizzorusso et al., 2006). In the spinal cord following a spinal cord injury 
the use of ChABC caused increased synaptic plasticity and higher levels of 
functional recovery to be observed (Massey et al., 2006).  
The fundamental drawback of using ChABC is it does not specifically remove 
PNNs, as it also digests CS and HA present throughout the ECM of the CNS. 
Therefore, methodologies that use ChABC struggle to separate the effects 
caused by the removal of PNNs, from the effects caused by the removal of 
CS and HA from the loose ECM. Experiments using ChABC have highlighted 
potential functional roles of PNNs that required further characterisation to 
specifically implicate PNNs.  
Alternative methods for directly altering PNN structure have been devised to 
more specifically modulate PNNs. One method involved creating a hapln1 
knockout mouse model (Carulli et al., 2010). By targeting hapln1 this method 
was able to disrupt PNN assembly while limiting the changes to the loose 
ECM. The hapln1-knockout mice maintained juvenile levels of synaptic 
plasticity in the visual cortex and cuneate nucleus, providing strong evidence 
that PNNs are directly involved in regulating synaptic plasticity in the CNS. 
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Further evidence implicating PNNs in reducing synaptic plasticity strengthens 
this hypothesised function (Pizzorusso, 2002; Pizzorusso et al., 2006; Massey 
et al., 2006; Galtrey et al., 2008; Carulli et al., 2010). The work by Carulli et al 
(2010) specifically implicated the role of the PNN structure in modulating 
neuronal function. However, the mechanism by which the removal of PNNs 
changed neuronal function remained unclear.  
A number of mechanisms have been suggested for how PNNs may alter 
neuronal function (Figure 2; Wang and Fawcett, 2012). Each mechanism will 
be described in more detail in the remainder of this section below. The 
likelihood is that PNNs use a combination of mechanisms to alter neurological 
function, which may partially explain the varying disease pathologies that 
PNNs have been associated with. 
 
Figure 2. A schematic representation of hypothesised mechanisms for how 
PNNs may exert functional change to neurological systems.  
The figure is courtesy of: (Wang and Fawcett, 2012). 
 
1.2.3 A Sink for cation storage to allow increased neuronal activity to 
occur 
PNNs are polyanionic in nature which may attract cations that enhance the 
excitability of fast-spiking neurons (Balmer, 2016). Fast-firing neurons are 
often surrounded by PNNs which has been observed both in vivo as well as 
in vitro (Härtig et al., 1994; Härtig et al., 1999; Morris and Henderson, 2000; 
Reimers et al., 2007). It has been hypothesised that PNNs may provide 
insulation from excess potassium produced by the cell during periods of high 
activity (Brückner et al., 1993). PNNs have been observed to surround fast 
spiking, parvalbumin positive, inhibitory GABAergic interneurons, therefore it 
may be possible that PNNs help maintain this fast-firing behaviour by 
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providing a favourable ECM environment for this activity to occur (Härtig et 
al., 1992). Therefore, this mechanism proposes that the structural properties 
of the PNN create a favourable environment through the anionic nature of the 
biochemical components accumulating counterions (cations) within the 
pericellular coat.  
 
1.2.4 PNN molecular components may directly regulate neuronal activity 
through signalling 
CSPGs are an essential component of PNNs that have been observed to 
directly inhibit neurite outgrowth (Oohira et al., 1991; Wang and Fawcett, 
2012). The CSPG core proteins, absent of glycosaminoglycan (GAG) chains, 
were sufficient to inhibit neurite outgrowth (Oohira et al., 1991). CS chains 
have also been observed to have an inhibitory effect on CNS neurons (Snow 
et al., 1996; Niederöst et al., 1999; Dyck and Karimi-Abdolrezaee, 2015). 
Therefore, the direct signalling of the PNN molecular components provides a 
potential biochemical mechanism for altering neuronal behaviour (Lee et al., 
2010; Fisher et al., 2011; Wang and Fawcett, 2012; Harris et al., 2013). The 
mechanism may require the presence of GAGs, as ChABC caused this 
signalling to be altered (Lee et al., 2010; Harris et al., 2013). The neuronal 
transmembrane leucocyte common antigen-related phosphatase receptor has 
also been implicated in interacting with CSPGs to negatively regulate axonal 
growth (Fisher et al., 2011). What remains unknown is if the direct signalling 
observed when presenting these molecules to CNS cells alone, as opposed 
to presenting them as part of a supramolecular structure, changes or 
potentially impedes this direct signalling. To analyse this, it is important to 
understand how PNNs are assembled and how the molecular components 
are embedded within the structure (this is addressed in objective 2 in section 
1.6).   
  
1.2.5 Signalling molecules interact with PNNs to regulate activity 
PNNs have been observed to sequester numerous guidance molecules, via 
their interaction with CS chains (Sugiyama et al., 2008; Chang et al., 2010; 
Kwok et al., 2011; Miyata et al., 2012; de Winter et al., 2016). In particular, 
molecules linked with reducing, or limiting synaptic plasticity and axonal 
growth have been identified, including semaphorins and Orthodenticle 
Homeobox 2 (Otx2) (Pasterkamp and Kolodkin, 2003; Bouzioukh et al., 2006; 
Beurdeley et al., 2012; Dick et al., 2013; de Winter et al., 2016). Semaphorins 
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have been implicated in synaptic plasticity and stabilisation  (Pasterkamp and 
Kolodkin, 2003; Bouzioukh et al., 2006). CS-E has been observed to 
sequester semaphorin 3a (Sema3a) with high affinity, suggesting that 
regulating specific GAG sulfation patterns within the PNN may act as a 
mechanism for regulating guidance molecule sequestration (Dick et al., 2013; 
Vo et al., 2013; Djerbal et al., 2019). Otx2 has been linked with reducing 
synaptic plasticity  (Beurdeley et al., 2012). Otx2 is sequestered through the 
binding of the RK peptide sequence of Otx2 to CS-GAGs within the PNN. Otx2 
also interacts specifically with the di-sulfated CS-D and CS-E with high affinity, 
further supporting the role of GAG sulfation pattern regulation in facilitating 
PNN function  (Beurdeley et al., 2012). These two examples of sequestered 
signalling molecules demonstrate how PNNs could function through 
regulating the abundance of these molecules interacting with the PNN 
surface. It further demonstrates the need for a systematic analysis of the 
distribution of the PNN-associated molecules, as the biochemical composition 
of the film will affect the interactions of these sequestered molecules (this is 
addressed in objective 1 in section 1.6).   
 
1.2.6 A barrier to the movement of post-synaptic receptors on the cells 
surface 
PNNs may also function by limiting post-synaptic receptor movement on the 
cell surface. The observation that the lateral diffusion of α-amino-3-hydroxy-
5-methyl-4-isoxazolepropionic acid (AMPA) receptors was limited by the 
presence of PNNs surrounding hippocampal neurons provided strong 
evidence for this mechanism (Frischknecht et al., 2009). It is therefore 
plausible that PNNs may compartmentalise the neuronal surface limiting the 
movement of post-synaptic receptors. This compartmentalisation may act as 
a mechanism for stabilising synapse formation in the CNS. To date only AMPA 
receptors have been observed to be affected by this mechanism, so it is 
unknown if other post-synaptic membrane-bound proteins are affected in the 
same way. Other receptor types have yet to be analysed. Also, the exact 
mechanism for the reduction in lateral diffusion remains unclear, as it is not 
known whether AMPA receptors are being tethered to the PNN structure or 
are being physically blocked by the presence of the PNN structure on the cell 
surface. Through understanding the assembly and structural properties of 
PNNs it may provide an insight into the precise mechanism for this mechanism 
of compartmentalising post-synaptic receptors (this is addressed in objective 
2 in section 1.6).  
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1.2.7 Physical barrier 
PNNs may function through acting as a physical barrier, preventing new 
synaptic connections from forming. This hypothesis specifically highlights the 
presence of PNNs physically blocking the availability of the neuronal surface 
preventing new synapses from forming. It is currently unclear whether PNNs 
assemble around already formed synapses, or if PNNs compartmentalise the 
surface to facilitate the formation of certain synaptic types. This research gap 
highlights the importance in analysing the assembly and formation of PNNs 
(this is addressed in objective 2 in section 1.6). 
As well as potentially blocking synapse formation, the physical barrier 
produced by PNNs may also provide a neuroprotective function. It has been 
demonstrated that neurons were less affected by the Tau-protein, a molecule 
associated with Alzheimer’s disease, when they were surrounded by PNNs 
(Suttkus et al., 2016). Furthermore, neurons ensheathed by PNNs have 
increased protection from β-amyloid protein, another toxic protein aggregate 
linked to Alzheimer’s disease (Miyata et al., 2007). Potentially the mechanism 
of protection provided by PNNs may be through physically blocking these 
molecules from reaching the cell surface. If the PNN structure is too dense for 
the molecules to pass through the PNN surface, then it may not be possible 
to diffuse through the pericellular structure and be internalised by the cell. 
Surfaces of HA have previously been demonstrated to exclude certain protein 
macromolecules (Ogston, 1966). It remains unknown if PNNs can influence 
the diffusion of molecules to the cell surface, however, by gaining an 
understanding of the biomechanical properties of PNNs will help in 
understanding if this mechanism is partially responsible for PNNs function.    
It is also worth noting that the neuroprotective function may also be provided 
by the negatively charged PNN structure, that repels similarly charged 
molecules and traps oppositely charged molecules within the PNN. Support 
for this hypothesis is provided by the observation that PNNs provide 
neuroprotection against oxidative stress (Morawski et al., 2004; Suttkus et al., 
2012; Cabungcal et al., 2013; Suttkus et al., 2014). Therefore, the physical 
PNN barrier on the surface of neurons may prevent molecules that are 
detrimental to neurons from being internalised through trapping them via their 
charge. Therefore, by understanding the biochemical composition of PNNs 
will allow for a greater understanding of how these mechanisms could be 
regulated.  
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1.3 The importance of cellular mechanosensing in the 
nervous system 
Having identified the numerous potential mechanisms for how PNNs may 
function, what remains clear is the need to establish the precise structure of 
PNNs. PNNs are a large, aggregated pericellular structure that form on the 
surface of neurons in the CNS, whereby they are likely to fundamentally 
change the physical properties of the neuronal surface. One mechanism that 
has yet to be discussed is the possibility that PNNs could function via a 
biomechanical signalling mechanism. In this section biomechanical signalling 
within the nervous system will be discussed to provide the reasoning for 
proposing this potential mechanism of function for how PNNs partially exert 
their function in the CNS.   
 
1.3.1 Defining mechanosensing 
Mechanosensing requires the conversion of mechanical forces into 
intracellular biochemical signals (Franze et al., 2013). When considering the 
role of mechanosensing in relation to PNNs there are two distinct types of 
mechanosensing to consider. First is mechanosensing by cells ensheathed 
by PNNs. In this case the conversion of a mechanical force is in reference to 
the cell being deformed by an external force such as fluid flow (Franze et al., 
2013). It is possible that the presence of a PNN ensheathing a neuron could 
provide a layer of protection to modulate mechanical deformation, thereby 
reducing the ability of the cell to detect changes to the biomechanical 
properties of its environment. The second type of mechanosensing is by the 
incoming cell that then interacts with the PNN surface. In this case the 
mechanical forces are generated from the incoming cell itself through actin 
myosin contractility along stress fibres or within the cell cortex (Sukharev and 
Sachs, 2012; Franze et al., 2013). The actively generated forces are then 
converted into intracellular biochemical signals to actively measure the 
stiffness of its environment, modulating neuronal behaviour, which will be 
described further in section 1.3.3. 
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1.3.2 Hypothesised mechanisms of mechanosensing 
1.3.2.1 Stress sensitive ion channels 
Stress sensitive ion channels are fast-acting channels located within the cell 
membrane (Sukharev and Sachs, 2012; Franze et al., 2013). One example of 
a stress-sensitive ion channel is the potassium-selective ion channel TREK1 
that has been identified as being involved in setting the resting potential of 
neurons (Patel and Honore, 2002; Honoré, 2007; Sukharev and Sachs, 2012). 
Changes in tension in the cell membrane lead to a conformational change in 
the ion channel resulting in a fast and immediate influx of ions into the cell 
(Franze et al., 2009; Chalfie, 2009; Hardie and Franze, 2012; Sukharev and 
Sachs, 2012). The resulting ion influx has been observed to influence axon 
pathfinding, cell movement and the retraction of the growth cone (Lee et al., 
1999; Gomez and Zheng, 2006; Franze et al., 2009; Franze et al., 2013). 
Tension in the cell membrane detected by stress sensitive ion channels has 
also been linked  with the clustering of neurotransmitter vesicles at the 
presynaptic cleft and clustering membrane receptors (Orr et al., 2006; Siechen 
et al., 2009; Franze et al., 2013).  
 
1.3.2.2 Integrin mediated   
Integrins are transmembrane proteins that cluster together to form 
macromolecular complexes called focal adhesions on the cell surface (Moore 
et al., 2010; Roca-Cusachs et al., 2012; Halder et al., 2012; Franze et al., 
2013). Actin-myosin stress fibres can attach to these focal adhesions and 
exert tensile forces on the integrins that is exerted onto the ECM through the 
physical attachment. In response to this tensile force soft ECM surfaces would 
easily deform, therefore the integrins would maintain their conformational 
shape, while stiffer ECM surfaces would deform less, therefore the tension put 
on the integrins would increase which may lead to the exposing of cryptic 
binding sites that facilitate biomechanical signalling (Moore et al., 2010; Roca-
Cusachs et al., 2012; Halder et al., 2012; Franze et al., 2013). It is important 
to note that integrins are not the only mechanosensitive molecules present 
within focal adhesions, as focal adhesions are complex structures made up of 
over 150 different types of proteins (Zaidel-Bar et al., 2007; Oakes and Gardel, 
2014). Both talin and vinculin molecules have also been observed to be 
mechanosensitive molecules present within focal adhesions (Del Rio et al., 
2009; Grashoff et al., 2010; Kanchanawong et al., 2010). 
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1.3.2.3 Transcriptional regulation  
The previous two mechanisms are short-term, immediate mechanosensing 
mechanisms. It is important to note that there is also evidence for longer term 
mechanosensing that occurs through transcriptional regulation (Mammoto et 
al., 2012; Franze et al., 2013). This regulation may occur through the direct 
mechanosensing of the nucleus, which is directly connected to the 
cytoskeleton (Maniotis et al., 1997; Wang et al., 2009). This hypothesised 
mechanism suggests that as there is evidence that the nucleus is already 
under pre-tension, any deformations caused by the cell surface will directly 
transmit to the nucleus causing a change to nuclear shape, that results in a 
change in transcriptional regulation (Mazumder et al., 2008; Mazumder and 
Shivashankar, 2010). 
G-actin levels have also been implicated as they have been observed to 
change in response to stiffness of substrates which correspondingly regulate 
transcription factors such as serum response factor (SRF) (Miralles et al., 
2003; Franze et al., 2013). SRF inactivation has been specifically linked to 
reduced neurite growth during development, ineffective neuronal migration 
and a decrease in dendritic length and number (Kalita et al., 2012). Therefore, 
mechanosensing may affect neuronal cells over longer time-periods.  
 
1.3.3 Cells in the nervous system detect and respond to biomechanical 
changes of substrates 
As discussed in section 1.2 the properties of the PNN structure is likely to play 
an important function in various mechanisms of PNN function, including 
regulating synaptic plasticity, increasing synaptic stability and 
neuroprotection. It is important to note that there is currently no evidence that 
PNNs change the biomechanical properties of the neuronal surface, though it 
appears that the structure of PNNs are important to their function, as 
attenuated PNNs caused changes to neuronal plasticity (Carulli et al., 2010). 
Therefore, the structural properties of PNNs appears to be functionally 
important. Cell bodies and growth cones in the nervous system actively pull 
on their surroundings to measure the stiffness of substrates (Bray, 1979; 
Harris et al., 1980; Betz et al., 2011; Koch et al., 2012). A softer substrate 
causes less strain to the active cell (Schwarz and Gardel, 2012). Therefore, 
the cell bodies and growth cones of cells in the CNS have the ability to detect 
changes to the biomechanical properties of substrates. Growth cones, which 
have been measured by atomic force microscopy (AFM), appear to 
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structurally more sensitive to detecting changes to the mechanical properties 
of substrates (Betz et al., 2011).  
Various studies have demonstrated the ability of neuronal and glial cells to 
respond to changes in the mechanical properties of the ECM surface 
(Flanagan et al., 2002; Georges et al., 2006; Kostic et al., 2007; Jiang et al., 
2008; Jiang et al., 2010; Previtera et al., 2010; Stabenfeldt and Laplaca, 2011; 
Franze et al., 2013; Moshayedi et al., 2014). In reference to PNNs, this 
suggests that both glial cells and neurons could actively detect the PNN 
surface and potentially respond to it. Neurons have been observed to 
preferentially grow on softer, more compliant surfaces, displaying greater 
branching, increased neurite extension and longer axons (Flanagan et al., 
2002; Kostic et al., 2007; Jiang et al., 2008; Jiang et al., 2010; Previtera et al., 
2010; Stabenfeldt and Laplaca, 2011). Glial cells have been observed to 
increase in cell attachment area in response to stiffer surfaces (Georges et 
al., 2006; Cullen et al., 2007; Jiang et al., 2008; Moshayedi et al., 2010; 
Moshayedi et al., 2014). The foreign body response by astrocytes and 
microglia has also been observed to be upregulated in response to stiffer 
surfaces (Moshayedi et al., 2014). It remains unknown if PNNs are able to 
modulate astrocytes and microglia behaviour through a biomechanical 
signalling mechanism. This highlights the importance in determining the 
biomechanical properties of PNNs and how these properties may be 
modulated through cross-linking molecules, as currently these properties 
remain uncharacterised (this is addressed in objective 2 in section 1.6).  
As well as actively detecting their physical environment, neuronal cells have 
also been observed to respond to dynamic mechanical stimuli in their 
environment (LaPlaca et al., 2005; Cullen and LaPlaca, 2006; Franze et al., 
2013). Neurons have been observed to change dendritic length in response 
to dynamic mechanical cues (Jiang et al., 2010). Additionally, changes to the 
cytoskeletal composition, morphological shape and survival rates have also 
been observed in response to dynamic cues (LaPlaca et al., 2005; Cullen and 
LaPlaca, 2006; Franze et al., 2013). With reference to PNNs, it is possible that 
the cells ensheathed by PNNs may have this active mechanosensing impeded 
by the presence of the PNN structure on the surface. Furthermore, the 
presence of PNNs ensheathing neurons may provide insulation and 
neuroprotection from these mechanical stimuli. Therefore, it is important to 
consider the structure of the PNN and the biomechanical properties of the 
macromolecular structure. 
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1.4 Molecular components of PNNs 
To better understand the biomechanical properties of PNNs it is important to 
consider the various molecular components that combine to form the 
supramolecular PNN structure. A variety of PNN-associated molecular 
components are known with the potential to form highly heterogenous 
biochemical compositions (Carulli et al., 2006; Galtrey et al., 2008; Foscarin 
et al., 2017; Irvine and Kwok, 2018). The importance of CSPGs, HA and Hapln 
aggregation was highlighted by work in cartilage where aggrecan (Acan) was 
specifically studied (Hascall and Heinegård, 1974a; Hascall and Heinegård, 
1974b; Heinegård and Hascall, 1974). Although PNNs are also composed of 
an aggregation of CSPGs, HA and Haplns, the ultrastructure of PNNs is 
different, as HA is tethered to the cell surface of neurons. Further work has 
since observed other CSPGs aggregating in these cartilage-like structures 
(Matsumoto et al., 2003; Rauch et al., 2004; Seyfried et al., 2005). It is 
important to consider the molecules associated with PNNs. In this section HA, 
Haplns, CSPGs and Tn-R will be discussed in detail in reference to PNNs, as 
all of have been observed within the macromolecular structure.  
 
1.4.1 HA 
HA is a ubiquitous ECM and cell surface GAG that is composed of repeating 
disaccharide units of D-glucuronic acid and N-acetylglucosamine, bound 
through alternating 𝛽-1,4 and 𝛽-1,3 glycosidic bonds (Meyer, 1958; 
Rodriguez-Martinez et al., 2016). HA is the only non sulfated GAG, making it 
a linear polymer with a molecular composition consistent across the 
polysaccharide chain. HA synthesis occurs on the cell surface, as opposed to 
the Golgi apparatus where other GAGs are synthesised (Prehm, 1984). HAS 
molecules, of which there are 3 isoforms: HAS1, HAS2 and HAS3 synthesise 
HA and extrude it into the pericellular space (Spicer and McDonald, 1998; 
Tien and Spicer, 2005; Törrönen et al., 2014). The different HAS isoforms 
produce HA at different rates and of varying molecular weight (Itano et al., 
1999). Both neurons and astrocytes express HAS, therefore possess the 
potential to synthesise HA that is contributed to the PNN surface (Asher and 
Bignami, 1991; Marret et al., 1994; Miyata et al., 2005; Giamanco et al., 2010; 
Cargill et al., 2012; Bugiani et al., 2013). It is important to note that only HA 
provided by neurons to the PNN structure is likely to be surface-tethered, as 
HA provided by glial cells is unlikely to come into contact with the neuronal 
surface where it could be captured by CD44 receptors. The relative amounts 
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of HA contributed by each cell type to the production of PNNs remains 
unknown. Furthermore, the size of the HA molecules within PNNs is not 
known either (this is addressed in objectives 1 and 3 in section 1.6).   
 
1.4.2 Haplns 
Haplns are a family of glycoproteins that were first characterised in cartilage 
through the identification of cartilage and proteoglycan link protein (Crtl1) / 
Hapln1 (Hardingham, 1979). Later brain link protein (Bral1) / Hapln2 and Bral2 
/ Hapln4 were identified (Hirakawa et al., 2000; Spicer et al., 2003). Hapln1 
contains 2 link modules and an Ig-like loop that function to stabilise the HA / 
CSPG complex (Hardingham, 1979; Nieduszynski et al., 1980; Binette et al., 
1994; Morgelin et al., 1994; Watanabe et al., 1997; Matsumoto et al., 2003; 
Spicer et al., 2003; Bekku et al., 2003; Rauch et al., 2004; Shi et al., 2004). 
Both Hapln1 and Hapln4 have been observed to co-localise with PNNs in the 
CNS (Asher et al., 1995; Carulli et al., 2006; Deepa et al., 2006; Galtrey et al., 
2008; Carulli et al., 2010; Kwok et al., 2010; Bekku et al., 2012; Edamatsu et 
al., 2018). Hapln4 has been observed to be specifically upregulated in the 
cerebellum and brainstem (Bekku et al., 2012; Edamatsu et al., 2018). 
Interestingly, the removal of Hapln1 was enough to cause the attenuation of 
PNNs in the brain and was correlated with an increase in synaptic plasticity  
(Carulli et al., 2010; Romberg et al., 2013). Furthermore, Hapln1 has also 
been observed to preferentially interact with the versican (Vcan) G1 domain 
in comparison with the Acan G1 domain (Shi et al., 2004). Little is known about 
the combinatorial rules of interactions for how each of the Haplns interacts 
with each CSPG to stabilise a ternary complex with HA. Therefore, it is 
plausible that the distribution of Haplns may regulate the CSPGs that are 
incorporated into the assembly of PNNs. Currently, the distribution of Haplns 
throughout the CNS is not known, therefore a systematic analysis, as done in 
chapter 3, would provide insights into how the Haplns may be involved in the 
structural regulation of PNNs. 
 
1.4.3 CSPGs  
CSPGs are large molecules comprised of a core protein and a number of 
covalently linked GAGs. Specifically, phosphacan (Pcan), as well as the 
lectican family of CSPGs, that includes Acan, brevican (Bcan), Vcan and 
neurocan (Ncan) have been found to interact with PNNs and known to be 
important in the formation of the ECM (Ruoslahti, 1996; Carulli et al., 2006; 
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Deepa et al., 2006; Galtrey et al., 2008; Aspberg, 2012). The core protein of 
lecticans are relatively conserved, as they all contain a an N-terminal globular 
domain (G1) and a C-terminal globular domain (G3) (Sandy et al., 1990; 
Yamaguchi, 2000). Of note Pcan does not contain a G3 domain. The G1 
domain contains an immunoglobulin repeat and 2 link modules and is known 
to interact with HA and Haplns (Watanabe et al., 1997; Yamaguchi, 2000; 
Matsumoto et al., 2003; Kwok et al., 2011). The G3 domain contains a C-type 
lectin domain that is flanked by 2 epidermal growth factor-like repeats and a 
complement regulatory protein-like domain (Doege et al., 1987; Zimmermann 
and Ruoslahti, 1989; Rauch et al., 1992; Yamada et al., 1994; Yamaguchi, 
2000; Kwok et al., 2011; Aspberg, 2012). With reference to PNNs the G3 
domain has been observed to interact with Tn-R in a calcium-dependent 
manner (Aspberg, 1995; Aspberg et al., 1997). It is however worth noting that 
fibulin-1, fibulin-2, tenascin-C and fibrillin-1 have also been observed to 
interact with the G3 domain of lecticans (Rauch et al., 1997; Aspberg et al., 
1999; Olin et al., 2001; Isogai et al., 2002; Day et al., 2004; Aspberg, 2012). 
Between the G1 and G3 domain is a central region of different lengths 
depending on the molecule, which is the region where GAGs are attached to 
the core protein covalently via a tetrasaccharide linker. 
 
1.4.3.1 Acan 
In the CNS, Acan has been observed to primarily be produced by neurons 
(Matthews et al., 2002; Carulli et al., 2006; Giamanco and Matthews, 2012). 
It is the most well characterised CSPG known to co-localise with PNNs 
throughout the CNS (Carulli et al., 2006; Deepa et al., 2006; Galtrey et al., 
2008; Irvine and Kwok, 2018). A conditional CNS Acan knockout mouse 
model has also been produced that demonstrated that the loss of Acan in vivo 
caused the ablation of PNN structures in the brain (Rowlands et al., 2018). 
Acan is the most well characterised lectican due to it being present in cartilage 
tissue where it was first described (Hascall and Sajdera, 1970; Hascall, 1988). 
Acan is the only lectican that contains a G2 domain that possess 2 link 
modules (Kwok et al., 2011; Aspberg, 2012). The central domain of Acan is 
made up of approximately 1161 amino acid residues and has previously been 
characterised as being the most glycosylated lectican, containing between 80 
– 120 GAGs (Yamaguchi, 2000; Kiani et al., 2002). Acan in cartilage tissue 
has been specifically measured using AFM, therefore of all the CSPGs its size 
has been the well characterised (Ng et al., 2003). However, it is important to 
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note that it not known if cartilage Acan is representative of Acan found in the 
brain (this is addressed in objective 1 in section 1.6).  
 
1.4.3.2 Bcan 
Bcan was first cloned in 1994 and has been observed to have the shortest 
central domain of the lecticans, containing approximately 300 amino acid 
residues (Yamada et al., 1994; Yamaguchi, 2000). Approximately 3 GAG 
chains are thought to interact with the central domain of Bcan (Yamaguchi, 
2000). Bcan is a lectican that is specific to the CNS and is known to co-localise 
with PNNs (Yamaguchi, 2000; Carulli et al., 2006; Deepa et al., 2006; Galtrey 
et al., 2008). In the adult brain a significant proportion of Bcan has previously 
been observed to exist without any GAG side-chains attached (Yamada et al., 
1994; Yamaguchi, 1996). Furthermore, there is a splice variant of Bcan that 
is glycosylphosphatidylinositol (GPI)-anchored to the cell surface, containing 
a cleaved central domain with a short signal sequence (Seidenbecher et al., 
1995; Yamaguchi, 2000).  
 
1.4.3.3 Vcan 
Vcan exists in the CNS in at least 4 isoforms that have previously been 
characterised (Zimmermann and Ruoslahti, 1989; Dours-Zimmermann and 
Zimmermann, 1994; Zako et al., 1995; Ito et al., 1995). The central domain of 
each Vcan isoform differ in size, with one isoform lacking the entire central 
domain (Yamaguchi, 2000). The length of the entire fully-formed central 
domain creates the largest lectican species, though due to its numerous 
spliced forms it is considered to be the lectican most varied in size (Ito et al., 
1995; Zako et al., 1995; Yamaguchi, 2000). Unglycosylated full-length Vcan 
is ~ 360 kDa (Ito et al., 1995; Zako et al., 1995). Throughout the CNS Vcan is 
known to associate with PNNs (Carulli et al., 2006; Deepa et al., 2006; Galtrey 
et al., 2008).  
 
1.4.3.4 Ncan 
Ncan is a lectican specific to the CNS (Rauch et al., 1992; Yamaguchi, 2000). 
Ncan has been found to co-localise with PNNs throughout the CNS (Carulli et 
al., 2006; Deepa et al., 2006; Galtrey et al., 2008). Multiple splice variants of 
Ncan exist, though full length the core protein is ~ 245 kDa in an adult rodent 
brain, with ~ 3 CS GAG chains interacting with the central domain (Rauch et 
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al., 1991). Ncan is expressed by both neurons and astrocytes, though 
astrocytes have been observed to express Ncan more abundantly in culture 
(Oohira et al., 1994).  
 
1.4.3.5  Pcan 
Pcan is a soluble splice variant of the receptor-type protein tyrosine 
phosphatase transmembrane protein (Maurel et al., 1994). Although it is not 
a lectican, Pcan is a CSPG that shares some similarities to the lectican family, 
containing an N-terminal (G1), and a central domain, though lacking a G3 
domain (Maurel et al., 1994). However, the RPTP form of Pcan has a C-type 
lectin domain. Pcan has also been found to co-localise with PNNs throughout 
the CNS (Carulli et al., 2006; Deepa et al., 2006; Galtrey et al., 2008). Tn-R 
has also been observed to interact with Pcan, with this interaction being 
calcium-dependent (Xiao et al., 1997).  
 
1.4.4 Tn-R 
Tn-R is a glycoprotein predominantly expressed in the CNS where 2 isoforms 
have been observed (Schachner et al., 1994; Aspberg, 1995; Faissner, 1997; 
Woodworth et al., 2002; Lundell et al., 2004; Morawski et al., 2014). Tn-R is 
known to interact with the G3 domain of lecticans and Pcan in a calcium-
dependent manner (Aspberg, 1995; Aspberg et al., 1997). The lecticans 
interact with Tn-R with different affinities, as Bcan has been observed to 
interact with the highest affinity of the lecticans  (Aspberg et al., 1997; 
Hagihara et al., 1999). Tn-R has been hypothesised as an integral part of 
PNNs, with a proposed role in the cross-linking of the PNN structures due to 
Tn-R forming dimeric and trimeric structures (Aspberg, 1995; Chiquet-
Ehrismann and Tucker, 2011; Morawski et al., 2014).  
 
1.4.5 Cellular contributions of molecular components to PNNs 
To gain an understanding of how these PNN-associated molecular 
components self-organise to assemble the supramolecular PNN structure it is 
important to consider where the components are contributed from. 
Components contributed by cells ensheathed by PNNs will be added to the 
PNN surface differently to components contributed by the ECM where the 
components will interact with the surface of the PNN structure first. To 
highlight this, only HA provided by the cells ensheathed by PNNs can be 
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surface bound to the cell, therefore will be incorporated differently to the PNN 
surface in comparison with HA contributed from the ECM by other cells. Using 
a combination of in situ hybridisation and immunohistochemistry to analyse 
the contributions of PNN components provided by neurons and glial cells in 
the rat cerebellum found: neurons contributed Acan, Ncan, Tn-R and low 
levels of Bcan; astrocytes contributed Bcan at much higher levels compared 
with neurons; oligodendrocytes contributed Vcan, Bcan and expressed Tn-R 
at higher levels compared with neurons; oligodendrocyte precursor cells and 
synantocytes contributed Vcan, Pcan and contributed Tn-R at higher levels 
compared with neurons (Carulli et al., 2006). Additionally, Ncan has also been 
observed to be contributed by astrocytes during development, but is 
contributed only by neurons in the adult rat cerebellum (Carulli et al., 2007).  
To further analyse how the contributions of components affects PNN 
assembly neurons were cultured in vitro to observe PNN formation in the 
absence of glial cells (Miyata et al., 2005; Giamanco and Matthews, 2012). 
Miyata et al (2005) observed neurons cultured in vitro produced PNNs that 
contained Ncan, HA and Pcan. In this particular analysis no other PNN 
components were investigated. Giamanco & Matthews (2012) observed that 
Acan was transcriptionally upregulated in the absence of glial cells, while 
PNNs produced in the absence of glia did not contain Bcan, Hapln1 or Tn-R. 
Additionally, glial cells have been observed to express most PNN components 
when analysed by reverse transcription polymerase chain reaction, where 
they were specifically found to not express Acan or HAS3, which supports the 
in situ hybridisation analysis (Carulli et al., 2006; Giamanco and Matthews, 
2012). Therefore, it is possible for PNNs to be assembled by neurons in vitro 
in the absence of glial cells, however the biochemical composition of these 
structures are different, supporting the hypothesis that PNN components are 
contributed by both neurons and glial cells.   
 
1.4.6 Temporal expression and staining pattern of PNN components  
It is important to consider when the PNN components are expressed when 
considering how they assemble and self-organise to form the supramolecular 
structure on the neuronal cell surface. PNNs, are first detected at P7 in the rat 
CNS, which correlates with the expression of Acan and Hapln1 at low levels 
(Carulli et al., 2007; Galtrey et al., 2008). This observation suggests that 
Hapln1 and Acan, may be important in triggering the assembly of PNNs. 
Although PNNs are first observed around P7 in the rat cerebellum and spinal 
cord, in the visual cortex of mice PNNs are not observed until later, around 
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P14 (Carulli et al., 2010). This implies that there may be temporal differences 
in the expression of PNN components in different CNS regions. It is important 
to note that analysis of gene expression does not consider the potential for 
the components to be post-transcriptionally regulated. 
 
1.5 Structural heterogeneity of PNNs 
1.5.1 Heterogeneity in the PNN-associated components 
Although a variety of molecular components have been identified it remains 
unclear how these molecules precisely interact during the formation of PNNs 
(this is addressed in objective 2 in section 1.6). PNN-associated molecules 
have been observed to be differentially distributed throughout the CNS 
regions, however this has not yet been correlated with changes to PNN 
structure (Carulli et al., 2006; Galtrey et al., 2008; Bekku et al., 2012). 
Furthermore, heterogeneity in the biochemical composition of PNNs has been 
previously observed (McRae et al., 2007; Irvine and Kwok, 2018; Ueno et al., 
2018; Miyata et al., 2018).   
HA, Haplns and CSPGs are known to be essential to the formation of PNNs 
(Deepa et al., 2006; Carulli et al., 2010; Kwok et al., 2010). It is important to 
note the potential molecular diversity in these essential PNN components that 
are present in the CNS. HA can be synthesised at different sizes by three 
isoforms of HAS (HAS1, 2 and 3) (Itano et al., 1999). There are also five 
CSPGs (Acan, Bcan, Vcan, Ncan and Pcan) known to be associated with the 
PNN structure, as well as three Haplns (Hapln1, Hapln2 and Hapln4) (Miyata 
et al., 2005; Carulli et al., 2006; Deepa et al., 2006; Carulli et al., 2007; Galtrey 
et al., 2008; Zimmermann and Dours-Zimmermann, 2008; Kwok et al., 2011; 
Wang and Fawcett, 2012; Giamanco and Matthews, 2012). The variety of 
sizes and varying degree of glycosylation observed in the different molecular 
components of PNNs is demonstrated in Figure 3. This highlights how the 
relative contribution of each individual molecular component could change the 
physical properties of the surfaces in a unique way. Specifically, the sizes of 
the different CSPGs range from approximately 100 – 375 nm, therefore the 
relative abundance of each CSPG within PNNs are likely to change the 
physical properties of the film. Furthermore, the different levels of 
glycosylation observed on the different CSPGs will also contribute to changes 
to the structure of PNNs. Although the presence of the molecules within PNNs 
have been observed, the relative abundance of PNN-associated components 
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in different CNS regions remains unclear (this is addressed in objective 1 in 
section 1.6). 
Each specific CSPG molecule also has the potential to be highly 
heterogeneous in structure due to alternative splicing of the core protein that 
could occur during synthesis, or as a product of enzymatic cleavage by matrix 
metalloproteinases (MMPs) (Yamaguchi, 2000; Kiani et al., 2002; Morawski 
et al., 2012). Additional heterogeneity in CSPG structure could be produced 
through varying the degree of glycosylation of the core protein. It is unknown 
whether lecticans in different regions display varying glycosylation patterns 
(this is addressed in objective 1 in section 1.6). Furthermore, it is important to 
note that yet further heterogeneity could be produced through varying the 
sulfation pattern of the GAG chains (Foscarin et al., 2017).  
 
 
Figure 3. Size comparison of PNN-associated molecules.  
This figure was produced using the core protein and GAG chain amounts summarised 
in the review by  Bandtlow and Zimmermann (2000). To determine the nm size the 
CSPGs were compared with the size of the Acan core protein determined by Ng et al 
(2003). Therefore, the sizes of the other CSPGs are an approximate estimate 
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1.5.2 Proposed structure of PNNs 
A macromolecular structure of PNNs was proposed by (Kwok et al., 2011). 
This model proposed that Acan interacts with HA within the HA films that are 
tethered to the cell surface by HAS molecules (Figure 4). On interaction with 
surface bound HA films Acan has previously been observed to increase the 
surface compliance of HA films, highlighting the ability of CSPGs to influence 
the biomechanical properties of HA films (Attili and Richter, 2013). It has not 
yet been established if other CSPGs have a similar effect, though theoretically 
there is no reason why the interaction would not be similar. The interaction of 
HA and CSPGs is then stabilised by Hapln1, as has previously been observed 
using surface plasmon resonance (SPR) (Shi et al., 2004). Furthermore, the 
proposed model of the macromolecular structure of PNNs suggests Tn-R 
crosslinks CSPGs via their G3 domain (Aspberg, 1995; Deepa et al., 2006; 
Galtrey et al., 2008; Suttkus et al., 2014; Morawski et al., 2014). What remains 
unclear is how these molecules self-organise and assemble into the proposed 
macromolecular structure (this is addressed in objective 2 in section 1.6). 
 
 
Figure 4. A schematic representation of the macromolecualr structure of PNNs. 
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1.5.3 Heterogeneity of PNN morphologies  
PNNs have been observed in many CNS regions, with a couple of studies that 
have focussed on analysing the distribution of PNNs throughout the CNS 
(Seeger et al., 1994; Bertolotto et al., 1996). Numerous sub-populations of 
neurons were observed to be ensheathed by PNNs, with both studies 
highlighting the differences in appearance of PNNs surrounding specific 
neuronal populations (Seeger et al., 1994; Bertolotto et al., 1996). A variety of 
PNN structures have been observed throughout the CNS (Arnst et al., 2016; 
Ueno et al., 2017b; Dzyubenko et al., 2018; Sigal et al., 2019). Specifically, 
two distinct PNN morphologies have been observed that have been 
suggested to be associated with different maturation states: a reticular PNN 
structure observed in the adult CNS; a punctate structure observed with 
greater frequency in the younger CNS, implying an immature PNN state 
(Figure 5) (Ueno et al., 2017a; Ueno et al., 2017b; Richter et al., 2018). If the 
hypothesis that the two morphological states being associated with different 
maturation states is correct, then it proposes a further question of what causes 
the phase transition from the punctate to the reticular state. This currently 
remains unknown (this is addressed in objective 2 in section 1.6).  
 
                             Punctate                   Reticular  
 
Figure 5. Images taken from a recent paper suggesting that 2 distinct 
morphological PNN states are present in the CNS.  
Punctate was defined as patchy stain surrounding neurons, while reticular is defined 
as the identifiable net-like structure. Images are taken from (Ueno et al., 2017a). 
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When comparing studies that have utilised histochemistry and imaging 
techniques to analyse PNNs, there appears to be morphologically distinct 
PNNs observed in different CNS regions (Brückner et al., 1996; Carulli et al., 
2006; Deepa et al., 2006; Gert Brückner et al., 2006; Carulli et al., 2007; 
Galtrey and Fawcett, 2007; Ueno et al., 2017b; Yamada and Jinno, 2017). 
Specifically, PNNs in the cortical and hippocampal regions look 
morphologically distinct to PNNs observed in the cerebellum and spinal cord 
(Figure 6). Cortical and hippocampal PNNs form around the soma and 
proximal dendrites of neurons and appear to produce a thinner surface layer. 
In comparison cerebellar and spinal cord PNNs form only around the soma 
and appear to have a thicker morphology. The difference in the size of soma 
implies that the neuronal sub-types that the PNNs are surrounding in these 
regions is likely to be different. What remains unknown is if the 
morphologically distinct PNNs are caused by changes to the biochemical 
composition of the surface (this is addressed in objective 1 in section 1.6). 
Furthermore, it remains unclear if the different morphologies are integral to 
PNN function.   
 
 
Figure 6. Representative confocal microscopy images of PNNs taken in the 
cortical and cerebellar regions of the CNS  
The marker Wisteria floribunda agglutinin (WFA) was used to stain PNNs using the 
protocol described by Souter and Kwok (2020). Cortical PNNs display observable 
staining on the soma and dendrites of neurons. Cerebellar PNNs only display 
observable staining around the soma. The net-like structure observed in cortical image 
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1.6 Objectives of this thesis 
Throughout the introduction numerous knowledge gaps have been highlighted 
that represent the objectives of this thesis. Section 1.4 defined the biochemical 
components often observed in PNNs, highlighting the numerous splice 
variants and enzymatically cleaved forms of each molecule. Section 1.5 then 
highlighted the heterogeneity of PNN biochemical components and identified 
that a systematic analysis that interrogated this heterogeneity has not yet 
been done. By defining the biochemical heterogeneity of PNN components in 
specific CNS regions may present an opportunity to modulate PNNs region 
specifically in the future. Therefore, this became the first objective of this 
thesis. 
Section 1.3 explained the importance of biomechanical signalling in the CNS 
and highlighted that to date an analysis of how PNNs change the 
biomechanical properties of the neurons they surround has not been done. 
Furthermore, section 1.5 defined different PNN phenotypes that have been 
observed throughout the CNS and presented a knowledge gap in the 
understanding of how the PNN components interact and self-organise into 
these supramolecular PNN structures. As PNNs play an important role in 
synaptic plasticity in the CNS, it is important to understand the mechanisms 
by which PNNs exert their function. Cells in the CNS have been observed to 
mechanosense and alter their behaviour depending on stiffness of surfaces, 
therefore the formation of PNNs and the resulting changes to the 
biomechanical properties of the surface may modulate cell behaviour. 
Understanding these mechanisms may offer new therapeutic avenues for 
targeting neurological diseases linked with PNNs. Therefore, objective 2 
aimed to investigate the interactions involved in establishing PNNs by 
establishing a methodology for measuring PNN formation using QCM-D that 
allowed for both biochemical and biomechanical measurements of the 
surfaces simultaneously.  
In section 1.4 the importance of GAGs, specifically HA and CS chains 
attached to CSPGS were explained. The importance of surface-bound HA in 
the establishment of PNNs is further discussed in section 1.5. Although 
current methodologies for sizing GAGs exist, that are discussed extensively 
in section 5.1, currently there is not a methodology for measuring the size of 
surface-bound GAGs. As there is a growing number of therapeutic products 
that are incorporating GAGs that requires stringent quality control of GAGs 
that includes the sizing of GAG chains, a methodology that can size GAGs 
efficiently and cheaply would be useful for both industrial and academic 
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applications. Therefore objective 3 aimed to establish a methodology for sizing 
surface-bound GAGs using QCM-D. A secondary aim was to also expand on 
current methodologies using polyacrylamide gel electrophoresis (PAGE) by 
increasing the range of size markers available.  
 Therefore, the explicit objectives of this thesis are:  
1. To conduct a systematic analysis of the molecular components of 
PNNs using Western blotting. 
a. Investigate the distribution of each component in distinct 
anatomical areas in the CNS. The specific regions included 
were the cortical, hippocampal, cerebellar and cervical spinal 
cord regions.  
b. Determine the heterogeneity and relative abundance of splice 
variants of the various PNN components.  
c. Determine if there is biochemical heterogeneity of PNN 
components present in distinct CNS regions.  
 
2. To investigate the molecular interactions and supramolecular self-
organisation underpinning PNN formation using QCM-D. 
a. Investigate the molecular interactions that underpin the 
supramolecular self-organisation and assembly of PNNs. 
b. Establish a methodology for investigating the assembly of PNNs 
and measuring the biomechanical properties of PNNs. 
 
3. To establish a methodology for measuring the length of GAGs.  
a. Expand on current methodologies for sizing GAGs using PAGE 
by defining the ratio of GAG migration rate with protein migration 
rate to expand the range of size markers available.  
b. Establish a methodology for measuring the size of surface-
bound GAGs using QCM-D. 
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Chapter 2: Methodology 
2.1 Western blotting  
2.1.1 Animals 
Adult, female Sprague-Dawley rats (260 – 290 g) from Charles River were 
used in this study. All animals were housed in standard housing conditions 
with a 12 hour light / dark cycle with food ad libitum. Where possible animals 
were housed in groups of 2 – 4 per cage. The work was performed under the 
regulations of the Animals Scientific Procedures Act 1986 and covered by the 
Home Office project license (number: 70/8085) and PIL for Luke Souter 
(number: IAF9AE2C3). 
 
2.1.2 Brain lysate preparation  
Three adult, female Sprague-Dawley rats were sacrificed using a CO2 
chamber and the cortex, hippocampus, cerebellum and cervical spinal cord 
(cSC) regions were dissected and isolated. Each of the rat dissections was 
done separately, creating 12 samples in total (n = 3 for each CNS region). 
Once dissected the tissue was immediately submerged in 1 mL cold 
cOmpleteTM Lysis-M, ethylenediaminetetraacetic acid (EDTA) - free buffer 
(Roche: 04719964001) within a homogeniser that was submerged in ice. 
Samples were homogenised on ice for 1 min then transferred to a 1.5 mL 
Eppendorf tube. They were then centrifuged at 13,000 rpm for 5 min at 4 °C. 
The supernatant was collected and a PierceTM bicinchoninic acid assay (BCA) 
assay (Thermo Scientific: 23225) was performed. The BCA results were 
analysed using a plate reader (FLUOstar Omega) to determine protein 
concentration. Each sample was then diluted to 5 mg/mL with phosphate 
buffered saline (PBS) pH 7.4, aliquoted and stored at -80 °C until required.  
 
2.1.3 Sodium dodecyl sulfate – polyacrylamide gel electrophoresis 
(SDS-PAGE ) 
One aliquot of each sample was thawed and 30 µg of total protein was mixed 
with loading buffer. The loading buffer consisted of 2.5% (v/v) 2-
mercaptoethanol and Laemmli buffer (69.45 mM Tris-HCl, pH 6.8, 11.1% [v/v] 
glycerol, 1.1% lithium dodecyl sulfate (LDS), 0.005% bromophenol blue). As 
all samples were previously diluted to the same concentration the ratio of 
sample to loading buffer was equal in each lane. All samples were then heated 
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at 90 °C for 5 min using a dri-blockTM (Techne). The denatured samples were 
loaded into a pre-cast 15 well, 1 mm thick, 4 – 15% Tris-glycine gel (Biorad: 
456-8086) and ran using Tris-glycine SDS (TGS) running buffer (Bio Rad: 
161-0772; 25 mM Tris, 192 mM glycine, 0.1% w/v SDS, pH 8.3). Initially, the 
samples were run for 15 minutes at 80 V to allow for efficient stacking to occur, 
then the voltage was increased to 100 V for 1 hour 45 min. The first 2 lanes 
of each gel contained protein ladders: lane one contained 10 µL Hi-markTM 
pre-stained high molecular weight (HMW) protein standard (Invitrogen), the 
second lane contained 10 µL of precision plus proteinTM all blue protein 
standards (Biorad). Two ladders were chosen instead of one due to the large 
range of sizes of molecules being analysed. Using the two ladders together 
allowed for a larger range of sizes to be analysed on the same gel. Triplicates 
of each sample were measured on different days for reproducibility of the 
results.  
 
2.1.4 Western blotting 
After protein separation using SDS-PAGE the samples were electro-
transferred onto a Polyvinylidene fluoride (PVDF) membrane (0.4 µL pore 
size) in transfer buffer (25 mM Tris-HCL, 192 mM glycine, 10% methanol) 
overnight (≤ 16 hours) at 50 V at 4 °C in Biorad transfer tanks. These transfer 
conditions required careful optimisation to ensure that efficient transfer of the 
HMW material occurred, without affecting the lower molecular weight 
molecules. By transferring in the cold room, it ensured the gel did not overheat 
throughout the long transfer time.  
All of the following wash steps were performed at room temperature. The 
membranes were briefly rinsed with Tris buffered saline with tween (TBS-T: 
20 mM Tris base, 130 mM NaCl2, 0.1% tween, pH 7.4), then blocked in 5 % 
(w/v) milk (Biorad) for 1 hour, before incubating with primary antibodies (Table 
1) for 2 hours in TBS-T containing 5% milk. The membranes were briefly 
rinsed 3 times with TBS-T then washed 3 times with TBS-T 10 min per wash. 
They were then incubated with secondary antibodies (Table 1) for 1 hour, then 
a further 3 brief rinses with TBS-T, followed by 2 times washes with TBS-T. 
Finally, 2 washes 5 min per wash in Tris buffered saline (TBS) were done 
before treating with PierceTM enhanced chemiluminescence (ECL) western 
blotting substrate (Thermo Scientific: 32106) then documented using a Fujifilm 
chemiluminescent imager.  
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The membranes were stripped with 0.1 M glycine pH 2.5 for 15 min at room 
temperature, then 45 min at 37 °C. The membranes were then briefly rinsed 
5 times with TBS-T before repeating the steps above probing for actin. 
 









Anti-Acan Rabbit 1 : 1,200 0.42 Abcam (ab1031) 
Anti-Bcan Sheep 1 : 1,200 0.83 R&D (AF009) 
Anti-Ncan Mouse 1 : 500 0.74 DSHBc (1F6) 
Anti-Vcan Mouse 1 : 500 0.34 DSHBc (12C5) 
Anti-Pcan Mouse 1 : 500 0.33 DSHBc (3F8) 
Anti-Hapln4 Mouse 1 : 1,200 0.83 R&D (AF4085) 
Anti-Hapln1 Goat 1 : 1,200 0.83 R&D (AF2608) 
Anti-Tn-R Goat 1 : 1,200 0.83 R&D (AF3865) 
HABPa - 1 : 1,200 0.20 Amsbio (HKD-BC41) 
Anti-actin Mouse 1 : 10,000 0.20 Abcam (ab6276) 
Secondary Antibodies 
Anti-mouse HRPb Horse 1 : 20,000 0.05 Vector labs (PI-2000) 
Anti-rabbit HRPb Goat 1 : 20,000 0.05 Vector labs (PI-1000) 
Anti-goat HRPb Horse 1 : 20,000 0.05 Vector labs (PI-9500) 
 
a) HA binding protein (HABP) 
b) Horseradish peroxidase (HRP) 
c) Developmental studies hybridoma bank (DSHB) 
 
 
2.1.5 Densitometry  
The results from each lane in each gel were normalised by dividing the 
intensity of the PNN-associated molecule by the intensity of actin. This creates 
a percentage that is used as the arbitrary unit (A.U.) measurement throughout 
this thesis. Densitometry was performed using FIJI ImageJ imaging software 
(NIH), drawing boxes around each of the bands in the lanes. A box was then 
drawn in the same lane where no bands were present. The mean intensity in 
the un-banded box, was then subtracted from the banded box to standardise 
for the gel background. The same process was then done for the actin results 
in the same lanes. By dividing the densitometry result for the molecules by the 
actin result taken from the same lane the data is normalised and accounted 
for any discrepancies in the amount of sample loaded into each lane.  
 
2.1.6 Statistics 
Each sample was run in triplicate, therefore the mean and standard deviation 
could be taken. A linear regression analysis was performed using a one-way 
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analysis of variance (ANOVA) to compare the different CNS regions for each 
PNN-associated molecule, followed by a post hoc Tukey test. Similarly, the 
same statistical setup was used to compare different size bands where 
multiple bands were present. Results were classed as statistically significant 
at p ≤ 0.05. As the affinities of each antibody to its target is different, it was 
not possible to statistically compare results where different antibodies were 
used.  
 
2.2 Quartz crystal microbalance with dissipation monitoring 
(QCM-D) 
QCM-D is an acoustic measuring technique that works in liquid and can be 
used to examine soft surfaces (Reviakine, Johannsmann and Richter, 2011). 
The benefit of the technique is it allows for changes in surface organisation at 
the interface to be analysed in real-time in vitro. The technique can measure 
the areal mass density and the mechanical properties of the surface bound 
layer. The areal mass density includes the adsorption of molecules as well as 
hydrodynamically coupled solvent.  The following section aims to describe 
how the measurements ascertained by QCM-D can be used quantitively to 
define the properties of the surface. To do this the detailed explanations 
provided by Reviakine, Johannsmann and Richter (2011) and Tellechea et al 
(2009) will be summarised below.  
 
2.2.1 Quantitative explanation of QCM-D 
QCM-D functions by oscillating a piezo-electric crystal at its resonance 
frequency 𝑓* defined as (Reviakine, Johannsmann and Richter, 2011): 
𝑓* = 𝑛𝑐/2𝑑  (1) 
Where 𝑛 is the overtone order (odd), 𝑐 is the speed of sound in quartz and 𝑑 
is the crystal thickness. By switching the external voltage on and off 
intermittently the piezoelectric produces a voltage during these decaying 
mechanical oscillations. Therefore, both the frequency, and the rate of decay 
are measured, yielding two parameters per overtone: the resonance 
frequency 𝑓* and the dissipation 𝐷* (Reviakine, Johannsmann and Richter, 
2011). As there is a linear relationship between resonance frequency and 
changes in the resonator mass it is possible to use QCM-D as a microbalance 
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(Sauerbrey, 1959). The relationship can be defined as (Reviakine, 







Where 𝑚2345 is the areal mass density of the film, 𝜌2345 is the density of the 
adsorbed film, ℎ2345 is the thickness of the adsorbed film and C is the mass 
sensitivity constant (dependent solely on the material properties of the quartz 
crystal and the fundamental resonance frequency 𝑓8). The relationship 
between the resonance frequency / bandwidth, the liquid’s viscosity and 
liquid’s density can be used to measure the viscosity of the material surface 
as it can be defined by (Reviakine, Johannsmann and Richter, 2011): 
∆𝑓* = −∆Γ* = −
𝑓*







Where Γ* is the quantity gamma, 𝜌<=> is the liquids density, 𝜂<=> is the liquids 
viscosity and  𝜔8 is the angular fundamental resonance frequency. 𝜔8 can be 
defined in terms of 𝑓8 by (Reviakine, Johannsmann and Richter, 2011): 
𝜔8 = 2𝜋𝑓8 (4) 
Equation 3 describes a decrease in frequency and increase in dissipation as 
both being proportional to the square root of the product of liquid viscosity and 
liquid density (Reviakine, Johannsmann and Richter, 2011). The 
measurements are sensitive to the bulk liquid, hence it is imperative to make 
additional measurements in the liquid alone in order to define the contribution 
of the material surface. 𝐷* is the inverse of the quality factor (Q factor) which 
is a dimensionless parameter that describes the damping of the oscillation at 
resonance. This is achieved by relating the amount of energy stored to the 
amount of energy lost. Therefore, 𝐷* is defined as the energy dissipated per 
oscillation, divided by the total energy stored in the system.  
Equations 1 – 4 above introduce how ∆𝑓 and ∆𝐷 are related to the areal mass 
density and the material properties of the surface, specifically viscosity. It is 
therefore possible to derive the density of material being deposited on the 
surface, the surface thickness and the biomechanical properties of the film 
under certain conditions. One of the key assumptions when quantitatively 
analysing QCM-D data is that the surface is laterally homogeneous, meaning 
there is an even spread of each molecule across the material surface.  
Depending on the properties of the film being formed on the sensor surface 
varying methodologies for analysing the data quantitatively can be used. An 
important distinction is defining the difference between a soft and a sufficiently 
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rigid film by using the statements (Reviakine, Johannsmann and Richter, 
2011): 
∆Γ* ≪ −𝑓* (5) 
Or  
∆𝐷*/(−∆𝑓* 𝑛⁄ ) ≪ 4 × 10IJHzIM   (6) 
Where 4 × 10IJHzIM is the value for the resonance frequency of a 5 MHz 
crystal (derived from Equation 1), used for the experiments throughout this 
thesis. All HA films formed throughout this thesis were classified as soft films 
(Equation 6; see appendix 1). These equations derive from the physics of the 
sensing methodology. The oscillation of a rigid film couples fully to the 
oscillation of the sensor, and therefore its dissipation would be expected to be 
zero. Soft films will produce a finite dissipation as they will not couple. A 
surface is required to be sufficiently rigid for the Sauerbrey equation to be 
used to ascertain the areal mass density of the surface. As the surface-bound 
films produced throughout this thesis are soft, the Sauerbrey equation could 
not be used. However, as all surfaces produced throughout this thesis had a 
measure of ∆𝐷 > 0, the surfaces are thick and soft enough for the viscoelastic 
properties of the film to be measured (Reviakine, Johannsmann and Richter, 
2011). The viscoelastic properties are represented by (Reviakine, 
Johannsmann and Richter, 2011): 
G = GP + iG′′ (7) 
Where G is the complex shear modulus, GP is the storage modulus (otherwise 
known as the spring constant), i is the imaginary unit (the square root of −1) 
and G′′ is the loss modulus. The loss modulus can be described as (Reviakine, 
Johannsmann and Richter, 2011): 
GPP = ωη (8) 
Where ω = 2π𝑓 is the angular frequency of deformation. In Equation 8 
viscosity η relates the applied force to the rate of deformation, therefore can 
be thought of as a friction coefficient (Reviakine, Johannsmann and Richter, 
2011). In order to be measured the thickness of the films being produced on 
the sensor surface have to be thinner than the wavelength of the shear-
acoustic wave propagating throughout the surface. Therefore, there is a 
maximum thickness for which QCM-D measurements can be accurately 
measured. To determine this maximum penetration depth of the shear wave 
in liquid 𝛿 can be determined by (Reviakine, Johannsmann and Richter, 
2011): 
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𝛿 = X2𝜂<=>	 X2𝜋𝑛𝑓8𝜌<=>Y⁄ Y
Z.\ (9) 
For water at 5 MHz (𝑛 = 1), 𝛿~ 250nm, therefore any surfaces larger than this 
size would require different methodologies for assessing their material 
properties. For surfaces thinner than this maximum thickness the relationship 
between frequency, bandwidth, areal mass density of the film and its 
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Where 𝑚2345 can be described by (Reviakine, Johannsmann and Richter, 
2011): 
𝑚2345 = 𝜌2345ℎb=<c (12) 
The frequency dependent compliance of the film J can be described by 
(Reviakine, Johannsmann and Richter, 2011): 
J = JP − 𝑖JPP = GIM (13) 
Where JP is the elastic and JPP is viscous component of compliance, 
respectively. The value of 𝜌2345 in soft matter can be roughly approximated to 
be 1 g/cm3 for biopolymer films solvated by water (Reviakine, Johannsmann 
and Richter, 2011). Equations 10 and 11 can be re-written when (𝑛 = 1), 𝛿~ 
250nm as the dispersion in ∆𝑓*/𝑛 will be small, therefore it is possible to 






𝑛𝜔8𝜂<=>J2345P  (14) 
To summarise the section above, it is possible to use ∆𝑓 and ∆𝐷 to measure 
the material properties of the film by comparing the relationship between them 
to determine the elastic compliance. For simplicity, throughout the thesis 
Equation 14 has been re-written as ∆𝐷/−∆𝑓. The benefit of Equation 14 is it 
is a very simple relationship that can be readily extracted from QCM-D data 
to provide a simple, relative measure of film softness. This is in contrast to 
other, potentially more accurate analytical methods which require some form 
of nonlinear regression analysis, referred to as viscoelastic modelling. More 
compliant, soft films will have a higher ∆𝐷/−∆𝑓, while a less compliant, rigid 
film with have a low ∆𝐷/−∆𝑓. 
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The areal mass density measured by ∆𝑓 includes both the mass of the 
molecule adsorbing onto the surface, as well as the mass of the solvent. 
Therefore, in order to define the density of molecules adsorbing onto the 
surface the contribution to mass by the solvent needs to be defined. This can 
be done by using an additional optical technique for measuring the mass of 
the molecules adsorbing onto the surface, such as spectroscopic ellipsometry. 
This has previously been done for the HA molecule HA50, therefore the 
density of HA50 on the surface can be defined. However, it has not yet been 
done for Acan or Hapln1 therefore it is not possible to measure the density of 
these molecules using this technique, but instead the results compare the 
relative changes in ∆𝑓 to define the relative abundance of each molecule.  
Although it is possible to fit the data to viscoelastic model, due to the large 
number of parameters required it is difficult to gain meaningful data without 
the requirement of further measurements being made with different measuring 
techniques to ascertain the film properties required.  
 
2.2.2 Measurements using QCM-D 
All measurements were performed in situ under continuous sample flow with 
sub-second time resolution at room temperature (23 °C) with a Q-Sense E4 
system with 4 independent standard flow modules (Biolin Scientific AB). Flow 
speeds of 10 to 20 µL/min were kept constant using a syringe pump (World 
precision instruments) with 20 mL syringes (Terumo).  
Measurements of shifts in frequency (∆𝑓) and shifts in dissipation (∆𝐷) were 
taken at the fundamental frequency (n = 1), and six overtones (n = 3, 5, 7, 9, 
11 and 13), which correspond to resonance frequencies (fn ≈ 15, 25, 35, 45, 
55 and 65 respectively). For chapter 4 the 5th overtone (n = 5) was used to 
present ∆𝑓 and ∆𝐷. Any other overtone would have provided comparable 
results. For chapter 5 the 3rd overtone was used, to facilitate comparison with 
previously published data which were collected by collaborators using the 3rd 
overtone.  
Running buffer (10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES), 150 mM NaCl2, 5 mM CaCl2, pH 7.4) was used in all experiments 
unless specified otherwise and used within 2 weeks. Before use the running 
buffer was filtered using 0.22 µm Polyethersulfone (PES) membrane syringe 
filters (Merck: SLGPO33RS) and de-gassed. All of the molecules used 
throughout the QCM-D measurements are provided in Table 2. 
 
  - 34 -  
Table 2. Molecules used in QCM-D experiments 




Lipids   
DOPCa - Avanti (850375P) 
DOPE-cap-biotinb - Avanti (870273P) 
DODA-tris-NTAc - - 
Protein   
Streptavidin 55 Sigma (S4762) 
Hapln1 45 R&D (2608-HP) 
Tenascin-R 147 R&D (3865-TR) 
Proteoglycan   
Acan (bovine articular cartilage) ~ 2,500 Sigma (A1960) 
Acan (pig laryngeal) ~ 2,500 - 
Biotinylated HA   
HA_dp15 3.2 - 
HA50 58 ± 3 Hyalose (HYA-B50-200) 
HA250 280 ± 14 Hyalose (HYA-B250-200) 
HA500 530 ± 27 Hyalose (HYA- B500-200) 
HA1000 837 ± 42 Hyalose (HYA-B1000-200) 
 
a) 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC). 
b) 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(cap biotinyl) (DOPE-cap-
biotin). 
c) Dioctadecyldimethylammonium-tris-nitrilotriacetic acid 
 
2.2.3 Preparation of liposomes 
Liposomes were prepared using the protocol established by Richter and 
Brisson (2003). Briefly, lipids were dissolved in chloroform, then mixed in 
desired amounts to achieve the ratio of lipids required (see appendix 2). A 
stream of nitrogen gas was used to dry the lipids in order to form a thin film 
that is beneficial for maximising the extraction of organic solvent. Further 
drying was achieved using a vacuum desiccator for 2 hours. The lipids were 
then re-suspended to a concentration of 2 mg/mL by vortexing with HEPES 
buffer. Small unilaminar vesicles were achieved through 5 freeze-thaw cycles 
using a combination of liquid nitrogen and warm water, followed by sonication 
using a tip-sonicator (Fisher Scientific) operated in pulse mode at 30% duty 
cycle for 30 min at 4 °C. To remove any metal debris from sonication, the lipid 
samples were centrifuged at 4 °C for 15 min (16,000 g), then transferred to a 
fresh 1.5 mL tube and stored at 4 °C for up to 6 months.  
 
2.2.4 Passivation of tubes and chamber preparation 
The chamber walls and tubing were first passivated using 600 µL of 10 mg/mL 
bovine serum albumin (BSA) (Sigma: A1933) per flow chamber at 50 µL/min 
flow speed. At an increased flow rate of 100 µL/min for 20 minutes, 2 mL of 
ultrapure water (resistance 18.2 MW • cm at 25 ºC; Barnstead Nanopure 
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Diamond, Thermo Scientific) was flowed through each chamber to remove 
any excess BSA. After the passivation step the chambers were dried by 
flowing air through the chambers at 200 µL/min for 5 minutes, then each 
chamber was dried further manually with nitrogen gas before placing the 
experimental sensor into the chamber.  
Silicon sensors (Biolin Scientific: QSX303) were used for all QCM-D 
measurements. Before use the sensors were cleaned by briefly rinsing them 
with ultrapure water, 100% ethanol, ultrapure water then drying with nitrogen 
gas. The sensors were placed in a UV/ozone chamber ProCleanerTM plus 
chamber (Bioforce nanosciences) for at least 30 minutes then immediately 
placed into the QCM-D chambers.  
 
2.2.5 Lipid bilayer and streptavidin monolayer formation 
Both the liposomes, followed by streptavidin were injected in HEPES buffer at 
a flow speed of 20 𝜇L/min. Liposomes were injected for 15 min, followed by a 
wash step that involved injecting HEPES for 10 min at 20 𝜇L/min. Then 
streptavidin was injected for 15 min followed by a further 10 min wash step 
with HEPES.  
 
2.2.6 Washing protocol 
The wash protocol was done after each experiment on the QCM-D sensors, 
tubes and chamber, allowing the same sensors and equipment to be re-used. 
The flow rate was increased to 200 µL/min, then ultrapure water was injected 
for 5 minutes, followed by 2% SDS for 10 minutes, then 5 minutes ultrapure 
water and 10 minutes 100% ethanol. A final 5 min ultrapure water injection 
was performed before clearing the tubes and chamber for 5 minutes with air. 
The sensors and chambers were then dried with nitrogen gas before storing 
at room temperature for reuse.  
 
2.2.7 Data acquisition and analysis 
All QCM-D results were collected using QSoft (Biolin) and were analysed 
using a combination of QTools (Biolin) and Origin. Using QTools values of ∆𝑓 
and ∆𝐷 could be recorded, while Origin was used to create the graphs, 
including the ∆𝐷 −∆𝑓	⁄ plots. All experiments were run in at least duplicate. The 
average result, plus or minus the standard deviation are recorded throughout 
this thesis when discussing ∆𝑓 and ∆𝐷.  
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Chapter 3: A systematic analysis of the molecular 
components of PNNs using Western blotting 
3.1 Introduction 
To establish the interplay between the biochemical and biomechanical 
properties of PNNs ultrastructure, it is essential to first characterise the 
biochemical components of mature PNNs. The structure of PNNs are known 
to include a variety of molecular components that have the potential to 
establish highly heterogeneous biochemical compositions (Carulli et al., 2006; 
Galtrey et al., 2008; Foscarin et al., 2017; Irvine and Kwok, 2018). However, 
the information remains scattered. A systemic characterisation and 
understanding of their heterogeneity will provide an important foundation for 
determining the surface properties of PNN neurones.  
The essential components of PNNs have been described in detail in chapter 
1 and will be briefly summarised here. HA, CSPGs, and Haplns have been 
observed to be essential to the formation of PNNs (Deepa et al., 2006; Carulli 
et al., 2010; Kwok et al., 2010). Considering there are three isoforms of HAS 
(HAS1, 2 and 3), five common CSPGs (Acan, Vcan, Bcan, Ncan and Pcan) 
and three Haplns (Hapln1/Crtl1, Hapln2/Bral1 and Hapln4/Bral2) that have 
been associated with PNNs the molecular diversity of the molecules alone 
could potentially establish a variety of distinct PNN structures (Miyata et al., 
2005; Carulli et al., 2006; Deepa et al., 2006; Carulli et al., 2007; Galtrey et 
al., 2008; Zimmermann and Dours-Zimmermann, 2008; Kwok et al., 2011; 
Wang and Fawcett, 2012; Giamanco and Matthews, 2012). Tn-R has been 
established as an essential PNN molecule that has a proposed cross-linking 
role through the binding of CSPG G3 domains (Aspberg, 1995; Deepa et al., 
2006; Galtrey et al., 2008; Suttkus et al., 2014; Morawski et al., 2014). 
Furthermore, other molecules are also known to interact with the PNN surface, 
including Otx2 and Sema3a (Beurdeley et al., 2012; Dick et al., 2013; Carulli 
et al., 2013; de Winter et al., 2016; Djerbal et al., 2019). Recently, Sema3a 
has been observed to cross-link GAG surfaces, therefore has also been 
implicated in the cross-linking of the PNN surface (Djerbal et al., 2019).  
Many of the PNN-associated molecules show yet more molecular diversity. 
Each CSPG molecule in particular can be highly heterogenous in structure, 
due to alternative splicing of the core protein. This could occur during the 
synthesis of the molecule, or as a product of enzymatic cleavage by MMPs 
(Yamaguchi, 2000; Kiani et al., 2002; M Morawski et al., 2012). Additional 
heterogeneity of each CSPG can then be produced through the degree of 
  - 37 -  
glycosylation of CS chains associated with the core protein. Although beyond 
the scope of this chapter, it is worth noting that further heterogeneity can be 
produced through differing the sulfation pattern of GAG chains, as these have 
been observed to be differentially regulated within PNNs as a function of age 
(Kitagawa et al., 1997; Foscarin et al., 2017). Therefore, a variety of molecular 
structures for each individual CSPG is possible yet has not been 
systematically analysed in the CNS.  
Two multimeric variants of Tn-R have been observed in the CNS at different 
molecular weights (Woodworth et al., 2002; Morawski et al., 2014). The 
mechanism of Tn-R cross-linking of CSPG molecules has been proposed 
through the clustering of Tn-R molecules into dimeric and trimeric structures, 
therefore the degree of Tn-R clustering offers further potential heterogeneity 
(Yamaguchi, 2000). Each HAS molecule synthesises different lengths of HA, 
therefore further heterogeneity of PNN structure could be regulated through 
the size of the HA chains (Itano et al., 1999). Thus, one would predict that a 
variety of PNN morphologies would be observed through the production of 
PNNs using different combinations of the PNN-associated molecules.  
Numerous PNN structures have been observed using a combination of 
histochemical and imaging techniques (Arnst et al., 2016; Ueno et al., 2017b; 
Dzyubenko et al., 2018; Sigal et al., 2019). Specifically, two distinct 
morphological surface states have been observed that have been attributed 
to different maturation states: a punctate structure observed with greater 
frequency in the younger CNS, suggesting an immature PNN state; a reticular 
PNN structure observed in the adult CNS resembling the more commonly 
reported structure (Ueno et al., 2017b; Richter et al., 2018). It is unknown what 
changes occur to PNNs to cause the phase transition from the granular to the 
reticular state.   
The key proposal of this chapter is that some of the structural heterogeneity 
of PNNs is at least partially caused by biochemically distinct compositions of 
PNN-associated molecules. Heterogeneity in biochemical composition has 
been previously observed (McRae et al., 2007; Irvine and Kwok, 2018; Ueno 
et al., 2018; Miyata et al., 2018). Differences in the distribution of  PNN-
associated molecular components has also been observed throughout the 
CNS, however this has so far not been correlated specifically with changes to 
the structure of PNNs (Carulli et al., 2006; Galtrey et al., 2008; Bekku et al., 
2012). An established PNN marker is the lectin Wisteria floribunda agglutinin 
(WFA) that preferentially interacts with the GalNAc sugar moiety, a key 
component in CS chains (Kurokawa et al., 1976; Härtig et al., 1992; Seeger 
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et al., 1994). Recently, many independent observations have been made that 
WFA-negative PNNs exist, implying that there are biochemically distinct 
populations of  PNNs (McRae et al., 2007; Ueno et al., 2017b; Yamada and 
Jinno, 2017; Irvine and Kwok, 2018; Ueno et al., 2018; Miyata et al., 2018). 
The previous research referenced above has focussed on the use of 
histochemical and imaging techniques to analyse the biochemical 
composition of PNNs. Although useful for understanding the molecular 
distribution of PNN-associated molecules, a key limitation of the technique is 
its inability to distinguish between splice variants, molecular clusters, or 
differentially glycosylated molecules of the same species. Therefore, PNNs 
could have the same imaging profile yet have structurally distinct 
compositions. The aim of this chapter was to use Western blotting to profile 
these potential differences. As Western blotting differentiates molecules by 
molecular weight, splice variants and clustered molecules would migrate 
through the gel at different migration rates, so would therefore be 
distinguishable via this method. Furthermore, the degree of glycosylation 
would also be distinguishable, as the addition of GAG chains would also affect 
the migration rate of the molecules. To date, limited evidence using Western 
blotting has compared the relative abundance of each PNN-associated 
molecule within CNS regions. Deepa et al (2006) have previously isolated and 
analysed PNN-specific material from whole brain samples using Western 
blotting, however a regional analysis was not conducted.  
Four CNS regions were compared in this chapter to reflect the morphologically 
distinct PNN structures found throughout the CNS. As well as granular and 
reticular morphologies that have been observed to reflect PNN maturity, other 
morphologically distinct populations have been observed. Specifically, PNNs 
in the cortex, hippocampus, cerebellum and spinal cord have been particularly 
well characterised using histochemistry and fluorescent microscopy 
techniques (Brückner et al., 1996; Carulli et al., 2006; Deepa et al., 2006; Gert 
Brückner et al., 2006; Carulli et al., 2007; Galtrey and Fawcett, 2007; Ueno et 
al., 2017b; Yamada and Jinno, 2017). When comparing images of PNNs 
analysed in the spinal cord and cerebellum they have distinct morphological 
features in contrast to images analysed in the cortex and hippocampus, as 
discussed in section 1.5.3. Cerebellar and spinal cord PNNs only form around 
the soma of neurons and appear to form a thicker surface layer, in comparison 
to cortical and hippocampal PNNs that form around the soma and proximal 
dendrites and appear to have a thinner morphology. It has not yet been 
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established what biochemical differences in PNNs in these regions may cause 
these distinct morphological phenotypes.  
Differences in the distribution of  PNN-associated molecular components have 
been observed independently via researchers focussing specifically on one of 
the molecular component or one distinct CNS region (Carulli et al., 2006; 
Galtrey et al., 2008; Bekku et al., 2012). It is difficult however to directly 
compare this research through the composition of a meta-analysis due to 
variations in the rodent models and the age of the animals used. Currently no 
systematic analysis investigating the distribution of the PNN-associated 
molecules throughout the CNS, alongside the distribution of their potential 
splice variants has been performed. The aim of this chapter was to conduct 
this analysis to highlight insights into the potential molecular heterogeneity 
that may be present in PNNs in different CNS regions that may partially reflect 
the different morphological phenotypes.  
3.2 Methodology 
3.2.1 SDS-PAGE and Western blotting 
A comprehensive description of the methodologies for the brain lysate 
preparation, SDS-PAGE and Western blotting can be found in section 2.1. 
Section 2.1 also contains a list of antibodies used.  
 
3.2.2 Acan samples 
Bovine articular cartilage Acan (Sigma: A1960) was dissolved in PBS buffer 
to 1 mg/mL. Acan isolated from pig laryngeal cartilage in general lacks a G3 
domain and was kindly provided by John Sheehan (University of North 
Carolina, USA). Both bovine articular cartilage and pig laryngeal cartilage 
were used as a comparison to aid the characterisation of CNS Acan isolated 
from CNS tissue lysate.  
 
3.2.3 ChABC incubation  
 60 µg of protein from cervical spinal cord (cSC) samples, and 10 µg of bovine 
articular cartilage ACAN and glycosylated Acan without a G3 domain were 
incubated O/N at 37°C with 1 U/mL ChABC in TBS (20 mM Tris base, 130 
mM NaCl2, pH 8.0) that also contained 0.05 M sodium acetate to activate the 
enzyme ChABC. The next day 10 µg sample per lane was then loaded into a 
4-15% tris-glycine gel. 
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3.3 Results 
Specifically, the PNN-associated molecules that were targeted in this analysis 
included, HA, Hapln1 and Hapln4, as they have previously been observed to 
be crucial in PNN formation (Deepa et al., 2006; Carulli et al., 2007; 
Zimmermann and Dours-Zimmermann, 2008; Carulli et al., 2010; Kwok et al., 
2010; Kwok et al., 2011; Wang and Fawcett, 2012; Giamanco and Matthews, 
2012). Hapln2 was not included because an effective antibody to detect the 
molecule in Western blots is currently lacking. Hapln3 was not analysed as it 
is not expressed in the CNS (Ogawa et al., 2004). The lecticans (Acan, Bcan, 
Ncan, Vcan) and the CSPG Pcan were also targeted as they are known to be 
prominent binding partners of HA and have been observed to contribute to the 
PNN structure (Ruoslahti, 1996; Yamaguchi, 2000; Bandtlow and 
Zimmermann, 2000; Rauch et al., 2004; Carulli et al., 2006; Deepa et al., 
2006; Galtrey et al., 2008; Zimmermann and Dours-Zimmermann, 2008; Kwok 
et al., 2011; Wang and Fawcett, 2012; Giamanco and Matthews, 2012). Tn-R 
was targeted as it has been previously characterised as associating with 
PNNs and has been implicated in a cross-linking role in the stabilisation and 
formation of PNNs (Aspberg, 1995; Lundell et al., 2004; Morawski et al., 
2014).  
 
3.3.1 Acan: multiple distinct molecular species of Acan are present in 
the CNS 
Acan is the most prominent and well characterised member of the lecticans, 
co-localising widely with the PNN binding lectin WFA to such a degree that 
Acan has been suggested as being a marker for PNNs in the ventral spinal 
cord (Ueno et al., 2017b; Irvine and Kwok, 2018). The size of Acan can be 
affected by the enzymatic cleavage by MMPs, as well as by the number of 
GAG chains attached to the core protein (Kiani et al., 2002; M Morawski et al., 
2012). The aim was to determine the relative abundance of these Acan 
species in the CNS regions of the cortex, hippocampus cerebellum and cSC.  
When comparing the total amount of Acan in each region, there was 
significantly higher levels of Acan present in the cSC in comparison with the 
cortical and cerebellar regions (p ≤ 0.005 and p ≤ 0.05 respectively), with it 
trending towards significance in the hippocampus (p = 0.091; Figure 7). 
Between the cortical, cerebellar and hippocampal regions there were no 
significant differences observed. However, the relative abundance of the 
spliced variants of Acan were unique in each CNS regions, as multiple bands 
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of different molecular weights were present in each lane. Therefore, three 
specific molecular weight ranges were defined to analyse the distribution of 
Acan species further. Acan species ³ 250 kDa reflected relatively full-length 
Acan with varying degrees of glycosylation, as the molecular weight of Acan 
core protein is ~ 250 kDa (Kiani et al., 2002). The differing degree of 
glycosylation of the Acan core protein is responsible for the smearing effect 
observed at this size range, which will be discussed in section 3.3.1.1. 
Furthermore, section 3.3.1.1 will address the possibility that there is an Acan 
fraction that is too large to enter the gel. Acan species between 100 – 250 kDa 
reflected both the less glycosylated and enzymatically cleaved forms of the 
core protein as bands were present in this size region as opposed to a smear. 
An Acan species at ~ 45 kDa suggested an unglycosylated, highly truncated 
core protein of Acan.  Previously, Mort et al (2016) observed Acan species 





Figure 7. The total amount of Acan was higher in the cSC, in comparison with 
the brain regions.  
Densitometry results alongside a representative Western blot image for Acan in each 
CNS region. Actin was used as a control for the amount of protein loaded and used to 
standardise the densitometry results. The lines within the graph represent the mean 
and standard deviation (n = 3). Each sample was ran in triplicate. The lines above the 
graph represent statistical significance: p ≤ 0.05 (*), p ≤ 0.005 (**). 
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There were significantly higher levels of Acan species ³ 250 kDa in the cSC 
in comparison with the other 3 regions (Figure 8A). This implies that less post-
translational modification of Acan species occurs in the cSC in comparison to 
the brain regions. This is further supported when comparing Acan species 
between 100 – 250 kDa, as although not statistically significant there was a 
trend suggesting less Acan species were present at this size range in 
comparison with the cortical, hippocampal and cerebellar regions (Figure 8B). 
For the Acan species at ~ 45 kDa there were no significant differences found 
between any of the CNS regions, however this may reflect the comparatively 
small amounts of these Acan species present in the tissue lysate in contrast 
to the other size ranges. Although not significant, there was a trend suggesting 
a larger amount of Acan species at ~ 45 kDa were present in the cortical and 
hippocampal regions in comparison with the cerebellar and cSC regions 
(Figure 8C).  
 
 
To further analyse the Acan distribution, Acan species within each specific 
CNS region were also compared. This was achieved by comparing the values 
presented in Figure 8A, B and C for each specific CNS region, which is why 
the 3 plots are presented on the same scale.  
 
 
Figure 8. Densitometry comparison of the different Acan species in each CNS 
region demonstrated the heterogeneity in the distribution of Acan species 
between the different CNS regions.  
Densitometry results alongside a representative Western blot image for Acan in each 
CNS region. All graphs are presented using the same scale to aid comparisons 
between the different Acan species. A Acan ≥ 250 kDa comparison. B Acan 100 – 250 
kDa comparison. C ~ 45 kDa Acan comparison. For all results Actin was used as a 
control for amount of protein loaded and used to standardise the densitometry results. 
The lines within the graph represent the mean and standard deviation (n = 3).  Each 
sample was ran in triplicate. The lines above the graph represent statistical 
significance: p ≤ 0.005 (**), p ≤ 0.0005 (***). 
A B C
ActinActin
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Within the cortical region there was significantly more Acan species between 
100 – 250 kDa in comparison to Acan species at ~ 45 kDa and  ³ 250 kDa (p 
≤ 0.05 and p ≤ 0.05 respectively). There was no trend observed between Acan 
species at ~ 45 kDa and ³ 250 kDa. Therefore, the less glycosylated, 
enzymatically cleaved Acan species was most abundant in the cortical region.  
A similar distribution was observed in Acan species in the cerebellum, a less 
glycosylated, enzymatically cleaved Acan species was also found to be the 
most abundant.  There was significantly more Acan species between 100 – 
250 kDa compared with Acan species at ~ 45 kDa (p ≤ 0.05). Although not 
significant, there was trend towards more Acan species being present in 
comparison to Acan species ³ 250 kDa (p = 0.093), yet there was no trend 
observed between Acan species at ~ 45 kDa and ³ 250 kDa. 
Within the hippocampus, there were significantly less Acan species at ~ 45 
kDa Acan in comparison with Acan species between 100 – 250 kDa (p ≤ 0.05). 
There was also a trend, though not significant of less Acan species at ~ 45 
kDa in comparison with Acan species ³ 250 kDa (p = 0.099). There was no 
statistical difference found between Acan species between 100 – 250 kDa and 
Acan species ³ 250 kDa (p = 0.775). Therefore, in the hippocampal region 
there was relatively similar levels of Acan species that were full length to 
species that were enzymatically cleaved, though fewer highly truncated Acan 
species were observed.  
Within the cSC there was significantly more Acan species ³ 250 kDa in 
comparison to Acan species between ~ 45 kDa and 100 – 250 kDa (p ≤ 0.005 
and p ≤ 0.005 respectively). No trend was observed between Acan species 
between ~ 45 kDa and 100 – 250 kDa. Therefore, in the cSC region full-length, 
glycosylated Acan species were the most abundant.  
 
3.3.1.1 Acan in the CNS is less glycosylated than Acan found in cartilage 
As Acan species in the cSC were observed to be the most glycosylated, Acan 
species in this region were further investigated to observe the degree of 
glycosylation observed when compared with Acan outside the CNS. Bovine 
articular cartilage and Acan from pig larynx were used for comparison. They 
were selected as Acan species in cartilage are known to be highly 
glycosylated and pig laryngeal Acan is highly glycosylated though in general 
lacks a G3 domain (Kiani et al., 2002). To determine the degree of 
glycosylation a less glycosylated control was prepared for each sample by 
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incubating the samples with ChABC to enzymatically cleave the CS 
sidechains (Figure 9). 
Acan species were not observed in the untreated samples of bovine articular 
cartilage and the pig larynx, while a smear of 200 – 500 kDa was observed in 
cSC sample. After ChABC treatment, a smear of 250 – 500 kDa was observed 
in the bovine articular cartilage sample and a smear of 200 – 500 kDa was 
observed in the pig laryngeal sample, suggesting that the native untreated 
samples were too large to migrate into the 4-12% polyacrylamide gel. The 
smearing also indicated that only a partial digestion of the CS sidechains was 
achieved for these samples. This suggested that untreated Acan species 
found in bovine articular cartilage and the pig laryngeal Acan were too large 
to migrate into the 4-12% polyacrylamide gel and this was caused by the 
degree of glycosylation of the core protein. In contrast the majority of 
untreated cSC Acan species was able to penetrate into the gel, suggesting 
that the Acan species are comparatively less glycosylated in the cSC. When 
the cSC Acan species were treated with ChABC the smear migrated further 
down the gel to ~200 kDa, implying that the core proteins were partially 
glycosylated. Similar to bovine articular cartilage and pig laryngeal Acan, an 
overnight ChABC treatment did not seem to be sufficient in digesting all CS 
chains and therefore did not reduce the samples to single neat bands.  
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Figure 9. Comparison of Acan species.  
Acan from cSC tissue lysate (rat SD2) was compared with bovine articular cartilage 
and pig laryngeal Acan that was either ChABC (+) or untreated (-).  
 
3.3.2 Pcan: glycosylated Pcan was most prevalent in the cerebellar 
region  
Pcan has been observed in PNNs and is able to interact with Tn-R in a 
calcium-dependent manner (Xiao et al., 1997; Carulli et al., 2006; Deepa et 
al., 2006; Galtrey et al., 2008). The core protein can be alternatively spliced, 
therefore core proteins of multiple molecular weights can be produced. The 
aim was to characterise the relative abundance of these Pcan species in the 
four CNS regions.  
Pcan is significantly more prevalent in the cerebellum in comparison with the 
cSC (p ≤ 0.0005), cortex (p ≤ 0.0005) and hippocampus (p ≤0.05; Figure 10). 
There was also significantly more Pcan present in the hippocampus in 
comparison with the cSC (p ≤0.005). Comparatively, there was less Pcan 
present in the cSC in contrast to the other CNS regions. In all regions 
smearing was present above 460 kDa, which is larger than the size of the 
unglycosylated ~ 173 kDa core protein (Maurel et al., 1994). The smearing is 
therefore likely to be a consequence of the variation in the degree of 
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glycosylation of the Pcan species. It is worth noting the absence of Pcan at 
lower molecular weights, suggesting no enzymatic cleavage has occurred to 




Figure 10. Comparison of Pcan abundance between CNS regions.  
Densitometry results alongside a representative Western blot image for Pcan in each 
CNS region. Actin was used as a control for the amount of protein loaded and used to 
standardise the densitometry results. The lines within the graph represent the mean 
and standard deviation (n = 3). Each sample was ran in triplicate. The lines above the 
graph represent statistical significance: p ≤ 0.05 (*), p ≤ 0.005 (**), p ≤ 0.0005 (***). 
 
3.3.3 Bcan: species of Bcan are differentially distributed throughout the 
CNS 
Bcan is a nervous-system specific lectican that is known to co-localise with 
PNNs in the CNS (Yamaguchi, 2000; Carulli et al., 2006; Deepa et al., 2006; 
Galtrey et al., 2008). It has the shortest core protein central domain of the 
lecticans measuring ~ 145 kDa, therefore is also proposed to have the least 
CS chains attached to it, with a significant portion of Bcan existing without any 
CS chains (Yamada et al., 1994; Yamaguchi, 1996; Yamaguchi, 2000). Bcan 
is known to be alternatively spliced, as there is a GPI – anchored form of Bcan 
  - 47 -  
that is the only known example of a  membrane-bound lectican (Seidenbecher 
et al., 1995). The aim was to characterise the relative abundance of these 
Bcan species in the four CNS regions.  
Although there were no statistical differences in Bcan amounts between any 
of the CNS regions there were differences in the Bcan species observed 
(Figure 11). In the cortex and hippocampus there was a trend of increased 
Bcan species between 145 kDa and 460 kDa in comparison with the 
cerebellum and cSC (Figure 12A). Smearing was not observed in the 
cerebellum and cSC, with only a band observed at ~145 kDa that corresponds 
with the molecular weight of the unglycosylated full-length Bcan (Yamada et 
al., 1994). In contrast smearing was observed in the cortical and hippocampal 
regions, suggesting Bcan in these regions were more glycosylated. In the cSC 
there was a trend observed of an increased level of a ~ 50 kDa Bcan species 
that was present in lower amounts in the other CNS regions (Figure 12B). 
Interestingly, this specific size has previously been characterised as a product 
of enzymatic cleavage by MMPs (Matthews et al., 2000). It is also worth noting 
that an 80 kDa splice variant of Bcan that has previously been observed in the 





Figure 11. Comparison of Bcan abundance between CNS regions.  
Densitometry results alongside a representative Western blot image for Bcan in each 
CNS region. Actin was used as a control for the amount of protein loaded and used to 
standardise the densitometry results. The lines within the graph represent the mean 
and standard deviation (n = 3). Each sample was ran in triplicate. 





Figure 12. Comparisons of specific Bcan species between the different regions 
of the CNS.  
Densitometry results alongside a representative Western blot image for Bcan in each 
CNS region. A Bcan species between 145 kDa and 460 kDa were compared. B Bcan 
fragment size ~50 kDa were compared. 
 
3.3.4 Vcan: no differences in Vcan abundance throughout the CNS 
Vcan is a lectican that is known to associate with PNN structures in the CNS 
(Carulli et al., 2006; Deepa et al., 2006; Galtrey et al., 2008). The 
unglycosylated full-length core protein is ~ 360 kDa, however it is known to 
have many splice variants therefore there is a diversity of potential Vcan 
species (Ito et al., 1995; Zako et al., 1995; Yamaguchi, 2000). The aim was to 
characterise the relative abundance of these Vcan species in the four CNS 
regions.  
Bands of Vcan species were observed at ~ 360 kDa, ~ 200 kDa, ~ 160 kDa 
and ~ 40 kDa, which suggests a diverse range of core protein sizes in each 
CNS region (Figure 13). When compared to previous studies these sizes are 
comparable to the 2 isoforms (V0 and V1) that are found >350 kDa and the 
isoform V2 that is found ~ 200 kDa (Foulcer et al., 2015). The band at ~ 40 
kDa may be the cleaved N-terminal fragment of V1 (Sandy et al., 2001; 
McCulloch et al., 2009). There was no trend observed in the total abundance 
of Vcan present in each CNS region, as all displayed similar Vcan levels. 
Smearing was not observed in any of the CNS regions, indicating that Vcan 
may be relatively unglycosylated in these regions.  
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Figure 13. Comparison of Vcan abundance between CNS regions. 
Densitometry results alongside a representative Western blot image for Vcan in each 
CNS region. Actin was used as a control for the amount of protein loaded and used to 
standardise the densitometry results. The lines within the graph represent the mean 
and standard deviation (n = 3). Each sample was ran in triplicate. 
 
3.3.5 Ncan: glycosylated Ncan is most prevalent in the cortical region 
Ncan is also a nervous-system specific lectican that is known to co-localise 
with PNNs in the CNS (Rauch et al., 1992; Yamaguchi, 2000; Carulli et al., 
2006; Deepa et al., 2006; Galtrey et al., 2008). Full-length unglycosylated 
Ncan in the adult rat brain has a core protein ~ 245 kDa and has been 
observed to average 3 CS chains per core protein making the glycosylated 
Ncan species ~ 300 kDa in total size (Rauch et al., 1991). Ncan also has 
splice variants of approximately ~150 kDa and ~180 kDa that have previously 
been characterised (Rauch et al., 1991). The aim was to characterise the 
relative abundance of Ncan species in the four CNS regions.  
Ncan species were observed as a smear between 150 – 300 kDa (Figure 14), 
suggesting a combination of glycosylated full-length and truncated Ncan were 
present. The size of the smear also suggests that Ncan in these regions may 
have more than 3 CS chains, making them more glycosylated than has 
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previously been reported (Rauch et al., 1991). Ncan was most prevalent in the 
cortical region, in comparison with hippocampal, cerebellar and cSC regions 
(p ≤0.005). There was no trend observed between the other regions, as they 
all had similar levels of Ncan present. A band at ~ 100 kDa in the cerebellar 
and cSC regions was observed that was not detected in the cortex and 
hippocampus, suggesting a particularly unglycosylated enzymatically cleaved 




Figure 14. Comparison of Ncan abundance between CNS regions.  
Densitometry results alongside a representative Western blot image for Ncan in each 
CNS region. Actin was used as a control for the amount of protein loaded and used to 
standardise the densitometry results. The lines within the graph represent the mean 
and standard deviation (n = 3). Each sample was ran in triplicate. The lines above the 
graph represent statistical significance: p ≤ 0.005 (**). 
 
3.3.6 Hapln1 is most abundant in the cortical region 
Hapln1 is a 45 kDa protein that has been observed to co-localise with PNN 
markers in the CNS and is an essential component of the PNN structure 
(Carulli et al., 2006; Deepa et al., 2006; Galtrey et al., 2008; Carulli et al., 
2010; Kwok et al., 2010). The removal of Hapln1 was enough to cause the 
attenuation of PNN structures in the brain (Carulli et al., 2010; Romberg et al., 
2013). The aim was to characterise the abundancy of Hapln1 in the four CNS 
regions. 
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Only one band at 45 kDa was observed in all CNS regions (Figure 15). There 
was significantly more Hapln1 present in the cortical region in comparison with 
the hippocampal, cerebellar and cSC regions (p ≤0.0005, p ≤0.0005, p ≤0.005, 
respectively). A trend suggested that Hapln1 was least abundant in the 
hippocampal region, though this trend was only significant when compared 
with the cSC (p ≤0.005) and cortical regions.  
 
 
Figure 15. Hapln1 is most abundant in cortical lysate, in comparison with the 
other CNS regions observed by Western blot.  
Densitometry results alongside a representative Western blot image for Hapln1 in each 
CNS region. Actin was used as a control for the amount of protein loaded and used to 
standardise the densitometry results. The lines within the graph represent the mean 
and standard deviation (n = 3). Each sample was ran in triplicate. The lines above the 
graph represent statistical significance: p ≤ 0.05 (*), p ≤ 0.005 (**) p ≤ 0.0005 (***). 
 
3.3.7 Hapln4 distribution was different to the distribution of Hapln1  
Hapln4 is also a 45 kDa protein that has been established as an important 
PNN molecule, especially in the formation and function of PNNs in cerebellum 
and brainstem (Bekku et al., 2012; Edamatsu et al., 2018). The aim was to 
characterise the abundancy of Hapln4 in the four CNS regions. 
Only one band at 45 kDa was observed in all CNS regions, with all regions 
observed to contain approximately equal amounts of Hapln4 (Figure 16). As 
the staining was not strong, it is difficult to assess if any differences in the 
relative abundancy of Hapln4 is present between the regions. However, when 






















  - 52 -  
the distribution pattern of Hapln4 was compared with the distribution pattern 
of Hapln1, it was clear that they are distinctively different, as Hapln4 is not 
significantly upregulated in any one of the CNS regions analysed.  
 
 
3.3.8 Tn-R: no differences in Tn-R abundance throughout the CNS 
Tn-R is specific to the CNS where it has been observed to associate with 
PNNs through the cross-linking of CSPGs (Aspberg, 1995; Lundell et al., 
2004; Morawski et al., 2014). Two isoforms have been characterised at 160 
kDa and 180 kDa, however Tn-R molecules can interact with each other to 
form dimeric and trimeric Tn-R structures (Chiquet-Ehrismann and Tucker, 
2011; Morawski et al., 2014). The aim was to characterise the abundancy of 
Tn-R in the four CNS regions. 
Multiple bands of Tn-R were observed in all CNS regions ranging from ~ 160 
kDa to molecular weights much greater than (≫) 460 kDa with the total 
abundance of Tn-R found to be similar in all regions (Figure 17). Four distinct 
size ranges were observed in all CNS regions that reflect the different 
aggregates of Tn-R that were formed: monomeric Tn-R between 160 – 180 
kDa, dimeric Tn-R between 320 – 360 kDa, trimeric Tn-R between 480 – 540 
 
 
Figure 16. Comparison of Hapln4 abundancy between CNS regions.  
Densitometry results alongside a representative Western blot image for Hapln4 in each 
CNS region. Actin was used as a control for the amount of protein loaded and used to 
standardise the densitometry results. The lines within the graph represent the mean 
and standard deviation (n = 3).  Each sample was ran in triplicate. 
Actin
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kDa and large aggregates of Tn-R ≫ 460 kDa. This was slightly unexpected 
as the samples were ran in reducing conditions, therefore the aggregates 
would have been expected to disassociate into their monomeric Tn-R subunits 
of either 160 or 180 kDa, as has been observed previously (Aspberg, 1995; 
Aspberg et al., 1997). The results reported here were similar to observations 
by Woodworth et al (2002) where dimeric and trimeric aggregates were found 
after heat treating tissue lysate and using  SDS-PAGE gel. Potentially, in this 
experiment the percentage of 2-mercaptoethanol (2.5% v/v) was not sufficient 
to efficiently dissociate the aggregates. This may also explain why a band ≫ 
460 kDa is observed, as it may resemble an aggregated Tn-R species that is 
forming a complex with CSPGs, though this is only a suggestion. 
 
 
Figure 17. Comparison of Tn-R abundance between CNS regions.  
Densitometry results alongside a representative Western blot image for Tn-R in each 
CNS region. Actin was used as a control for the amount of protein loaded and used to 
standardise the densitometry results. The lines within the graph represent the mean 
and standard deviation (n = 3). Each sample was ran in triplicate. 
 
3.3.9 HA: Lack of smearing suggests HA is observed at discrete sizes 
throughout the CNS regions  
HA is a non-sulfated GAG that is essential for the formation of PNNs. HA 
molecular weight (Mw,GAG) has the potential to be highly heterogeneous, as 
HA chains synthesised by HAS enzymes have been characterised between 
100 kDa to 2 MDA (Itano et al., 1999). Furthermore, both hyaluronidases and 
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chondroitinases can enzymatically cleave HA chains to vary the size 
distribution further (Stern, 2004; Stern and Jedrzejas, 2006). Therefore, the 
expectation was that large smears would be present in each of the 4 CNS 
regions, reflecting the heterogeneity Mw,GAG.  
It is important to note that in this analysis HA chains were being compared 
with the molecular weight of protein standards (Mw,protein). As the migration rate 
between GAG chains and proteins would not be expected to be equal Mw,GAG 
could not be identified without first characterising the relationship between 
Mw,protein and Mw,GAG migration rates. In chapter 5 this relationship is 
quantitatively described at a ratio of 1 kDa (Mw,GAG): 1.7 ± 0.1 kDa (Mw,protein). 
For this reason the results will be reported using Mw,protein and Mw,GAG values 
for clarity.  
In all CNS regions smearing was not observed, as 4 distinct HA bands were 
observed at: Mw,protein ~  65 kDa, ~ 120 kDa, ~ 500 kDa and ≫ 460 kDa (Figure 
18). The relative abundance of total HA was significantly higher in the cSC 
region in comparison with cortical (p ≤ 0.005), hippocampal (p ≤ 0.05) and 
cerebellar (p ≤ 0.005) regions. When the distinct HA size bands were 
compared, the cSC region had significantly more HA at Mw,protein ~ 500 kDa 
and Mw,protein ≫ 460 kDa in comparison with the cortical, hippocampal and 
cerebellar regions (Figure 19). Furthermore, for Mw,protein ≫ 460 kDa HA it was 
least abundant in the cerebellar region that was significantly different when 
compared with the hippocampal and cSC regions (Figure 19A). For Mw,protein  
~ 120 kDa HA there was a trend suggesting HA was least abundant in the 
cortical region, though this trend was only significant when compared with the 
cSC region (Figure 19C). No differences were found between the CNS regions 
for Mw,protein ~ 65 kDa HA.  
The lack of smearing was unexpected as it implies that HA within the CNS is 
produced at specific sizes. For Mw,protein ≫ 460 kDa it is possible that there is 
a large range of potential HA chains within the band that cannot be 
discriminated due to insufficient power in separation of high molecular weight 
species using 4-20% polyacrylamide gel. Therefore, it is not the gel system 
that cannot resolve the bands, but the percentage of the gel used which limited 
separation due to insufficiently large pore sizes. To discriminate these larger 
HA bands in future work the use of agarose gels may be more appropriate. 
Similar phenomenon of defined HA sizes has also been observed previously 
with our project student (Figure 20). Separation of GAGs isolated from rat 
brain and nasal cartilage showed that HA bands were present specifically in 
brain samples. HA bands of ~  65 kDa and ~ 120 kDa were observed in brain, 
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while these are absent in the nasal cartilage. The lack of bands or a smear in 
nasal cartilage sample is likely due to the retention of large HA species stuck 
in the well. Therefore, the presence of specific HA bands may be a feature 
specific to the CNS. In addition, the appearance of bands suggests that the 
HA may still be associating with HA binding molecules. To test this hypothesis 
in future work the experiment could be ran again with the samples first being 
pre-treated with proteases to remove proteins from the sample. Furthermore, 
ChABC treatment had no effect on the HA band sizes of the brain lysate 
samples. The absence of HA between under 400 kDa in the nasal cartilage 
samples suggested that the HA was too large to migrate into the 
polyacrylamide gel. It is important to note that the results may also be caused 
by non-specific binding of the HA marker HABP, as the bands at ~ 65 kDa 
and ~ 120 kDa were not removed by ChABC treatment, which suggested that 
they were not HA fragments. Further experiments will be required to confirm 
the identity of HA in the CNS (Clark et al., 2011; Yuan et al., 2015). 
 
 
Figure 18. Comparison of HA amounts in CNS regions.  
Densitometry results alongside a representative Western blot image for HA in each 
CNS region. Actin was ran as a control for amount of protein loaded, and used to 
standardise the densitometry results. The lines within the graph represent the mean 
and standard deviation (n =3). Each sample was ran in triplicate. The lines above the 
graph represent statistical significance: p ≤ 0.05 (*), p ≤ 0.005 (**). 
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Figure 19. Densitometry comparison of the different HA sizes demonstrates the 
heterogeneity of HA throughout the CNS.  
Densitometry results alongside a representative Western blot image for HA in each 
CNS region. A HA ≫ 460 kDa at the top of the gel. B HA band ~ 500 kDa C HA band 
~ 120 kDa. D HA band ~ 65 kDa. For all results Actin was ran as a control for amount 
of protein loaded and used to standardise the densitometry results. The lines within 
the graph represent the mean and Standard deviation (n =3). Each sample was ran in 
triplicate. The lines above the graph represent statistical significance: p ≤ 0.05 (*), p ≤ 
0.005 (**), p ≤ 0.0005 (***). 
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Figure 20. Comparison of rat nasal cartilage HA with brain lysate HA indicated 
that lower molecular weight HA species are brain specific. CNS. 
Western blot image of rat nasal cartilage and brain lysate that has been incubated (40 
mU overnight) with (+) and without (-) ChABC. Only HA species below 400 kDa were 
interrogated in this analysis using HABP as the probe for HA. No difference in band 
sizes were observed between rat brain lysate samples that were incubated with and 
without ChaBC. Rat nasal cartilage lysate was absent of HA bands below 400 kDa. 
This image is courtesy of Emma Sewart supervised by Jessica Kwok at the University 
of Cambridge.  
 
3.3.10 Summary of Western blot results  
The results of the Western blot analysis were summarised into a single table 
to allow for an easier comparison of the distribution molecules present in each 
CNS region (Table 3). Although direct comparisons between the PNN-
associated molecules was not possible due to the differing binding affinities of 
the antibodies used, the relative abundance of each molecule throughout the 
different CNS regions could be compared.  
In the cSC region the relative abundance of  ≥ 250 kDa Acan, and Hapln1 
and was higher. The relative abundance of Pcan, 100 – 250 kDa Acan and 
Hapln1 was higher in the cerebellar region. In the hippocampus species of 
Acan ≥ 250 kDa and between 100 – 250 kDa were comparatively more 
abundant, alongside an increased abundance of Pcan. The cortical region a 
comparatively increased abundance of Acan species between 100 – 250 kDa, 
Pcan, Bcan, Ncan and Hapln1. In all regions the relative abundance of Tn-R, 
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Vcan, Hapln4 and Acan species between ~ 45 kDa was similar in all CNS 
regions.  
 
Table 3. A heat map summarising the relative abundance of PNN molecules using 
Western blot densitometry analysis.  
All molecules were graded as either: low intensity (blue), medium intensity (orange) or 
strong intensity (red) by comparing the relative abundance of each molecule within 
each CNS region.  
Molecule (kDa) Cortex Hippocampus Cerebellum cSC 
CSPGs     
Acan (≥ 250)     
Acan (100 – 250)     
Acan (~ 45)     
Pcan     
Bcan     
Vcan     
Ncan     
Proteins     
Hapln1     
Hapln4     
Tn-R     
HA     
HA (~ 65)      
HA (~ 120)     
HA (~ 500)     
HA (≫ 460)     
 
3.4 Discussion 
Heterogeneity in the distribution of PNN-associated molecules analysed was 
observed when comparing the cortical, hippocampal, cerebellar and cSC 
regions. Furthermore, it is important to note that all molecules were observed 
in all CNS regions. When comparing the relative abundance of the PNN-
associated molecules between the CNS regions there was a unique 
abundance of molecules in each region. There was no simple trend of relative 
molecular abundance to describe the relationship between the 2 PNN 
morphologies described in section 1.5.3 when comparing the cortical and 
hippocampal regions with the cerebellar and cSC regions. Therefore, the 
distinct PNN morphologies cannot be distinguished by the molecules in this 
chapter alone, suggesting further molecules are involved such as Sema3a 
and Otx2 that are both known to interact with PNNs (Beurdeley et al., 2012; 
Dick et al., 2013; Djerbal et al., 2019). Alternatively, another explanation for 
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the results observed may be that the biochemical differences only become 
apparent at the level of PNN-specific lysates, and not at the level of whole 
tissue lysates owing to confounding contributions of the loose ECM. 
The high abundance of less or un-glycosylated CSPG species observed in all 
CNS regions provided a possible explanation for why histochemistry and 
imaging techniques detect PNNs that stain positively for Acan yet negatively 
for WFA (McRae et al., 2007; Irvine and Kwok, 2018; Ueno et al., 2018; Miyata 
et al., 2018). The varying degree of glycosylated CSPG species observed in 
this analysis implied that the degree of CSPG glycosylation may be regulated 
on the PNN surface. The sulfation pattern of CS within PNNs is known to be 
under temporal regulation, therefore there is precedent for GAG chain 
regulation influencing PNN function (Miyata and Kitagawa, 2015; Foscarin et 
al., 2017; Miyata et al., 2018). Furthermore, the interaction of PNN-associated 
molecules including Sema3a is influenced by the degree of glycosylation and 
can influence the structure of the PNN surface (Djerbal et al., 2019). The 
degree of glycosylation also has been shown to change the structural 
conformation of CSPGs, as a reduction in Acan glycosylation caused a 
reduction in the molecules persistence length (Ng et al., 2003). Determining 
the relationship between degree of CSPG glycosylation and the distinct PNN 
morphologies presents a potential mechanism for influencing the 
biomechanical properties of PNNs, specifically the thickness of the PNN 
surface. 
Pcan is known to have a smaller molecular weight in comparison with Acan 
due to it being less glycosylated and having a smaller core protein size 
(Yamaguchi, 2000). Therefore, the observation that Acan and Pcan 
glycosylated CSPG species were found at similar molecular weights at > 460 
kDa suggested that Acan is less glycosylated than in other previously 
characterised regions such as cartilage (Morgelin et al., 1994; Kiani et al., 
2002; Matthews et al., 2002; Roughley and Mort, 2014; Mort et al., 2016). This 
was then supported by the comparison with cartilage tissue that suggested 
Acan was more glycosylated in comparison with the CNS (Figure 9). The 
distinct Acan species observed in the CNS is quite dramatically different in 
size in comparison with other tissues and has not previously been reported. 
The smaller size of Acan in the CNS suggests it may function, at least in part, 
via a different mechanism other than resisting compressive forces. This 
unique result will require further interrogation to understand the mechanistic 
role of these Acan species.  
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The degree of glycosylation could be affected not only by the number of GAG 
chains associated with the PNN surface, but also the size of the individual 
GAG chains. When modelling other tissues it has been observed that 
increasing the size of GAG chains increased the hydrodynamic radii of the 
CSPGs, which increased their ability to resist stress (Grande-Allen et al., 
2004). Although the size of GAG chains has not been specifically interrogated 
in cartilage, a reduction in overall GAG composition was associated with 
reduced quality of the joint (Mort et al., 2016). There is also specific evidence 
that the CSPG Acan caused a swelling of tethered HA surfaces (Attili and 
Richter, 2013). Therefore, by reducing the abundance of GAG chains 
associated with CSPGs, either through reduced size or the amount of GAG 
chains, presents a potential mechanism for altering the thickness of PNN 
surfaces. It would also affect the phase separation behaviour quite 
substantially, with films made from less voluminous molecules being easier to 
phase separate than films made from bulky molecules. 
The ~ 45 kDa ACAN species was relatively more abundant in the 
hippocampal and cortical regions, in comparison with the cerebellar and cSC 
regions which suggested that more ACAN degradation is occurring within 
these regions. This may indicate more aggrecanases being present in the 
cortical and hippocampal regions. Interestingly, the difference in the relative 
abundance of the ~ 45 kDa ACAN species was the only correlation that was 
observed between the distinct PNN morphologies (cortical and hippocampal 
PNNs versus cerebellar and cSC PNNs). Acan is known to be a prominent 
PNN-associating molecule, therefore the regulation of Acan abundance within 
PNNs by MMPs may be partially responsible for the distinct morphologies 
observed.  
The variation in molecular abundance may also be a reflection in the variation 
of different cell types. The molecular contributions to PNNs by different cell 
types has previously been observed (Carulli et al., 2006; Giamanco and 
Matthews, 2012). The results suggest that the ratio of neurons to glial cells, 
as well as the ratio of different glial cells, will likely change the molecular 
makeup of the loose ECM, as the different cell types synthesise different 
molecules (Carulli et al., 2006). 
The high relative abundance of Hapln1 in the cortical region may reflect the 
involvement of the molecule in other processes besides its role as an essential 
component of PNNs. Hapln1 plays an important role in the ECM for producing 
cortical folding in the neocortex, therefore the increased abundance of Hapln1 
in this region may reflect this (Long et al., 2018). This may go some way to 
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also providing an explanation for why an increase in the relative abundance 
of Hapln4 is not observed in the cortical region. This highlights the difficulty in 
extrapolating too much when considering the effect of the relative molecular 
abundance on PNN structures alone. However, the higher abundance of 
Hapln1 may as a result make the forming PNNs easier in this region, as 
without Hapln1 PNNs lose their structure (Carulli et al., 2010). 
Previous work has established the presence of Hapln4 as a component found 
in PNNs in both the cerebellum and cortex (Edamatsu et al., 2018; Sucha et 
al., 2020). Interestingly when Hapln4 is not present it does not prevent PNN 
formation, but does change the molecular composition of other ECM 
components (Sucha et al., 2020). However, it is important to note that the 
Hapln proteins appear to preferentially bind specific CSPGs with higher 
affinity, therefore the distribution of these proteins throughout the CNS may 
alter the composition of CSPGs in the region (Shi et al., 2004). Yet, although 
Hapln1 preferentially interacts with Vcan an increase in Hapln1 in the cortical 
region was not correlated with an increase in Vcan. An interesting future 
perspective would be to observe the relative proportion of Hapln1 molecules 
that are found interacting with Vcan, as opposed to other CSPGs, as it would 
indicate a mechanism for how the composition of CSPGs found interacting 
with the PNN surface could be regulated.  
One of the limitations of the Western blot technique is it is difficult to 
discriminate between the structure of molecules if they contain similar 
molecular weight. Therefore, the CSPG species that form the smears have 
the potential to be heterogenous in molecular structure (Figure 21A, B and C). 
As degree of glycosylation is affected by both the amount of GAG chains, as 
well as the size of each individual GAG chain Western blot analysis alone 
cannot distinguish between these distinct structures. Previously, 
heterogeneity in GAG chain sizes attached to CSPGs has been observed, 
however to date a systematic analysis of GAG chains attached to CSPGs has 
not been conducted (Rauch et al., 1991; Yamaguchi, 2000; Avram et al., 
2014). To determine if further heterogeneity in CSPG species are present, 
techniques such as AFM could be used to image individual CSPG molecules 
in the future, as was previously done when analysing Acan in cartilage tissue 
(Ng et al., 2003). 
The original intention of this analysis was to interrogate the PNN-associated 
molecules within each CNS region using a technique that specifically 
extracted the molecular components that form the PNN structure (Deepa et 
al., 2006; Kwok et al., 2014). Deepa et al (2006) examined PNN components 
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taken from whole brain lysates. However, when adapted for analysing specific 
brain regions the reduced amount of starting material reduced the sensitivity 
of the analysis making analysis difficult. In the future this could be achieved 
by increasing the animal samples used in the analysis to increase the amount 
of starting material. The analysis in this chapter was developed and optimised 
to efficiently transfer glycosylated CSPGs, therefore providing a robust 
methodology for analysing glycosylated CSPGs using Western blotting. 
Importantly, it provides an overview of the relative distribution of the PNN-
associated molecules in four CNS regions previously characterised as being 
PNN rich.   
 
 
In conclusion, this chapter highlights the heterogeneous distribution of PNN-
associated molecules in the CNS, providing unique insights into the molecular 
make-up of the PNN surfaces. Ncan and Hapln1 were found to be most 
abundant in the cortical region, while Pcan was found to be most abundant in 
the cerebellar region. Both Acan and Bcan were found to have multiple 
variants that were differentially distributed throughout the four CNS region 
analysed. The distribution of the molecules suggests how the differences in 
the different PNN morphologies may be biochemically produced, as well as 
 
 Figure 21. Schematic representations of the structure of cartilage Acan, 
alongside the possible structural variation observed in CNS Acan.  
Specifically, A, B and C would be of the same molecular weight yet present 3 entirely 
different Acan structures that cannot be discriminated between using the Western 
blotting methodology. D full length non-glycosylated Acan chain. E Acan without the 
G3 domain F Acan without the G1 domain. G A cleaved variant of Acan containing the 
G1 and G2 domain. H A cleaved variant of Acan containing the G3 domain. One 
cleavage event could create both G and H variants. I A cleaved Acan variant that could 
represent either the G1 or G3 domain.  
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providing insights into the availability of molecules in different regions of the 
CNS that may allow for the maintenance, as well as dynamic regulation of 
PNN surfaces. Future work focussing on how the molecular heterogeneity 
manifests in functional changes to the CNS will likely provide key insights into 
the mechanisms behind how the surfaces regulate CNS activity.   
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Chapter 4: QCM-D as a methodology to analyse 
molecular interactions and supramolecular self-
organisation underpinning PNN formation 
4.1 Introduction 
Although there is a proposed model for the assembly of PNNs, the detailed 
mechanism for the stabilisation of the morphologies of PNNs is not yet known 
(Yamaguchi, 2000; Kwok et al., 2011; Richter et al., 2018). Furthermore, 
although the PNNs form a large pericellular layer on the surface of neurons 
they surround, the biomechanical changes to the surface have yet to be 
described. 
The observation that punctate and reticular PNNs are distinct morphologies 
that reflect the maturation state of PNNs suggests that the formation of the 
PNN surface is gradual and can be influenced by molecules present in the 
extracellular space (Richter et al., 2018). Punctate PNNs are observed in the 
developing CNS, while reticular PNNs are more commonly observed in the 
developed CNS (Ueno et al., 2017b; Richter et al., 2018). How the transition 
occurs between these two morphological phenotypes is currently unclear. The 
application of perspectives from soft matter physics may offer the best current 
hypotheses for how this transition may occur. Firstly, self-organisation refers 
to the emergence of an overall order in space as a result of the collective 
interactions of individual components (Wedlich-Söldner and Betz, 2018). The 
individual components form supramolecular structures that aim to limit the 
overall free energy in the system. The lowest energy state is favoured. In 
terms of a system involving polymers of HA attached at one end to a surface 
two of the most important physical parameters are the mean surface density 
of HA and the surface tension at phase boundaries (Richter et al., 2018). 
Therefore, the process of supramolecular self-organisation can drive phase 
transitions in structures as new molecules are added to the system. One 
demonstration of this is the phase transition of HA surfaces caused by a  
smaller variant of tumour necrosis factor-stimulated gene-6 (TSG-6)  referred 
to as Link_TSG6 that is dependent on the mean surface density of HA 
attached to the surface (Richter et al., 2018). At high surface densities of HA 
reticular structures formed, while at low densities punctate structures formed 
(Baranova et al., 2011; Richter et al., 2018). Link_TSG-6 was responsible for 
the phase transition but it was dependent on other physical parameters of the 
system. One of the aims of this chapter was to understand the factors driving 
self-organisation in PNN formation by altering the density of molecular 
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components, as well as the sequential order of presentation of PNN-
associated molecules.   
PNNs are a large pericellular structure that fundamentally changes the 
biochemical composition of the cell surface that they surround (Carulli et al., 
2006; Deepa et al., 2006; Galtrey et al., 2008). They are also likely to change 
the biomechanical properties of the cell surface as well. What is currently 
unclear is what these biomechanical changes are. Cells in the CNS have the 
ability to sense changes to biomechanical properties of surfaces, with these 
interactions causing changes to cell behaviour (Flanagan et al., 2002; 
Georges et al., 2006; Jiang et al., 2008; Moshayedi et al., 2010; Koch et al., 
2012; Franze et al., 2013; Moshayedi et al., 2014; Bollmann et al., 2015; Koser 
et al., 2016; Moeendarbary et al., 2017). Therefore, it is plausible that PNNs 
may partially function via a biomechanical signalling mechanism. This 
highlights the importance of characterising the biomechanical properties of 
PNNs to help define how these properties differ from the properties of the 
cellular membrane, as well as the loose ECM. 
As the previous chapter demonstrated, PNNs have the potential to be 
composed of a large variety of PNN-associated molecules. The heterogeneity 
in the molecular composition of PNNs highlights why a well-defined in-vitro 
model is necessary to investigate which parameters are responsible for the 
supramolecular self-organisation of PNNs. One such parameter that can be 
carefully controlled in a well-defined in vitro system is the mean surface 
density of HA, which is difficult to define in vivo. It is currently unknown if the 
surface density of HA has an effect on the formation of PNNs. Furthermore, 
the density of other PNN associated molecules, including Haplns and CSPGs 
is not well understood in PNN structures, yet its effect can be investigated 
using an in vitro system. Therefore, by carefully controlling the molecular 
parameters during the formation of PNNs, it is possible to investigate self-
organisation, while simultaneously measuring the biomechanical properties of 
the film.  
To analyse the supramolecular self-organisation of PNNs the aim was to 
design a methodology to recreate PNNs in a carefully controlled, cell-free, in 
vitro system and measure the surfaces using QCM-D. QCM-D is an acoustic 
measuring technique that is described in detail in chapter 2. Briefly, the 
technique can measure changes in frequency (∆𝑓) to determine areal mass 
density (which includes hydrodynamically trapped solvent) and changes in 
dissipation (∆𝐷) to determine the mechanical properties of the surface bound 
layer. By combining these two measures the ratio ∆𝐷/−∆𝑓 can be determined, 
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which for ultrathin films (in the range of a few nm) is strictly proportional to 
elastic compliance. For thicker films although the proportionality is lost, the 
ratio of ∆𝐷/−∆𝑓 ratio remains a useful measure to quantify film softness (Du 
and Johannsmann, 2004; Reviakine et al., 2011; Eisele et al., 2012).  
Through the use of QCM-D, the molecular interactions of PNN-associated 
molecules can be observed, while simultaneously gaining information about 
the biomechanical properties of the surface. Furthermore, a model system has 
previously been developed for producing HA brushes, i.e. films of HA 
molecules that are surface-bound at one end, using QCM-D (Richter et al., 
2007; Baranova et al., 2011; Thakar et al., 2014). Briefly, by creating a 
monolayer of streptavidin on the sensor surface, HA biotinylated at the 
reducing end can then be immobilised with the reducing end attached to the 
surface (Richter et al., 2007; Baranova et al., 2011; Thakar et al., 2014). This 
is beneficial for modelling PNN surfaces as HA is synthesised by HAS 
enzymes on the cell surface that are extruded into the pericellular space 
(Spicer and McDonald, 1998; Itano et al., 1999; Tien and Spicer, 2005). HA is 
a vital component of PNNs and is hypothesised to remain bound to the HAS 
enzymes on the cell surface during the formation of PNNs. Therefore, the 
establishment of a methodology for the production of in vitro HA films using 
QCM-D aimed to recreate the hypothesised mode of HA attachment to  HAS 
molecules that is predicted to attach HA molecules via the reducing end 
(Weigel, 2015).  
Previously, the interaction of Acan with HA films has been measured using a 
combination of QCM-D, spectroscopic ellipsometry, AFM and reflection 
interference contrast microscopy (Attili and Richter, 2013). Interestingly, they 
found that Acan caused an increase in HA film compliance, highlighting the 
potential of PNN-associated molecules to influence the biomechanical 
properties of PNNs. Within this particular study QCM-D was used as a method 
that provided information on both the assembly of films, as well as providing 
a biomechanical measurement of the film, which was then further rigorously 
characterised using the other methodologies (Attili and Richter, 2013). The 
aim of this chapter was to build on this work to present PNN-associated 
molecules to the HA films sequentially. 
 
4.1.1 Target PNN model and the main design principles 
To establish a model for analysing the assembly of PNNs it is important to 
highlight the specific aspects of PNN supramolecular organisation that the 
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model is being optimised for. Firstly, the model aimed to recreate the 
presentation of HA as it would be on the cell surface while attached to HAS at 
the reducing end (Weigel, 2015). The methodology for the creation of HA 
brushes required the formation of a streptavidin monolayer, that in turn is 
attached to the QCM-D sensor surface via a supported lipid bilayer (Figure 
22). The production of stable lipid bilayers that form on QCM-D sensor 
surfaces has previously been described (Keller and Kasemo, 1998; Richter et 
al., 2006). It is important to note that that the streptavidin in the monolayer is 
not likely to be mobile in 2D, as at very high streptavidin density it is known to 
undergo 2D crystallisation (Ilya and Brisson, 2001).  
 
 
Figure 22. Schematic representation of how the orientation of HA is achieved 
on the sensor surface.  
The stably bound biotinylated lipid bilayer and streptavidin surface anchor HA50 
biotinylated at the reducing end.  
 
By producing a monolayer of streptavidin that is standardised for all 
experiments it established a reproducible baseline for ∆𝑓 and ∆𝐷 
measurments. This made comparisons between HA films of varying densities 
simpler, as non-specific binding of the PNN-associated molecules is 
standardised to the interaction with the streptavidin monolayer alone. HA 
density could then be controlled by altering the HA incubation time. 
Secondly, the model aimed to establish if the surface density of HA impacts 
the supramolecular assembly of the surfaces. In order to examine this, the 
molecular weight of HA used to establish the PNN model surface is an 
important consideration. The size of HA has an influence on the types of films 
that are formed, with increased HA size associated with creating less dense, 
more compliant HA films, as described in detail in chapter 5. Currently, the 
molecular weight of HA in PNNs is unknown, with chapter 3 highlighting HA 
molecules of varying length present within the CNS. Although an estimate of 
the size of HA is important for the accurate recreation of PNN surfaces, in 
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determining the molecular interactions with other PNN-associated molecules, 
as well as the formation of supramolecular structures the size of HA is less 
integral to the experiment.  
The surface density of HA is known to impact HA films, as it has the potential 
to change the conformational shape of each HA molecule (Richter et al., 
2018). As each HA molecule is negatively charged, the chains repel each 
other, therefore at higher surface densities this causes the HA chains to 
become more stretched, in an attempt to increase the distance between the 
HA molecules (Richter et al., 2018). Furthermore, high surface density HA 
surfaces may also sterically hinder the ability of PNN-associated molecules to 
interact with HA chains. If the spaces between the HA molecules are too small 
then molecules may only be able to interact with HA on the top of the HA films, 
as opposed to interacting within the films. To determine if HA density had an 
impact on the formation of PNNs the aim was to produce both high density 
and low density HA films. Specifically, the aim was to interrogate the effect of 
steric hindrance as a potential mechanism that could affect PNN formation.  
Thirdly, the model aimed to establish how the supramolecular structure self-
organised to stably assemble PNNs. Therefore, to investigate this process it 
was important to select appropriate PNN components for analysis. As 
mentioned previously, Acan is found in the majority of PNNs, therefore it was 
selected as the CSPG to model PNN surface formation (Carulli et al., 2006; 
Deepa et al., 2006; Galtrey et al., 2008; Kwok et al., 2010). Hapln1 was 
selected as it has also been established as an essential component in PNN 
formation (Carulli et al., 2006; Deepa et al., 2006; Galtrey et al., 2008; Kwok 
et al., 2010). The interesting distribution in the CNS observed in chapter 3 also 
suggested that the relative density of Hapln1 is regulated in different CNS 
regions, making it an interesting candidate for further analysis. The interaction 
of Acan with HA films has previously been observed using QCM-D, however 
this study did not investigate the role of Hapln1 (Attili and Richter, 2013). It is 
currently unknown whether the order of incubation is important to the 
formation of PNN surfaces. By differing the order of presentation of Acan and 
Hapln1 the aim was to establish if Hapln1 could stabilise these supramolecular 
assemblies either while pre-bound to HA, or with Acan pre-bound to HA.  
It is important to highlight the challenges in attempting to establish an in vitro 
model of PNNs. Previous work has highlighted that one CSPG, one link 
protein and HAS that synthesised HA and extruded it into the pericellular 
space were the essential molecules required to produce a PNN surface (Kwok 
et al., 2010). Kwok et al (2010) specifically used Hapln1 and Acan as the link 
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protein and CSPG, respectively, to recreate the cellular in vitro model. Hapln1 
has previously been observed to be essential to PNN formation (Carulli et al., 
2010). Acan has been suggested as an integral PNN component that is found 
surrounding the majority of PNNs in the CNS (Carulli et al., 2006; Deepa et 
al., 2006; Galtrey et al., 2008; Ueno et al., 2017b; Irvine and Kwok, 2018). 
Therefore, Acan and Hapln1 were selected as the molecules used to establish 
the in vitro PNN model. The aim of this chapter was to establish a new 
technique for modelling the formation of PNNs by presenting Hapln1 and Acan 
to the HA films sequentially.  
4.2 Methodology 
The QCM-D methodology is described in detail in chapter 2. In chapter 2 a 
quantitative description of QCM-D is provided, followed by a section 
describing how the measurements were taken using QCM-D. Chapter 2 also 
describes the passivation of tubes and chamber preparation, as well as the 
preparation of liposomes used to form the lipid bilayers. The methodology for 
forming the lipid bilayers and streptavidin monolayer are also provided in 
chapter 2. Values of ∆𝑓 and ∆𝐷 are presented at the end of the incubation 
period. The values of ∆𝑓 and ∆𝐷 were averaged over a 1 min period to account 
for any outliers. 
 
4.2.1 Producing the supported lipid bilayer and streptavidin monolayer 
The directional orientation of HA films was achieved by using HA biotinylated 
at the reducing end and the same methodology described by Richter et al 
(2007). Briefly, liposomes made of a combination of DOPC and DOPE-cap-
biotin in a ratio of 95 : 5 respectively were incubated over the sensor surface 
for 15 min at a flow speed of 20 𝜇L/min at a concentration of 50 𝜇g/mL. 
Streptavidin was then injected for 15 min at a flow speed of 20 𝜇L/min at a 
concentration of 20 𝜇g/mL.  
 
4.2.2 Creating HA films 
It is important to note that areal mass density measured by ∆𝑓 includes both 
the mass of the molecule adsorbing onto the surface, as well as the mass of 
the solvent. Therefore, an additional optical technique is required to separate 
the contribution to mass by the solvent to allow the density of HA to be defined. 
This has previously been measured for HA50, therefore it was possible to 
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define the surface density of HA molecules on the sensor surface using 
measurements of ∆𝑓 (Figure 23; Baranova et al., 2011). 
 
 
Figure 23. Relationship between HA50 surface density and ∆𝒇.  
This was achieved by simultaneously measuring HA surfaces using QCM-D and 
spectroscopic ellipsometry (Baranova et al., 2011). 
 
CSPGs are very large molecules, with measurements of Acan contour length 
(Lc) ~257 ± 87 nm for highly glycosylated Acan species (Ng et al., 2003). Ng 
et al (2003) also measured GAG Lc between 27 – 48 nm for GAGs attached 
to the core protein of Acan, allowing for the approximate width of Acan to be 
extrapolated from these measurements. The 52 – 96 nm range of Acan width 
is the largest possible width, as it assumes GAG chains at full extension, 
which is unlikely to be the case as the end-to-end length of GAG chain were 
measured between 19 and 40 nm, suggesting the width of Acan is more likely 
to be between 38 – 80 nm (Ng et al., 2003). Therefore, for Acan to insert itself 
between HA chains the approximate spacing of HA was required to be 38 – 
80 nm apart.   
 
4.2.2.1 Defining sparse HA50 films 
Assuming the width of Acan to be ~ 60 nm, the change in value of ∆𝑓 required 
to achieve a surface where the HA50 molecules are spaced approximately 60 
nm apart could be calculated using the following equations: 
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Where 𝑟𝑚𝑠 is root mean square (distance between each HA50 molecule), 𝐴 
is the area covered by each HA50 molecule, 𝑀n is the molecular weight of 
HA50, 𝑚 is the areal mass density of HA50 and 𝑁p is Avogadro’s constant. To 
calculate the change in ∆𝑓 for spacing HA50 (𝑀n = 58,000 Da) 60 nm apart: 
𝑟𝑚𝑠 = 6 × 10-8 m, therefore using Equation 15, 𝐴 (3.6 × 10-15  m2) could be 
calculated. The areal mass density 𝑚 of HA50 could then be calculated using 
Equation 16 to produce the value 𝑚 =  2.68 × 10-5 g/m2.To determine the ∆𝑓 
value from Figure 23, the value was converted to 2.68 ng/cm2. The range of 
∆𝑓 values was therefore considered to be ~ -1 Hz.  
As this value is a very small shift in ∆𝑓 for practical reasons the value ∆𝑓 = -5 
Hz as the value for sparse HA50 surfaces as a compromise between keeping 
the surface density as small as possible while still being able to detect the 
formation of HA50 films. -5 Hz shift corresponds to the value 10 ng/cm2, 
therefore the value 𝑚 = 1.0 × 10-5 g/m2. Using Equations 15 and 16, this 
sparse HA50 films have an 𝑟𝑚𝑠 = 31.0 nm. To summarise, in the sparse HA50 
condition HA50 molecules were spaced approximately 31.0 nm apart from 
each other on average.    
Using the worm-like chain model it was possible to approximate the radius of 
gyration of the HA50 chains as being 13 nm, which was extrapolated from the 
work previously published by Takahashi et al (2003). This can then be used 
to approximate the transition between 2 morphological HA surface types that 
has previously been described by Richter et al (2018). When HA50 chains are 
spaced close together (less than 13 nm) a combination of electrostatic 
repulsions and volume exclusion, caused by the close packing of HA 
molecules, will cause the HA50 chains to swell and produce a brush-like 
morphology. In contrast, when the HA50 chains are spaced far apart from 
each other (more than 13 nm) the HA50 chains are not able to interact with 
each other, therefore a mushroom-like morphology is more likely. Therefore, 
the HA50 surface morphology is likely to be in the mushroom-like state as the 
HA50 chains are spaced 31 nm apart.  
 
4.2.2.2 Defining dense HA50 films 
In contrast, high density HA films were defined at ∆𝑓 ~ -36 Hz, which 
corresponded to surface density of ~ 80 ng/cm2. Therefore, 𝑚 =  8.0 × 10-5 
g/m2, which gave an 𝑟𝑚𝑠 value of  11.0 nm when Equations 15 and 16 were 
used. So, in the dense HA50 condition HA50 molecules were spaced 
approximately 11 nm apart from each other on average. Using the worm-like 
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chain model to approximate the radius of gyration of HA50 to 13 nm, it 
indicated that the dense HA50 surfaces would be in the brush-like 
morphology.  
 
4.2.3 Manipulating Hapln1 density 
Two densities of Hapln1 were established to analyse how the density of 
Hapln1 effects the supramolecular self-organisation of the PNN surfaces. 
Dense Hapln1 was established as 50 min incubation of 5  𝜇g/mL. This value 
was chosen as it was at this point that the binding interaction became less 
efficient, suggesting it was nearing equilibrium. The second condition was 
referred to as sparse Hapln1 and was established by incubating Hapln1 for 10 
min at 5 𝜇g/mL. This was chosen as it caused a detectable shift in ∆𝑓 on dense 
HA films while being far smaller than the dense Hapln1 condition. 
 
4.2.4 Preparation of DODA-tris-NTA lipid bilayers for trapping 
polyhistidine-tagged Tn-R  
A dioctadecyldimethylammonium (DODA) lipid analogue with a chelator tris-
nitrilotriacetic acid (NTA) headgroup was kindly provided by Changjiang You 
and Jacob Piehler (Osnabrück University, Osnabrück, Germany) and was 
prepared as described by Beutel et al (2014). The tris-NTA headgroup 
comprised of three nitrilotriacetic acid moieties and was used to trap 
polyhistidine-tagged molecules to the sensor surface after Ni2+ ions were 
chelated to the tris-NTA headgroup. For the Ni2+ chelation to occur 10 mM 
NiCl2 was added to the HEPEs buffer during liposome incubation. The 
liposomes were prepared using the methodology describe in section 2.2.3. To 
prepare the supported bilayers liposomes made of a combination of DOPC 
and DODA-tris-NTA in a molar ratio of 99.5 : 0.5 were incubated over the 
sensor surface in HEPES buffer containing 10 mM NiCl2 for 15 min at a flow 
speed of 20 𝜇L/min and a concentration 50 𝜇g/mL. 
 
4.2.5 Statistics  
When two values were compared, an independent sample T-test was 
performed to ascertain if the values were significantly different. In all cases 
the assumptions were met, as there were no significant outliers, the samples 
were normally distributed, and the variances of the dependent variable were 
similar in each group.  When comparing the difference caused by the addition 
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of a molecule to the same HA film, such as the change in the ratio of ∆𝐷/−∆𝑓 
before and after Acan incubation, a repeated measures T-test was used to 
test for significance. When comparing multiple groups with each other, a 
general linear model was used, followed by a post hoc Tukey test. For all 
statistical tests, significance was established as p ≤ 0.05.  
4.3 Results   
4.3.1 Successful establishment of the HA model surface 
The first aim was to successfully recreate the supported lipid bilayer and 
streptavidin model surface that would provide the foundation for analysing the 
formation of PNN supramolecular self-organisation. When liposomes were 
incubated over the sensor surface, the characteristic two-phase behaviour 
was observed using ∆𝑓 and ∆𝐷 measurements as previously described by  
Richter et al (2007) (Figure 24). The first phase involved a decrease in ∆𝑓 and 
an increase in ∆𝐷, indicating that the vesicles were absorbing onto the sensor 
surface and remaining intact (Richter et al., 2006). In the second phase an 
increase in ∆𝑓 and a decrease in ∆𝐷 could be observed, before both ∆𝑓 and 
∆𝐷 measurements stabilised (∆𝑓 = -24 ± 0.4 Hz; ∆𝐷 = 0.02 ± 0.02 × 10-6; n = 
12), representative of the vesicles rupturing at high vesicular coverage and 
rupturing to form a good quality supported lipid bilayer  (Richter et al., 2006; 
Richter et al., 2007). Taken together it implied that the formation of a stable 
lipid bilayer on the QCM-D sensor was successfully established and formed 
as expected.  
Streptavidin was then presented to the surface where it bound stably to the 
free biotin moieties (Figure 24). The interaction of streptavidin with the lipid 
bilayer caused shifts in ∆𝑓 and ∆𝐷 (∆𝑓 = -28 ± 0.3 Hz; ∆𝐷 = 0.31 ± 0.04 × 10-
6; n = 12) that agreed with previously published results, therefore the 
interaction behaved as expected (Larsson et al., 2003; Richter et al., 2007; 
Dubacheva et al., 2017). Both ∆𝑓 and ∆𝐷 values stabilise before the end of 
the incubation period, suggesting all of the available streptavidin binding sites 
are occupied. Furthermore, the small increase in ∆𝐷 alongside the larger 
decrease in ∆𝑓 implied that the symmetric streptavidin molecules are densely 
packed on the surface (Larsson et al., 2003). 
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Figure 24. Successful establishment of the supported lipid bilayer and a 
monolayer of streptavidin on the QCM-D sensor surface.  
The 5th overtone was used to present shifts in frequency (∆𝑓; top row) and dissipation 
(∆𝐷; bottom row). Biotinylated liposomes were incubated at 50 𝜇g/mL, while 
streptavidin was incubated at 20 𝜇g/mL. The flow rate was kept constant at 20 𝜇L/min. 
The coloured regions establish the incubation period for the biotinylated liposomes 
(yellow) and streptavidin (beige). HEPES buffer was flowed over the surface for the 
other time periods. The QCM-D responses were consistent with the formation of good 
quality supported lipid bilayers and a monolayer of streptavidin respectively (Richter et 
al., 2007). To the right of the graphs are schematic representations of the predicted 
surface formed on the sensor surface at point 1, and 2.  
 
Throughout all the experiments the formation of the lipid bilayer and the 
streptavidin monolayer was standardised, therefore both parameters were 
fixed. Equally, it is worth noting that other parameters that were fixed 
throughout the experiments included the temperature of the chamber, the flow 
rate and the buffer used. An advantage of this experimental setup was the 
streptavidin monolayer did not interact strongly with either Hapln1 or Acan 
(Figure 25). Therefore, any interaction with the surface observed on 
incubating these molecules was due to the presence of the HA film. 
It is worth noting that unlike HA50 where a combinatorial approach using an 
optical technique and QCM-D has previously been analysed, for both Hapln1 
and Acan this has not been done. Therefore, although it is possible to 
measure the density of HA50 within the assembling film, it is not possible to 
measure the density of Acan or Hapln1 molecules that attached to the HA 
films. Instead, the relative changes in ∆𝑓 and ∆𝐷 were used to analyse the 
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Figure 25. Both Hapln1 and Acan did not interact with the streptavidin 
monolayer measured using QCM-D.  
Both Hapln1 (5 𝜇g/mL) and Acan (100 𝜇g/mL) were incubated at a flow rate of 10 
𝜇L/min. For Acan, the flow rate was increased to 20 𝜇L/min for the duration of the 
incubation period after the dashed line. 
 
Having successfully recreated the lipid bilayer and streptavidin surfaces, the 
next step was to consistently produce sparse and dense HA50 films. Sparse 
HA50 films could consistently be reproduced, with values of ∆𝑓 = -6 ± 1 Hz 
and ∆𝐷 = 2.3 ± 0.4 × 10-6 (Figure 26). The aim was to produce sparse HA50 
films with a shift in ∆𝑓 of approximately -5 Hz to space HA50 molecules 
approximately 31.0 nm apart (𝑟𝑚𝑠 = 31.0 nm), therefore the results 
demonstrated that this was successfully achieved. For dense HA50 surfaces 
HA50 was incubated for 50 min, producing shifts in ∆𝑓 of -36 ± 2 Hz and ∆𝐷 
14.2. ± 0.6 × 10-6, with the HA50 molecules being spaced approximately 11.0 
nm apart (𝑟𝑚𝑠 = 11.0 nm) (Figure 26). These results demonstrated that the 
creation of sparse and dense HA50 films were highly reproducible. The 𝑟𝑚𝑠 
values relate to the approximate distance between each HA50 anchor-point 
to the streptavidin monolayer.  
The next step was to determine the ratio of ∆𝐷/−∆𝑓 for dense and sparse 
surface bound HA50 films to approximate the measure of elastic compliance 
of the films (Figure 27). The ratio of ∆𝐷/−∆𝑓 were 0.39 ± 0.01 × 10-6/Hz for 
dense HA surfaces and 0.40 ± 0.03 × 10-6/Hz for sparse HA surfaces. 
Therefore, the change in density between sparse and dense HA50 films did 
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not have any implication on the ratio of ∆𝐷/−∆𝑓 as the results were not 
significantly different. 
       A                                                         B 
 
     C                                                            D 
 
Figure 26. Values of  ∆𝒇 and ∆𝑫 that demonstated that Sparse HA50 and dense 
HA50 films are highly reproducible.  
Biotinylated HA50 (1 𝜇g/mL) was incubated over a streptavidin monolayer at a flow 
rate of 10 𝜇L/min. A Representative ∆𝑓 and ∆𝐷 QCM-D plots for sparse (cyan and 
orange lines) HA films. B Representative ∆𝑓 and ∆𝐷 QCM-D plots for dense (blue and 
red lines) HA films. The plots include the formation of the lipid bilayer (yellow region) 
and the streptavidin monolayer (beige region). The blue regions indicate the incubation 
of HA50 C+D Sparse HA50 (n = 11 ; cyan and orange) and dense HA50 (n = 21 ; blue 
and red) are presented with the error bars indicating the standard deviation.  
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         A                                                          B  
 
Figure 27. Ratio of ∆𝑫/−∆𝒇 was equal for both sparse and dense HA50 films.  
A Representative plots of ∆𝐷/−∆𝑓	during the formation of sparse (cyan) and dense 
(blue) HA50 films. Formation of HA50 films was measured through the increase in −∆𝑓. 
The variability of results between −∆𝑓 values of 0 to 3 Hz is larger due to the tendencies 
for outliers affecting the measurements of the ∆𝐷/−∆𝑓 ratio, as small changes in both 
∆𝑓 and ∆𝐷 in this range have a large effect on the ratio, that stabilised around 4 Hz.  B 
Values of ∆𝐷/−∆𝑓 measured at the end of incubation for sparse HA50 (n = 11 ; cyan) 
and dense HA50 (n = 21 ; blue) films. 
 
4.3.2 Decreasing the density of HA films increased the binding of Acan 
and Hapln1 
4.3.2.1 Unstable interaction of Acan to HA films 
When Acan was introduced to sparse and dense HA films significantly larger 
shifts in ∆𝑓 and ∆𝐷 were observed on interaction with sparse HA films in 
comparison to dense HA films (Figure 28). The results described here indicate 
that Acan can interact with HA films irrespective of HA surface densities, 
although binding is apparently reduced for denser HA films. The negative ∆𝑓  
(∆𝑓 = -1.8 ± 0.4 Hz and positive ∆𝐷 (∆𝐷 = 2.3 ± 0.4 × 10-6) values indicated 
that Acan was able to interact with the sparse HA films. The positive ∆𝐷 (∆𝐷 
= 1.6 ± 0.2 × 10-6) value on interaction with dense HA films indicated that Acan 
interacted with the surface, however this interaction was undetectable using 
∆𝑓 (∆𝑓 = 0.7 ± 1.2 Hz). Of note, the slight positive ∆𝑓 value could have been 
caused by either a re-organisation of the HA film, suggesting a phase 
transition, or more likely it is an artefact of the very small values of ∆𝑓 detected. 
As expected, the results indicated that Acan interacted more strongly with 
sparse HA50 films, in contrast to dense HA films. The sparse HA50 films were 
produced specifically to space HA50 molecules approximately 11.0 nm apart 
to aid the penetration of Acan to interact within the film, by reducing steric 
hinderance. The results suggested that the larger interaction detected on 
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sparse HA50 films in comparison with dense HA films where HA molecules 
were packed closer together (approximately 11 nm apart), may be due to Acan 
interacting within the HA film.   
After the Acan incubation period during the wash step an increase in ∆𝑓 (2 ± 
0.01 Hz) and a decrease in ∆𝐷 (-1 ± 0.01 × 10-6) values could be observed on 
sparse HA films (Figure 28A). A decrease in ∆𝐷 (-1.25 ± 0.25 × 10-6) was also 
observed on dense HA films. This implied that Acan was dissociating from the 
HA films over time and was therefore not stably bound. To ensure that the 
changes in ∆𝑓 and ∆𝐷 were caused by Acan dissociation, Acan was then re-
introduced to the same HA films, where on re-incubation the original decrease 
in ∆𝑓 and increase in ∆𝐷 values were restored (Figure 28A). Therefore, Acan 
alone is not stably bound to HA films.  
The shifts in ∆𝑓 observed on Acan addition are small on both sparse and 
dense HA50 films in comparison with ∆𝑓 shifts on streptavidin and HA 
addition. Considering the large size of Acan, this result at first appears 
surprising. Values of ∆𝑓 are also affected by other parameters, including 
hydrodynamically trapped solvent, the thickness of the film, the mechanical 
properties of the bound molecules and the mechanical properties of the 
resulting film. To further determine how the surfaces change in response to 
Acan incubation the ratio of ∆𝐷/−∆𝑓 was analysed. 
The addition of Acan significantly increased the ratio of ∆𝐷/−∆𝑓 for both 
dense (p ≤ 0.0005) and sparse (p ≤ 0.0005) HA surfaces when compared 
with HA surfaces alone (Figure 29). These results indicated that the surfaces 
were becoming more compliant. The ∆𝐷/−∆𝑓  ratio was significantly larger on 
sparse HA surfaces (0.70 ± 0.06 × 10-6/Hz) in comparison with dense HA 
surfaces (0.46 ± 0.01 × 10-6/Hz) (Figure 29). Therefore, the addition of Acan 
caused sparse HA films to become significantly more compliant than dense 
HA films.  
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    A                                                                               B 
 
Figure 28. The density of HA50 films influenced Acan assembly.  
A Representative ∆𝑓 and ∆𝐷 QCM-D plots for sparse (cyan and orange lines) and 
dense (blue and red lines) HA films. The plots include the formation of the lipid bilayer 
(yellow region) and the streptavidin monolayer (beige region). The blue regions 
indicate the incubation of HA50 (1 𝜇g/mL), with the green regions indicating the 
incubation of Acan (100 𝜇g/mL). B Changes in ∆𝑓 and ∆𝐷 when Acan is introduced to 
sparse (cyan and orange; n = 5) and dense (blue and red; n = 10) HA50 films. The 
values represent the changes in ∆𝑓 and ∆𝐷 between the start and the end of Acan 
incubation (the difference between the start and end of the green region). Both ∆𝑓 (p 
≤ 0.0005) and ∆𝐷 (p = 0.018) values were significantly different. The mean and 
standard deviations are presented. The lines above the graph represent statistical 
significance: p ≤ 0.05 (*), p ≤ 0.0005 (***). 
 
 
Figure 29. The ratio of ∆𝑫/−∆𝒇 for sparse and dense HA50 films with and 
without the addition of Acan.  
Sparse HA50 films without Acan had a ∆𝐷/−∆𝑓	ratio of 0.40 ± 0.03 × 10-6/Hz (n = 11) 
and a ∆𝐷/−∆𝑓	ratio of 0.70 ± 0.06 × 10-6/Hz (n = 5) with the addition of Acan. Dense 
HA50 films without Acan had a ∆D/-∆f ratio of 0.39 ± 0.01 × 10-6/Hz (n = 21) and a 
∆𝐷/−∆𝑓	ratio of 0.46 ± 0.01 × 10-6/Hz (n = 10) with the addition of Acan. The mean 
and standard deviation are presented. The lines above the graph represents statistical 
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4.3.2.2 Stable interaction of Hapln1 with HA films 
Hapln1 was observed to readily interact stably with both dense and sparse 
HA50 films (Figure 30A). Hapln1 interaction with HA50 was stable, as no 
change in ∆𝑓 or ∆𝐷 was observed after the Hapln1 incubation during the wash 
step. A larger shift in ∆𝑓 was observed on Hapln1 interaction with sparse HA50 
films in comparison with dense HA50 films (p ≤ 0.05)  (Figure 30B). The larger 
negative shifts in ∆𝑓 observed on sparse HA50 films (∆𝑓 = -42 ± 6 Hz) in 
comparison with dense HA50 films (∆𝑓 = -29 ± 10 Hz) suggested that more 
Hapln1 was able to interact with the surface. However, it is difficult to conclude 
with certainty that more Hapln1 is interacting with sparse HA50 films, as other 
factors also contribute to shifts in ∆𝑓 including solute binding, trapped solvent 
and changes to the mechanical properties of the film. Until QCM-D is paired 
with another technique such as spectroscopic ellipsometry to gain a 
measurement of the change in density and thickness of the film on Hapln1 
incubation the difference in shifts in ∆𝑓 observed on dense and sparse HA50 
films indicate that HA density is causing a change to the assembly of films that 
requires further analysis. For this reason, to further determine how the 
surfaces change in response to Hapln1 incubation the ratio of ∆𝐷/−∆𝑓 was 
analysed. There was no difference in ∆𝐷 values measured on interaction with 
dense (∆𝐷 = 5.1 ± 1.0 × 10-6) and sparse (∆𝐷 = 5.0 ± 0.4 × 10-6) HA films. 
The ratio of ∆𝐷/−∆𝑓 for sparse HA / Hapln1 films (0.15 ± 0.01 × 10-6/Hz) was 
significantly lower than the ratio of dense HA / Hapln1 films (0.29 ± 0.02 × 10-
6/Hz) (Figure 31). For both dense and sparse HA films the addition of Hapln1 
caused a decrease in the ∆𝐷/−∆𝑓 ratio, indicating that Hapln1 caused HA 
films to become less compliant (more rigid). 
Although the size of Hapln1 is not known, it is assumed to be a globular protein 
so its size could be roughly estimated using its spherical volume to be 
approximately 3 – 5 nm in diameter (Erickson, 2009). In contrast, the size of 
HA50 is approximately 116 nm, therefore it is theoretically possible for 
approximately 29 Hapln1 molecules to interact with a single HA50 molecule. 
In both the sparse and dense HA50 conditions Hapln1 does not reach 
saturation, therefore there are still available Hapln1 binding sites after 
incubation. Although it cannot be concluded with certainty until additional 
measurements of the change in density of the surface are measured, the 
results indicated that it is likely that multiple Hapln1 molecules are interacting 
with each HA50 molecule, as reducing the density of HA50 in the sparse HA 
condition did not result in Hapln1 reaching saturation during the incubation 
period. 
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      A                                                                            B 
 
Figure 30. The density of HA50 films influenced Hapln1 assembly.  
A Representative ∆𝑓 and ∆𝐷 QCM-D plots for sparse (cyan and orange lines) and 
dense (blue and red lines) HA films. The plots include the formation of the lipid bilayer 
(yellow region) and the streptavidin monolayer (beige region). The blue regions 
indicate the incubation of HA50 (1 𝜇g/mL), with the red regions indicating the incubation 
of Hapln1 (5 𝜇g/mL). B Changes in ∆𝑓 and ∆𝐷 when Hapln1 is introduced to sparse 
(cyan and orange; n = 4) and dense (blue and red; n = 6) HA50 films. The values 
represent the changes in ∆𝑓 and ∆𝐷 between the start and the end of Hapln1 
incubation (the difference between the start and end of the red region). The mean and 
standard deviation are presented. The line below the graph represents statistical 
significance: p ≤ 0.05 (*). 
 
 
Figure 31. The ratio of ∆𝑫/−∆𝒇 for sparse and dense HA50 films with and 
without the addition of Hapln1.  
Sparse HA50 films without Hapln1 had a ∆𝐷/−∆𝑓	ratio of 0.40 ± 0.03 × 10-6/Hz (n = 
11) and a ∆𝐷/−∆𝑓	ratio of 0.15 ± 0.01 × 10-6/Hz (n = 4) with the addition of Hapln1. 
Dense HA50 films without Hapln1 had a ∆𝐷/−∆𝑓	ratio of 0.39 ± 0.01 × 10-6/Hz (n = 
21) and a ∆𝐷/−∆𝑓	ratio of 0.29 ± 0.02 × 10-6/Hz (n = 6) with the addition of Hapln1. 
The mean and standard deviation are presented. The lines above the graph represents 
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4.3.3 Stabilisation of HA and Acan is achieved by the addition of Hapln1 
irrespective of the order of incubation 
Having established the interaction of Hapln1 and Acan individually on HA 
films, the next step was to understand how the three molecules interact 
together to form macromolecular HA / Hapln1 / Acan films. The order of 
incubation of Hapln1 and Acan was investigated to determine if the presence 
of one of the molecules affects the interaction of the other molecule with the 
HA50 films. If Hapln1 is then immediately presented to the surface following 
Acan incubation a large decrease in ∆𝑓 and a large increase in ∆𝐷 can be 
observed (Figure 32D). Therefore, Hapln1 was able to interact with the HA / 
Acan surfaces. After HAPLN1 addition, during the wash step ∆𝑓 values did 
not increase and values of ∆𝐷 did not decrease (Figure 32E). This implied that 
following Hapln1 incubation Acan bound stably to the HA films.  
 
Figure 32. Acan interacts unstably with sparse (cyan and orange) and dense 
(blue and red) HA films without the presence of Hapln1.  
Representative ∆𝑓 and ∆𝐷	QCM-D plots for sparse (n = 2) and dense (n = 2) HA films. 
A The incubation period for Acan (100 𝜇g/mL): ∆𝑓 = - 2 ± 0 Hz, ∆𝐷 = 2 ± 0 × 10-6 for 
sparse HA films and ∆𝑓 = -0.5 ± 0.5 Hz, ∆𝐷 = 1.5 ± 0 × 10-6 for dense HA films. B 
Wash step following Acan incubation. C Re-incubation period of Acan (100 𝜇g/mL): ∆𝑓 
= -2 ± 0 Hz, ∆𝐷 = 1 ± 0 × 10-6 for sparse HA films and (∆𝑓 = 0.5 ± 0.5 Hz, ∆𝐷 = -1.25 
± 0.25 × 10-6 for dense HA films. D The incubation period for Hapln1 (5 𝜇g/mL): ∆𝑓 = 
- 37 ± 6 Hz, ∆𝐷 = 5.25 ± 0.75 × 10-6 for sparse HA films and ∆𝑓 = - 18 ± 1 Hz, ∆𝐷 = 
3.25 ± 0.25 × 10-6 for dense HA films. E The wash step following Hapln1 incubation. 
The coloured areas represent the incubation period for HA (blue), Acan (green) and 
Hapln1 (red). 
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The sequential order of incubation was then switched so Hapln1 was 
presented to HA films first, followed by Acan incubation (Figure 33). Following 
Acan incubation to HA / Hapln1 films Acan ∆𝑓 and ∆𝐷 values remained stable 
(Figure 33D). Therefore, Hapln1 was able to stabilise the interaction of Acan 
to HA films, irrespective of the order of incubation. The binding of Hapln1 to 
HA films did not interfere with its ability to stabilise Acan.  
During the wash step following Hapln1 incubation over dense and sparse HA 
films there was no change in ∆𝑓 or ∆𝐷 (Figure 33B). Therefore, the interaction 
of Hapln1 with HA films is stable, without the presence of Acan.  
 
 
Figure 33. Acan interacts stably with sparse (cyan and orange) and dense (blue 
and red) HA / Hapln1 films.  
Representative ∆𝑓 and ∆𝐷	QCM-D plots for sparse (n = 4) and dense (n = 6) HA films. 
A The incubation period for Hapln1 (5 𝜇g/mL): ∆𝑓 = -42  ± 6 Hz, ∆𝐷 = 5 ± 0.4 × 10-6 for 
sparse HA films and ∆𝑓 = -29 ± 10 Hz, ∆𝐷 = 5.1 ± 1.1 × 10-6 for dense HA films. B 
Wash step following Hapln1 incubation. C The incubation period for Acan (100 𝜇g/mL): 
∆𝑓 = -6.5 ± 2.5 Hz, ∆𝐷 = 1.6 ± 0.9 × 10-6 for sparse HA films and ∆𝑓 = -7 ± 3 Hz, ∆𝐷 = 
4.5 ± 0.3 × 10-6 for dense HA films. D The wash step following Acan incubation. The 
coloured areas represent the incubation period for HA (blue), Hapln1 (red) and Acan 
(green). 
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4.3.4 The density of Hapln1 influenced Acan interaction with HA / Hapln1 
films 
To further understand how Hapln1 influenced the interaction of Acan with HA 
films, HA / Hapln1 films of different Hapln1 density were created to observe 
how Acan interacted with them. When comparing the interaction of Acan on 
sparse HA films with either no Hapln1, sparse amounts of Hapln1 or dense 
amounts of Hapln1 it is clear that the interactions are not equal (Figure 34). 
The change in ∆𝑓 and ∆𝐷 on Acan incubation were not significantly different 
for sparse HA films (∆𝑓 = -1.8 ± 0.4 Hz, ∆𝐷 = 2.3 ± 0.4 × 10-6) alone and 
sparse HA / sparse Hapln1 films (∆𝑓 = -2.5 ± 0.7 Hz, ∆𝐷 = 3.5 ± 0 × 10-6) 
however, the change in the ratio of ∆𝐷/−∆𝑓 was. Interestingly, in the sparse 
HA / dense Hapln1 condition a significantly larger decrease in ∆𝑓 (∆𝑓 = -6.5 ± 
2.5 Hz) was measured in comparison to the other conditions, however this 
correlated with a significantly smaller shift in ∆𝐷 (∆𝐷 = 1.6 ± 0.9 × 10-6). 
Therefore, the ratio of ∆𝐷/−∆𝑓 was significantly smaller in the sparse HA / 
dense Hapln1 condition. Therefore, on sparse HA films Acan was less able to 
influence the mechanical properties as the density of Hapln1 increased. 
Sparse HA surfaces with less Hapln1 become more compliant on Acan 
incubation. 
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Figure 34. The density of Hapln1 within sparse HA films influenced the ability of 
Acan to change the ∆𝑫/−∆𝒇 ratio.  
Sparse HA films with either no Hapln1 (n = 5, beige), sparse amounts of Hapln1 (n = 
2, green) or dense amounts of Hapln1 (n = 4, purple) were compared. A The change 
in ∆𝑓 values on Acan incubation. B The change in ∆𝐷 values on Acan incubation. C 
The change in the ∆𝐷/−∆𝑓	 ratio on Acan incubation. The lines above the graph (below 
in A) represents statistical significance: p ≤ 0.05 (*), p ≤ 0.005 (**) and p ≤ 0.0005 (***). 
 
When Acan was incubated over dense HA films with no Hapln1 (∆𝑓 = 0.7 ± 
1.2 Hz, ∆𝐷 = 1.6 ± 0.2 × 10-6) and sparse amounts of Hapln1 (∆𝑓 = 0.6 ± 0.5 
Hz, ∆𝐷 = 1.8 ± 0.3 × 10-6), the change in values of ∆𝑓 and ∆𝐷 were not 
significant (Figure 35A, B). The change in ∆𝑓 and ∆𝐷 was significantly larger 
in the dense HA / dense Hapln1 condition (∆𝑓 = -7 ± 3 Hz, ∆𝐷 = 4.5 ± 0.3 × 
10-6) in comparison to the other conditions. Interestingly, in contrast to sparse 
HA surfaces, the change in the ratio ∆𝐷/−∆𝑓 was unaffected by the density 
of Hapln1 (Figure 35C). Therefore, regardless of the density of Hapln1 present 
in the HA film, Acan influenced the mechanical properties of the films similarly, 
causing them to become slightly more compliant. It is important to note that 
although the surfaces become more compliant, the increase in the ratio of 
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Figure 35. The density of Hapln1 within dense HA films did not influence the 
ability of Acan to change the ∆𝑫/−∆𝒇 ratio.  
Dense HA films with either no Hapln1 (n = 10, beige), sparse amounts of Hapln1 (n = 
5, green) or dense amounts of Hapln1 (n = 6, purple) were compared. A The change 
in ∆𝑓 values on Acan incubation. B The change in ∆𝐷 values on Acan incubation. C 
The change in the ∆𝐷/−∆𝑓	 ratio on Acan incubation. The lines above the graph 
represents statistical significance: p ≤ 0.0005 (***). 
 
4.3.5 Tn-R was not detected interacting with the HA / Hapln1 / Acan films  
Having established stable HA50 / Hapln1 / Acan films the aim was to analyse 
how Tn-R, another PNN-associating molecule that has been linked with cross-
linking Acan via the G3 domain, interacted with the films. Tn-R was not 
detected interacting with either the sparse HA50 or dense HA50 films that 
contained dense amounts of Hapln1 and Acan (Figure 36). This was an 
unexpected result as the assumption would be that Tn-R would be able to 
interact with the Acan present within the films. The result may indicate that the 
interaction of Tn-R with Acan cannot be detected due to the interaction taking 
place too far away from the sensor surface to be detected by shifts in ∆𝑓 or 
∆𝐷. However, as Tn-R is hypothesised to cross-link CSPGs the expectation 
would have been that the interaction would have been detected by a decrease 
in ∆𝐷/−∆𝑓 (Aspberg, 1995; Chiquet-Ehrismann and Tucker, 2011; Morawski 
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within the films due to the conformation of the film preventing the interactions 
from taking place. If the G3 domains of Acan are not present on the surface 
of the film, then the interaction with Tn-R may not be possible due to steric 
hinderance. Due to the size of Acan being distinctively larger than the HA50 
and Hapln1 molecules it is unlikely that all the G3 domains would be 
concealed within the film. One further possibility is that the bovine articular 
cartilage Acan present within the films may not contain G3 domains. As the 
percentage of G3 positive Acan molecules in the bovine articular cartilage was 
unknown this was considered to be the most likely explanation for the lack of 
Tn-R interactions observed.  
 
 
Figure 36. Both sparse HA50 (cyan and orange lines) and dense HA50 (blue and 
red lines) films containing Hapln1 and Acan did not interact with Tn-R.  
Representative ∆𝑓 and ∆𝐷	QCM-D plots for sparse (n = 2) and dense (n = 2) HA films. 
A The incubation period for Hapln1 (5 𝜇g/mL). B The incubation period for Acan (100 
𝜇g/mL). C The incubation period for Tn-R (20 𝜇g/mL) where no detectable changes in 
∆𝐷 or ∆𝑓 were observed. The coloured areas represent the incubation period for HA 
(blue), Hapln1 (red), Acan (green) and Tn-R (yellow). 
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To further understand why Tn-R was not detected interacting with the films 
the interaction assay and surface functionalisation with the QCM-D chamber 
was changed and used to investigate whether the interaction of Tn-R and 
Acan could be detected using QCM-D. This was achieved by using a lipid 
bilayer that contained tris-Ni2+-NTA groups that could anchor Tn-R molecules 
via their C-terminal polyhistidine-tag, which would be expected to lead to a 
favourable protein orientation on the surface (Figure 37). This meant that a 
stable surface of Tn-R could be produced that allowed Acan samples to be 
injected over it. As the interaction would occur closer to the sensor surface it 
was more likely to be detected by shifts in ∆𝑓 and ∆𝐷. This setup was possible 
as both the bovine articular cartilage Acan and pig laryngeal Acan samples 
used do not contain polyhistidine-tags. The reason for using pig laryngeal 
cartilage was due to it being mostly void of G3 domains. As the interaction of 
Tn-R with Acan is known to be calcium-dependent via the G3 domains of Acan 
the expectation was that Tn-R would be unable to interact with the pig 
laryngeal Acan and would only interact in conditions that contained calcium 
ions (Aspberg, 1995; Aspberg et al., 1997).  
 
 
Figure 37. A schematic representation of the predicted interaction of Tn-R and 
Acan when the Tn-R is trapped to the sensor surface via a lipid bilayer containing 
tris-Ni2+-NTA groups.  
 
Tn-R stably interacted with the DODA-tris-Ni2+-NTA lipid bilayer (Figure 38A). 
Unexpectedly, the interaction of Tn-R with the tris-Ni2+-NTA groups was 
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negatively affected by the presence of EGTA, as following Tn-R incubation 
shifts in ∆𝑓 and ∆𝐷 were ∆𝑓 = -4.5 ± 0.5 Hz, ∆𝐷 = 1.5 ± 0.3 × 10-6 (n = 3) in 
the no calcium ion conditions and ∆𝑓 = -19 ± 4.6 Hz, ∆𝐷 = 3.7 ± 0.9 × 10-6 (n 
= 5) in conditions containing calcium ions. Although the interaction of the Tn-
R polyhistidine-tag with the tris-Ni2+-NTA group is not calcium ion dependent, 
the presence of EGTA may have chelated Ni2+ ions that are involved in the 
process, resulting in the differences observed. To observe whether the two 
Acan samples interacted with the lipid bilayer controls were ran by injecting 
Acan into the chamber without the presence of Tn-R. Both bovine articular 
cartilage (∆𝑓 = -1.5 ± 0.5 Hz, ∆𝐷 = 0.8 ± 0.01 × 10-6 ; n = 2) and pig laryngeal 
Acan (∆𝑓 = -1.5 Hz, ∆𝐷 = 2 × 10-6 ; n = 1) interacted with the lipid bilayer, 
though the responses were small, suggesting that the interactions were minor. 
To account for these non-specific interactions these values were subtracted 
from the ∆𝑓 and ∆𝐷 values when assessing the interaction of the Acan 
samples with Tn-R. 
Both bovine articular cartilage and pig laryngeal Acan were not detected 
interacting with Tn-R in conditions without calcium ions, as no shifts in ∆𝑓 or 
∆𝐷 were observed (Figure 38). When bovine articular cartilage Acan was 
presented to Tn-R that was pre-bound to the lipid bilayer an interaction was 
detected that was more than the non-specific interactions of Acan with the 
lipid bilayer  (∆𝑓 = -1 ± 0.5 Hz, ∆𝐷 = 2.9 ± 0.15 × 10-6 ; n = 3). In contrast, 
when pig laryngeal cartilage was presented to the same surfaces the 
interactions were minor, as the shifts in in ∆𝑓 and ∆𝐷 were very similar to the 
shifts observed when presented to the lipid bilayer alone. Therefore, these 
results indicated that the interaction of Tn-R and Acan can be detected using 
QCM-D, with the interactions behaving as expected, as it required the 
presence of Acan G3 domains and calcium ions (Aspberg, 1995; Aspberg et 
al., 1997).      
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Figure 38. Tn-R interacts with bovine articular cartilage Acan in a calcium-
dependent manner.    
Representative ∆𝑓 and ∆𝐷	QCM-D plots for the interaction of bovine articular cartilage 
(light green ; 100 𝜇g/mL). and pig laryngeal cartilage (dark green; 100 𝜇g/mL) with Tn-
R (yellow ; 20 𝜇g/mL). The top row represents bovine articular cartilage, while the 
bottom row represents pig largyngeal Acan. The plots in the leftmost column represent 
experiments conducted without calcium ions due to the addition of 1mM EGTA (a 
calcium ion chelator) to the HEPES buffer. Both the middle and rightmost columns 
represent experiments conducted in HEPES buffer with the addition of 5 mM CaCl2. 
The wash step (grey) involved injecting 500 mM imidazole into the chamber. In all 
experiments following the wash step both ∆𝑓 and ∆𝐷 returned to the baseline. A The 
incubation period for Tn-R.  B The incubation period for Acan. C The incubation period 
for 500 mM imidazole. The shifts in ∆𝑓 and ∆𝐷 detected when moving from imidazole 
to HEPES buffer do not represent surface events but are due to changes in the solution 
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4.4 Discussion 
Through the successful establishment of a model surface for analysing the 
supramolecular self-organisation of PNN components, the importance of HA 
density has been highlighted. The binding of both Acan and Hapln1 were both 
affected by manipulating the density of HA50 films. Furthermore, the density 
of Hapln1 also influenced Acan interaction with HA / Hapln1 films, indicating 
that density of PNN components may be an important and integral factor in 
PNN assembly. The stabilisation of HA and Acan is achieved by the addition 
of Hapln1 irrespective of the order of incubation, emphasising the importance 
of Hapln1 in stabilising the supramolecular PNN surface. 
The interaction of Acan with HA films required Hapln1 to stabilise the 
interaction. Acan interaction with HA films alone is unstable. This supported 
previous work that measured the interaction of HA, Hapln1 and the G1 domain 
of Acan using SPR (Shi et al., 2004). Shi et al (2004) used pre-incubated Acan 
and Hapln1 and incubated them over HA surfaces together. Furthermore, 
Acan has previously been observed to interact with HA films reversibly (Attili 
and Richter, 2013).  
The results in this chapter suggested that Acan and Hapln1 do not need to 
form a complex prior to being introduced to HA films to form HA / Hapln1 / 
Acan complexes. Therefore, the sequential order of incubation of Hapln1 and 
Acan was unimportant for the formation of stable macromolecular complexes. 
In the formation of PNNs, Hapln1 has previously been highlighted as an 
essential component to the stable interaction of CSPGs with HA, as when 
Hapln1 is not present PNN surfaces are more diffuse and unstable (Carulli et 
al., 2010; Kwok et al., 2010). Mechanistically, this may partially be explained 
through the reversible binding of CSPGs to surface-bound HA without the 
presence of link protein.  
Hapln1 was able to interact with Acan when already bound to HA. The Acan 
binding site on Hapln1 was unimpeded by the interaction of Hapln1 with HA. 
Equally, Acan was able to form a stable complex with Hapln1 even when 
previously bound to HA. Although the crystal structure of Hapln1 is not known, 
it implied that the HA and Acan binding sites on the Hapln1 molecules must 
be spaced far enough away to not sterically impede each other.  
The interaction of Hapln1 with HA films was stable without the presence of 
Acan being required. This could present a potential mechanism for the 
restricted formation of PNNs on cell surfaces. HA is ubiquitously present in 
the pericellular space of most cells and within the CNS CSPGs are abundant 
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and integral to the ECM, yet not all cells in the CNS produce PNNs (Deepa et 
al., 2006; Rodriguez-Martinez et al., 2016). Potentially, Hapln1 may be 
required to stably interact with surface-bound HA, whereby the stabilised 
interaction would result in an accumulation of Hapln1 over time. As HA / 
Hapln1 films are able to stably interact with Acan, they would aggregate Acan 
over time. This may partially explain why the formation of PNNs was reduced 
without the presence of Hapln1 to stabilise the PNN structure. 
Dense HA films resulted in a reduction in the molecular interactions on Acan 
and Hapln1 incubation in comparison with sparse HA films. Therefore, a 
reduction in HA density resulted in an increase in surface-bound molecules. 
As the sparse HA films were specifically designed to space the HA molecules 
at a distance similar to the thickness of Acan molecules, this result implied 
that the reduced interaction with dense HA films is a result of steric hindrance. 
With the HA molecules spaced close together both Acan and Hapln1 appear 
to be unable to penetrate into the surface. On sparse HA films more binding 
sites were accessible which resulted in the greater interaction observed in this 
condition. This result suggests the importance of HA density within the 
pericellular space during the formation of PNNs. Currently, it is unknown how 
densely packed the HA molecules are within the pericellular space during the 
formation of PNNs. Potentially, further research could be done to predict this 
density by assessing the density of HAS molecules present within the cell 
surface using histochemical and imaging techniques.   
 
The introduction of Acan to both sparse and dense HA films caused an 
increase in ∆𝐷/−∆𝑓 that is likely to be a consequence of two-dimensional 
confinement (Attili and Richter, 2013). The increase in ∆𝐷/−∆𝑓 suggested 
that there is a swelling of the HA films that caused the softening effect 
measured. This swelling of the HA film and stretching of the HA chains is likely 
caused by a combination of volume exclusion by the presence of the 
additional Acan molecules and electrostatic repulsion caused by the 
negatively charged GAG chains (Attili and Richter, 2013). On sparse HA films 
caused the ratio ∆𝐷/−∆𝑓 to increase, while this increase was small on dense 
HA films. On sparse HA films it suggested that Acan was able to interact 
between the HA molecules, as was previously observed on larger HA 
molecules where the interaction of Acan greatly increased the value of ∆𝐷 
(Attili and Richter, 2013). Therefore, the surfaces become more compliant as 
a result of the combination of HA and Acan forming a homogenous film. In 
contrast, the limited increase in the ∆𝐷/−∆𝑓 ratio measured on dense HA films 
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suggested that the surface being formed was different. Potentially, Acan was 
only able to interact with the top of the dense HA50 surface. As the ratio of 
∆𝐷/−∆𝑓 is a measurement of the bulk surface, potentially the Acan may not 
interact in large enough densities to form a homogenous film on the surface 
of HA50 to effect the mechanical properties of the bulk film (Reviakine et al., 
2011). Future work investigating the topological properties of the surfaces 
formed by AFM may provide a greater indication of whether this explanation 
is correct. 
The interaction of Hapln1 with HA films alone was influenced by the density 
of the HA film. Hapln1 caused a reduction in the ratio ∆𝐷/−∆𝑓 which implied 
that Hapln1 is able to rigidify the surface, making it less compliant. This effect 
was more pronounced on sparse HA films, likely as a consequence of the 
increased Hapln1 interactions. This presents a potential mechanism for 
influencing the biomechanical properties of HA films through varying the 
degree of Hapln1 interaction.  
Furthermore, the density of Hapln1 also influenced the molecular binding of 
Acan. On sparse HA films, the presence of dense amounts of Hapln1 caused 
a reduction in the ability of Acan to affect the ∆𝐷/−∆𝑓 ratio. This may suggest 
that a high density of Hapln1 is able to collapse the HA films. This would 
present a scenario similar to the dense HA50 films, as Acan could then only 
interact with the top of the sparse HA surface. Without being able to 
incorporate into the HA surface Acan would be unable to influence the 
mechanical properties of the bulk HA surface. As Hapln1 density is reduced, 
the HA becomes less collapsed, thereby allowing Acan to become more 
incorporated into the HA surface between the HA molecules, where it could 
then affect the bulk properties of the surface more significantly. Therefore, this 
presents a potential mechanism for influencing the mechanical properties of 
PNNs through the regulation of Hapln1 density. 
The observation that Tn-R was not detected interacting with HA films that 
contained Acan suggested that there may not be enough Acan G3 domains 
available within the film to interact with. Furthermore, the interaction of Tn-R 
with Acan could be detected using QCM-D when Acan was presented to 
surface-anchored Tn-R. The interaction behaved as expected, supporting 
previous results that Tn-R interacts with Acan via the G3 domain in a calcium 
dependent manner (Aspberg, 1995; Aspberg et al., 1997). This result also 
provided evidence that the Acan sample used to create the in vitro PNN model 
surfaces does contain G3 domains. However, as the experiment used pre-
bound Tn-R that would only interact with G3 containing Acan variants, what 
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remains unknown is the percentage of Acan variants within the bovine 
articular cartilage Acan that are G3 positive. As the shifts in both ∆𝑓 and ∆𝐷 
were relatively small, it may indicate that the percentage of G3 positive Acan 
molecules is also small. This may explain why the interaction of Tn-R with 
Acan was not detectable.  
Through the demonstration of stable HA / Hapln1 / Acan films being formed 
within the QCM-D chambers, these results provided a proof of principle that it 
is possible to establish an in vitro PNN model surface using QCM-D that can 
measure both biochemical and biomechanical properties of the surface in real-
time. As PNNs have been observed to be potentially therapeutically relevant 
to a variety of neurological diseases, it highlights the importance of producing 
a method to interrogate PNN surfaces in an in vitro system that has the ability 
to be commercially scaled (Morawski et al., 2004; Pantazopoulos et al., 2010; 
McRae and Porter, 2012; Yang et al., 2015; Rankin-Gee et al., 2015; Enwright 
et al., 2016). To develop this model further, a measurement for the range of 
sizes of HA present within PNNs is required. Furthermore, developing this 
method through the purification of other PNN molecules, such as the other 
CSPGs and Haplns found in PNNs will allow for the recreation of more 
accurate PNN surfaces.  
In conclusion, a new technique for modelling the formation of PNNs has been 
established. This new method provides an extremely useful platform for the 
study and analysis of various PNN molecules to its formation. The technique 
has provided unique insights into the formation of PNNs, as irrespective of the 
order of incubation Hapln1 and Acan were able to form stable, PNN-like, 
macromolecular structures with surface-bound HA. Through altering the 
density of surface-bound HA, as well as the density of Hapln1 the mechanical 
properties of the films can be altered. Therefore, this indicates two potential 
mechanisms for altering the biomechanical properties of PNNs.   
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Chapter 5: Sizing GAGs  
5.1 Introduction 
This chapter focuses on the production of a methodology to measure the size 
of GAG chains using QCM-D. Although the methodology could eventually be 
used to measure the size of any disordered polysaccharide chain, the 
methodology has been produced and optimised for measuring the size of HA 
chains. The use of this method for measuring other GAG chains will be 
considered in the discussion section, with the introduction specifically 
focussing on the importance of HA size. As well as being the molecule that 
optimised the methodology, it is also essential for the formation PNNs (Kwok 
et al., 2010). Unlike other GAGs, HA is not sulfated and has no known post-
translational modifications, Therefore the size of the HA chains and where 
they are expressed are likely to contribute a major part of their function.  
HA function and biosynthesis by HAS is described in detail in section 1.4.1, 
therefore this chapter will focus specifically on the size of HA and the 
methodologies that can measure the size of the polymer chains. HA is known 
to have different biological functions depending on size (Jiang et al., 2007; 
Cyphert et al., 2015; Tavianatou et al., 2019). HA chain length appears to 
influence cell apoptosis, proliferation and mobility in vertebrates (West and 
Kumar, 1989; Day and Prestwich, 2002; Ghatak et al., 2002; Noble, 2002; 
Stern, 2003; Jing et al., 2006). The importance of HA size is suggested by the 
presence of 3 isozymes of HAS (HAS1, HAS2 and HAS3) that synthesise 
differing lengths of HA chains (Itano et al., 1999). HAS1 and HAS2 synthesise 
longer HA chains (200 kDa to 2 MDa) in comparison with HAS3 that 
synthesises shorter HA chain lengths (100 kDa to 1 MDa) (Itano et al., 1999). 
The range of sizes synthesised by HAS1 and HAS2 also differed, as HAS2 
consistently produced the largest HA chains, with HAS1 synthesising a wider 
range of HA sizes (Itano et al., 1999). The HAS enzymes also show differential 
expression patterns throughout embryogenesis, with HAS1 being 
preferentially expressed during early stages of development, HAS3 in late 
stages of development and HAS2 expression occurring throughout 
development, overlapping with the expression of both HAS1 and HAS3 (Tien 
and Spicer, 2005). Within the mature CNS it has been observed that HAS1 
mRNA is absent in the adult cerebellum (Carulli et al., 2006), though present 
in other regions suggesting that the pattern of HAS expression may differ in 
different CNS regions. 
  - 96 -  
In addition to control of HA size being regulated by its synthesis, the 
breakdown of HA by hyaluronidases present a second method for regulating 
HA size. Hyaluronidases function by specifically hydrolysing the 𝛽-1,4 linkage 
of the HA molecule (Stern, 2004; Stern and Jedrzejas, 2006). The expression 
pattern of different hyaluronidases differ throughout the mammalian body 
(Triggs-Raine et al., 1999). Hyaluronidases are known to be important in 
regulating the concentrations of HA, as deficiencies in hyaluronidases are 
associated with certain disorders including mucopolysaccharidosis IX, where 
increased levels of HA are observed (Natowicz et al., 1996; Triggs-Raine et 
al., 1999). It is also worth noting that reactive oxygen species produced during 
the inflammatory response have the ability to breakdown HA chains (Šoltés et 
al., 2006). Smaller HA chain sizes are associated with the inflammatory 
response, though alone do not appear to be enough to trigger inflammation in 
the skin (Muto et al., 2014). What is currently unknown is if hyaluronidases 
are used to regulate the size of HA chains tethered to the surface of cells.  
HA size is also an important consideration when determining its function in 
forming supramolecular assemblies with proteins. HA size could alter the 
ability for these structures to form, as well as potentially alter the biomolecular 
properties of the supramolecular assemblies. When discussing 
supramolecular assemblies throughout this thesis it has been in reference to 
the assembly of PNNs. However, it is important to note HA is important in the 
production of other supramolecular assemblies. One example is in the 
formation of cartilage, where HA is responsible for producing the soft, 
hydrated ECM supramolecular composition that helps protect joints from 
compressive forces, while also lubricating the joint (Balazs et al., 1967). In 
young, healthy cartilage, the majority of HA sizes were over 2.5 MDa, 
however, age-related decreases in HA size were observed over time, which 
correlated with decrease in the joint quality (Temple-Wong et al., 2016). 
Another example of a supramolecular assembly where HA is essential is the 
assembly of the cumulus cell-oocyte complex (COC) matrix (Cherr et al., 
1990). Like PNNs, the COC matrix requires cross-linking to stabilise the 
structure, as when cross-linking proteins were enzymatically degraded the 
structure was unstable (Cherr et al., 1990). Research on the COC matrix has 
identified heavy chains as direct cross-linkers of HA (Zhuo et al., 2001), as 
well as indirect cross-linkers including a tertiary complex involving pentraxin 3 
(PTX3), TNF-stimulated gene-6 (TSG-6) and inter-α-inhibitor (IαI) (Salustri et 
al., 2004; Scarchilli et al., 2007; Baranova et al., 2013; Baranova et al., 2014). 
TSG-6 induced cross-linking of HA has also been suggested as being 
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important to the inflammatory response (Baranova et al., 2011). The ability for 
HA to cross-link is likely to be dependent on the size of the HA chains.  
HA size is also important for recognition of cell surface receptors, such as 
CD44, where the mechanism of superselectivity has been proposed (English 
et al., 1998; Lesley et al., 2000; Wolny et al., 2010; Dubacheva et al., 2015). 
The mechanism of superselectivity proposed by Dubacheva et al (2015) 
directly implicates HA size as an important factor in this mechanism as  
increased HA size facilitated increased binding to more CD44 receptors, 
strengthening the interaction on artificial membranes (Wolny et al., 2010).  
It is important to note that there is a growing number of therapeutic products 
that are incorporating HA, therefore there is a requirement for the stringent 
quality control of HA that will include sizing of the HA chains, that would benefit 
from methodologies that can size HA efficiently and cheaply (Goa and 
Benfield, 1994). Protocols that aim to do this may eventually be useful to 
industrial applications, as well as to academia.   
Defining the relative size ranges of HA chains is important, as currently there 
is no agreed nomenclature for defining the different HA size ranges. A 
consequence of this is the differential categorisation of HA chains into HMW 
and low molecular weight (LMW). Depending on the article LMW HA can be 
categorised from being a few disaccharides to being 700 kDa (Cyphert et al., 
2015). Although there is agreement that HA chains of over 1 MDa are 
considered HMW (Cyphert et al., 2015), there is still debate on where the 
lower boundary of HMW HA should be. For this reason, throughout this 
chapter instead of using the HMW and LMW nomenclature, the sizes of the 
HA chain ranges will instead be directly stated.  
Methodologies for measuring the size of GAGs, as well as other 
polysaccharide chains are limited due to the disordered nature of the 
molecules. Unlike proteins that are more stable and can have their structure 
resolved using imaging techniques this is not possible with polysaccharides, 
as they do not form secondary or tertiary structures with themselves. The 
techniques for assessing GAG chain size often require a large amount of time 
to undertake and require a large volume of sample. Techniques that have 
been used in the past and will be discussed further in the following paragraphs 
include: AFM, polyacrylamide gel electrophoresis (PAGE), size exclusion 
chromatography - multi-angle laser light scattering (SEC-MALLS) and more 
recently solid-state nanopore sensors.  
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The benefit of using AFM to image GAGs by electrochemically trapping GAGs 
to a mica surface to prevent the movement of the chains is that through 
imaging multiple chains the heterogeneity of each GAG sample can be directly 
observed. Imaging the GAG chains and measuring the chains from the images 
generates a precise measure of GAG chain size, as demonstrated by the use 
of the technique to measure the size of CS chains attached to the core protein 
of Acan (Ng et al., 2003). The major drawback to this technique is the time 
taken to produce these measurements. Firstly, optimising an AFM 
methodology to create HA surfaces that are sparse enough to image, while 
dense enough to allow for multiple HA chains to be imaged at any one time is 
not a trivial task. The deposition of molecules is also potentially problematic 
for accurately measuring chain size, as if the HA chains coil, or form larger 
complexes with itself, it makes measuring chain length difficult or impossible.  
Furthermore, purifying the HA chains to a degree that allows for optimal 
imaging that avoids impurities in the starting sample is also not a simple task. 
Then optimising the AFM settings to image the HA chains and imaging enough 
HA chains to determine an average HA size for the population of HA 
molecules makes it prohibitively time consuming to perform on heterogeneous 
material. The major benefit of this technique is if the time was taken to perform 
the analysis a very precise measure of the size and heterogeneity of the HA 
chains would be produced. Also, as a validation technique to check the size 
of a known HA sample AFM is a useful technique.  
SEC-MALLS has been used successfully to quantify the size of HA chains 
(Hokputsa et al., 2003). It provides quantitative data and is often used by 
companies to validate the size of synthesised HA, where the aim is to produce 
HA with a small range of sizes. The limitation of this technique is in its 
sensitivity, especially when sizing smaller HA fragments (Hokputsa et al., 
2003). Also, from a technical aspect the experiments require long run times 
and slow column flow rates meaning the use of this technique as a high-
throughput method is limited by practical constraints.  
A recent development is the use of solid-state nanopore sensors to 
quantitatively assess HA size using small amounts of material (Rivas et al., 
2018). For HA larger than 1 MDa it performs well, however for HA below 500 
kDa  it is less accurate (Rivas et al., 2018). The current lack of accessibility of 
nanopore technology to laboratories is also another constraint on the use of 
the methodology currently. This method shows great promise as a quantitative 
method for measuring HA in solution, so may be a complimentary method for 
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assessing HA chains alongside a methodology for measuring HA chains that 
are tethered to surfaces.  
PAGE has been used previously as a method for measuring HA chain length 
between 5 - 500 kDa (Bhilocha et al., 2011; Cowman et al., 2011). 
Furthermore, in chapter 3 PAGE was used to observe distinct differences in 
HA chain length in the CNS in comparison to other tissues such as cartilage. 
One benefit of the method is they are cheap and quick to conduct. 
Furthermore, the samples do not require purifying if the method is used 
alongside Western blotting with a HA probe, making it a useful technique when 
determining size composition from cell or tissue lysate with minimal sample 
preparation, as demonstrated in chapter 3. Equally, using purified HA samples 
PAGE can also be conducted using Alcian blue to stain the polysaccharide 
chains (Lin et al., 1997). Using PAGE, it is possible to assess the broad 
heterogeneity of HA sizes in the sample, by measuring the length of the 
sample smear on the gel. It is also possible to size HA using a HA ladder of 
known sizes to standardise the results against (Lee and Cowman, 1994; 
DeAngelis et al., 1998). Protein standards have not been used previously to 
characterise HA size because the negative charge imparted on proteins is 
provided by the binding of SDS to the protein chain, while HA chains are 
naturally negatively charged and do not associate with SDS. This results in 
HA migrating through the gel at different rates to the protein ladders, therefore 
the migration distance cannot be directly compared. This affect will be further 
compounded by the difference in hydrodynamic radius between protein, HA 
and other GAGs. To date, no study has compared the different migrate rates 
of protein and HA within the same gel and aimed to quantify this relationship. 
One of the aims of this chapter is to measure this relationship to provide a 
method for qualitatively assessing HA size using protein standards.  
Although PAGE offers a qualitative assessment of GAG size, as has 
previously been demonstrated when analysing heparin, a linear sulfated 
polysaccharide (Volpi et al., 2012), the technique struggles to separate large 
HA chains due to the difficulty in creating polyacrylamide gels that have large 
enough pore sizes for the molecules to migrate. Furthermore, due to the 
smearing of heterogeneous GAG samples it makes it difficult to quantitatively 
compare average sizes from different samples. Therefore, a more thorough 
technique that produces a quantitative assessment would be more beneficial.  
With this in mind the aim was to develop a protocol for analysing unknown 
GAG sizes using QCM-D. The quantitative analysis of QCM-D measurements 
is discussed in detail in chapter 2 and will be briefly summarised here. QCM-
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D is an acoustic measuring technique that can measure changes in frequency 
(∆𝑓) to determine areal mass density and changes in dissipation (∆𝐷) to 
determine the mechanical properties of the surface bound layer. Using QCM-
D,  a methodology for analysing the terminal functionalisation of GAGs has 
previously been established (Richter et al., 2007; Thakar et al., 2014). In this 
chapter, the aim was to build on this work by using the technique to measure 
the ratio of ∆𝐷/−∆𝑓 for HA chains of known sizes, producing a standard curve 
to describe this relationship. the ratio ∆𝐷/−∆𝑓 is described in detail in chapter 
2. It has previously been shown to be a valuable measurement for molecular 
characterisation, specifically of shape and size (Tsortos et al., 2008; 
Papadakis et al., 2010). Previously, the viscoelastic model has been used to 
analyse QCM-D responses and has been used successfully to quantify the 
mechanical properties of surfaces of disordered proteins (Eisele et al., 2012). 
However, in order to fit the data to the viscoelastic model complimentary 
measurements using AFM and spectroscopic ellipsometry were required to 
ascertain meaningful results (Reviakine et al., 2011; Eisele et al., 2012). 
Richter et al (2007) were able to model film thickness of very soft HA films, 
but only when the film was constrained using reflection interference contrast 
microscopy. In an attempt to circumvent this requirement for extra measuring 
techniques, the aim was to establish a technique for measuring GAG chain 
length using only the ratio of ∆𝐷/−∆𝑓. For ultrathin films (in the range of a few 
nm) this quantity is strictly proportional to elastic compliance. For thicker films, 
the proportionality is lost but the ∆𝐷/−∆𝑓 ratio remains a useful measure to 
quantify film softness (Du and Johannsmann, 2004; Reviakine et al., 2011; 
Eisele et al., 2012).  
To summarise, the aims of this chapter are to first quantify the relationship of 
PAGE migration between protein and GAG samples to provide a method for 
qualitatively assessing GAG size using protein standards to establish a larger 
range of markers for use in GAG analysis using PAGE. The second aim is to 
establish a methodology for sizing GAG chains using the ratio of ∆𝐷/−∆𝑓 
measured by QCM-D. 
  
5.2 Methodology 
5.2.1 HA samples 
A range of 5 differently sized HA samples biotinylated at the reducing end 
were used for both the PAGE and QCM-D analysis (Table 4). These were 
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HA_dp15, the source and material is described in detail by Dubacheva et al, 
(2017); HA50 (Hyalose: SelectHA-B50), HA250 (Hyalose: SelectHA-B250), 
HA500 (Hyalose: SelectHA-B500) and HA1000 (Hyalose: SelectHA-B1000). 
The Mw of the HA samples were provided by the company (Hyalose) using 
SEC-MALLS.  
Samples of CS-A from sturgeon notochord (Seikagaku: 400658-1A), CS-B/DS 
from porcine intestinal mucosa (Sigma: CAS54328-33-5), CS-C from shark 
cartilage (Amsbio: 400675-1A), CS-D from shark cartilage (Amsbio: 400676-
1A) and CS-E from squid cartilage (Seikagaku: 400678-1A) were biotinylated 
at the reducing end by Goodenough (2018) and used in both the PAGE and 
QCM-D analysis.  
 
5.2.2 PAGE  
Using a 4-12% bis-tris glycine gel in denatured reducing conditions 3 µg of 
each CS sample was prepared at a 1:1 ratio with gel loading buffer (1× 20% 
glycerol, orange G1%, 80 mM tris and ran using the XCell SureLockTM (Novex, 
Invitrogen) system using 1× MOPS SDS running buffer (Novex, Invitrogen). 
The HA samples were prepared at the concentrations and molarity displayed 
in Table 4. After running the gel for 1 hour at constant 200 V the gel was then 
stained with 0.5% Alcian blue 8GX (Sigma: A5268) mixed with 2% acetic acid 
to allow for the polysaccharide chains to become visible, and de-stained with 
40% methanol, 8% acetic acid solution. As the Hi-MarkTM pre-stained HMW 
protein standard (Invitrogen) and precision plus proteinTM all blue protein 
standards (Biorad) used were already pre-stained they were visible without 
requiring a further protein stain.  
 
Table 4. HA samples used in the PAGE and QCM-D analysis. 
 Mean ± standard deviation (sd) were recorded. 
Biotinylated HA HA Mwa mean ± 
sd  
(kDa) 




HA_dp15 3.2d 7.5d 1 2.67 × 10IJ 
HA50 58 ± 3 116 ± 6 1 1.72 × 10It 
HA250 280 ± 14 560 ± 28 5 1.78 × 10It 
HA500 530 ± 27 1060 ± 54 10 1.89 × 10It 
HA1000 837 ± 42 1674 ± 84 20 2.39 × 10It 
a) Mw is the molecular weight.  
b) Nds is the number of disaccharides. 
c) Working concentration and molarity used for both PAGE and QCM-D 
experiments. 
d) Pure oligosaccharide with effectively no size variation.  
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5.2.2.1 Quantitative analysis  
To determine the migration distance (dmig) the distance between the top and 
bottom of the gel was measured dtotal. The dmig of each GAG sample was 
measured through quantitative analysis of the greyscale pixel intensity along 
each lane (see Appendix 3). The pixel intensity was measured by drawing a 
straight line spanning dtotal and measuring the intensity across the line. In 
photographs of the gel, a light colour (high pixel intensity) represents the 
background and a darkening (lower pixel intensity) the presence of sample. 
The position in the lane with the smallest pixel intensity, representing the 
location where most sample has accumulated, was defined as dmig. Values of 
dmax and dmin were quantified by identifying the points in the lane below and 
above dmig, respectively, where the pixel intensities measured half the value 
between the background intensity and the minimal intensity. dmax and dmin are 
measures of the spread in migration. For each lane, 3 lines were drawn and 
the mean value was measured. All dmig, dmax and dmin values were then divided 
by dtotal for normalisation, such that all values range between 0.00 and 1.00. 
All data shown represent normalised values. 
To determine the relationship between dmig (as well as dmax and dmin) and 
Mw,protein the values of the protein standards were combined (see Appendix 4) 
and a plot was produced. A line of best fit was then interpolated and used to 
determine the values of Mw,protein for each GAG sample. The relationship 
between Mw,protein to Mw,GAG was defined by the result measured for HA50. The 
relationship provided a ratio that was used to convert the effective Mw,protein 
values for CS samples to Mw,GAG values.  
 
5.2.3 QCM-D 
The same QCM-D protocol as described in chapter 4 was used to conduct the 
measurements, with the same flow rate and buffers used. The only difference 
in the analysis is the third overtone (𝑛 = 3) was used here to facilitate 
comparison with other, previously published data (Thakar et al., 2014). The 
molarity and concentration of HA presented to the sensor surface is displayed 
in Table 4. HA samples used in the PAGE and QCM-D analysis.. The number 
of repeats for each HA sample is displayed in Table 5. HA500 was measured 
in duplicate only due to limited sample availability. For each sample ∆𝑓 and 
∆𝐷 were measured and ∆𝐷/−∆𝑓 was calculated.  
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Table 5. The number of repeats of each HA size used in the QCM-D analysis. 








5.2.3.1 Modelling and statistics  
For each sample, the mean ∆𝐷/−∆𝑓 ± standard deviation was used to model 
the data to generate the standard curves. The quality of the fit of each 
standard curve was measured using R2. The Difference between sample 
∆𝐷/−∆𝑓 was compared using a one-way ANOVA with a post-hoc Tukey test, 
with statistical significance defined as p ≤ 0.05. 
 
5.3 Results  
The HA samples were synthesised in vitro to a defined molecular weight (Mw) 
with a narrow size distribution using a synchronised, stoichiometrically 
controlled polymerisation process involving Pasteurella multocida HAS by the 
company Hyalose (Jing and DeAngelis, 2004). These HA samples were used 
to establish trends for measuring GAG chain Mw,GAG using PAGE and QCM-
D. In the PAGE experiments Mw,GAG were compared with protein standards of 
a defined Mw,protein.  
CS samples of a larger range of chain sizes were used to validate the standard 
curves, as they have previously been analysed using PAGE and QCM-D by 
Goodenough (2018). Through the use of CS samples with a larger size 
distribution the samples could also be used to test the robustness of the 
methodologies for measuring heterogeneous GAG samples. Ideally, HA 
samples would have been used to validate the PAGE and QCM-D 
methodologies, however due to sample availability this was not possible.  
  
5.3.1 Measuring GAGs using PAGE  
The aim was to establish the relationship between migration rates of GAG and 
protein samples using PAGE by comparing the migration distance (dmig) of HA 
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samples of known Mw,GAG (GAG samples) with the dmig of protein standards of 
known Mw,protein using PAGE. 
 
5.3.1.1 Qualitative PAGE results 
The HA samples formed much tighter bands, in comparison to the CS samples 
which formed smears (Figure 39). This suggested that the HA samples have 
a smaller range of sizes in comparison to the CS samples, as expected. For 
HA250, HA500 and HA1000 dmig was small, therefore it is possible that the 
range of sizes may be larger than what is observed qualitatively, as the HA 
chains have migrated less to facilitate separation. Furthermore, the value of 
dmig for HA250, HA500 and HA1000 samples was smaller than the dmig for the 
largest protein standard making it difficult to define Mw,protein for these samples. 
HA_dp15 was not observed in the gel, however as it is only 3.2 kDa it is likely 
that it migrated through the entire gel, as the 10 kDa protein marker was 
observed at the bottom of the gel.  
HA50 dmig was the only HA measurement used for comparison with protein 
standard dmig, as it was the only sample that migrated within range of dmig 
protein standard measurements. HA50 (58 kDa) had a value according to the 
protein standards of Mw,protein ~ 100 ± 20 kDa when the PAGE results were 
qualitatively assessed. In contrast, the CS samples all produced smears, 
indicating that the samples contained a large range of CS chain sizes. 
Comparatively, CS-A migrated furthest through the gel, followed by CS-B, CS-
D and CS-C, with CS-E having migrated the least. However, to gain a more 
precise measurement of Mw,protein for HA50 and the CS samples, the results 
were compared using a quantitative analysis. This was performed by defining 
dmig (location where most sample has accumulated), dmin and dmax (measures 
of the spread in migration above and below dmig, respectively) as described in 
the methodology section for each GAG sample, and comparing these values 
with a plot comparing the dmig and Mw,protein values of the 2 protein standard 
ladders.   
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Figure 39. The relationship between GAG chains and protein standards using 
PAGE.  
Using Alcian blue both HA and CS chains can be observed. HA samples formed bands, 
suggesting a small range of HA sizes. Due to the distinct bands, it is possible to 
compare HA samples with the protein standards to determine the difference in 
migration rates. The CS chains formed smears, indicating that the samples are 
composed of a large range of GAG chain sizes. 
1) Protein ladders: Lane 1 is HiMarkTM (Invitrogen) with molecular weights of 460, 268, 
238, 171, 117, 71, 55, 41 and 31 kDa; Lane 2 is Precision plus proteinTM (Biorad) with 
molecular weights of 250, 150, 100, 75, 50, 37, 25, 20, 15 and 10 kDa. 
 
5.3.1.2 Relationship between protein standard dmig and Mw,protein  
Using a non-gradient, linear gel the expectation would be the value of protein 
standard dmig would decrease exponentially with increasing Mw,protein, therefore 
a log-linear scale was used to plot the datapoints (Figure 40) (Winston, 1989). 
The gradient gel used in this chapter caused the trend to deviate from a strict 
exponential dependence, though the monotonous relationship between 
increasing Mw,protein and decreasing dmig was maintained. A line of best fit was 















































  - 106 -  
 
Figure 40. The relationship between protein standard dmig and Mw,protein plot on a 
log-linear scale.  
A line of best fit was manually drawn (blue line) to estimate Mw,protein for HA50 and CS 
samples. The dashed green line represents the HA50 dmig measurement, with the 
dashed orange line representing the predicted Mw,protein. The coloured green area either 
side of the dashed lines represent dmin and dmax values. The orange area represents 
the corresponding Mw range. Precision plus proteinTM (black dots) and HiMarkTM (red 
dots) protein standards were used. The symbol size corresponds to the estimated error 
on the individual datapoints.  
 
5.3.1.3 Establishing ratio between Mw,protein and Mw,GAG 
GAG samples, unlike the protein standards, formed smears, therefore 
measurements of dmig as well as dmin and dmax were used to measure the range 
of GAG chain sizes present in the sample. Values of dmig, dmax and dmin for 
HA50 were converted to Mw,protein using the trendline in Figure 40 to 93 kDa, 
86 kDa and 110 kDa, respectively. These values were then compared with the 
company estimates for Mw,GAG (58 ± 3 kDa) to produce a ratio of 1 kDa 
(Mw,GAG): 1.7 ± 0.1 kDa (Mw,protein). Thus, HA50 runs at the same rate as a 
protein of 1.7 times its molecular mass. 
 
5.3.1.4 Estimating CS sample Mw,GAG using PAGE 
To estimate Mw,GAG  for CS samples a key assumption was made that that all 
GAG chains would run at an approximately equal rate, therefore the HA50 1 
kDa (Mw,GAG): 1.7 kDa (Mw,protein) ratio was applied to convert CS Mw,protein to 
Mw,GAG (Figure 41). The results of the quantitative analysis support the 
qualitative assessment. For CS-C and CS-E, the median result used to 
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compare relative Mw,GAG needed to be used cautiously, as the minimum in the 
intensity profile was rather shallow, making it difficult to locate the peak 
position with good resolution. 
 
 
Figure 41. Molecular mass values for the CS samples estimated using PAGE.  
Orange bars represent median values or Mw,GAG (derived from dmig) and error bars 
reflect the spreads as derived from dmin and dmax. The y axis began at 5.9 kDa (10 / 1.7 
kDa) to reflect the limit of detection and ended at 271 kDa (460 / 1.7 kDa) to reflect the 
accessible data range.  
 
5.3.2 Quantifying GAG sizes using QCM-D  
The aim was to establish the relationship between the ratio of ∆𝐷/−∆𝑓 and 
Mw,GAG of known HA samples (GAG samples) using QCM-D. The 
methodology was established by building on the methodology first described 
by Richter et al (2007) where a model system for creating reproducible 
surface-attached HA was described. This involved using a combination of a 
biotinylated lipid bilayer, a surface monolayer of streptavidin and HA 
biotinylated at the reducing end. This methodology is discussed in detail in 
chapter 4.  
 
5.3.2.1 The relationship between HA size and independent ∆𝑓 and ∆𝐷 
measurements 
Starting from the presentation of biotinylated-HA to the streptavidin monolayer 
the values of ∆𝑓 and and ∆𝐷 were measured throughout the incubation 
process. The minimum ∆𝑓 and maximum ∆𝐷 measurements reflect where the 
incubation has stopped and were used throughout the QCM-D analysis, 
unless specified otherwise. There was no clear trend in the dependence 
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between the final ∆𝑓 values and Mw,GAG, with HA50 showing the largest 
decrease in ∆𝑓 (-46.5 ± 2 Hz), and HA500 showing the least (-5 ± 1.5 Hz) 
(Figure 42A, bottom). HA1000 (-6 ± 2 Hz), HA250 (-12 ± 0.5 Hz) and HA_dp15 
(-14 ± 1 Hz) were in-between these two extremes. Equally, the relationship 
between the final ∆𝐷 values and Mw,GAG  was also not monotonous, as HA50 
(16.8 ± 0.6 × 10-6) showed the largest change and HA_dp15 the least (1.7 ± 
0.1  × 10-6), then HA1000 (6.0 ± 1.2  × 10-6), HA500 (6.5 ± 0.0  × 10-6) and 
HA250 (10.7 ± 0.4  × 10-6). To summarise, there is no simple trend between 
changing ∆𝑓 or ∆𝐷 and HA size. This is emphasised when the relationship 
between HA Mw,GAG and ∆𝐷 (Figure 42B top) or ∆𝑓 (Figure 42B bottom) are 
plot together. This was what motivated the use of the ∆𝐷/−∆𝑓 ratio for 
measuring Mw,GAG of HA chains. 
 
 
The lack of monotonous dependency between ∆𝑓 and Mw,GAG is due to ∆𝑓 
including the mass of the solvent, as well as the mass of adsorbed HA. 
 
Figure 42. The relationship between ∆𝒇 and ∆𝑫 for a range of HA sizes 
measured using QCM-D.  
A Representative QCM-D responses for the formation of HA brushes for a range of HA 
sizes. The start of incubation was at 4 min and the complete incubation process is 
displayed. The rinsing step is not shown for ease of analysis; note that minimal 
changes occurred upon rinsing. B The relationship between Mw and final changes in 
∆𝑓 (bottom) and ∆𝐷 (top). Each datapoint reflects an independent experiment (n = 7, 
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Furthermore, the surface coverage of HA films has previously been observed 
to change with increasing Mw,GAG With surface coverage known to effect the 
value ∆𝑓 values (Richter et al., 2007; Reviakine et al., 2011). At lower Mw,GAG 
the density of bound GAG chains is likely to be limited by the number of 
available binding sites. At this size the maximal number of GAG chains per 
unit area would remain constant, however the mass per unit area would 
increase with increasing GAG size (Thakar et al., 2014). In contrast, for larger 
GAG chains the forming GAG film impedes the binding of further GAG chains 
through steric hinderance, therefore causing a gradual reduction in the 
maximal number of GAG chains per unit area which could cause a reduction 
in the mass per unit area (Richter et al., 2007). Furthermore, other parameters 
including the effect of film softness, as well as the impact on HA concentration 
and incubation time on the coverage reached could also influence ∆𝑓. 
Therefore, without an independent measure of surface coverage to compare 
the relative surface coverage at different Mw,GAG, it makes using ∆𝑓 alone 
insufficient (Baranova et al., 2011).  
 
5.3.2.2 The relationship between HA size and the ratio of ∆𝐷/−∆𝑓 
The ratio of ∆𝐷/−∆𝑓 is dependent on the shape and Mw,GAG of the GAG chains 
(Tsortos, Papadakis and Gizeli, 2008; Tellechea et al., 2009). For globular 
objects the ratio of ∆𝐷/−∆𝑓 has been observed to reduce as a function of 
increased surface coverage due to the effect of hydrodynamically coupled 
water (Johannsmann et al., 2009). However, GAGs are not globular. Tsortos 
et al (2008) observed the ratio of ∆𝐷/−∆𝑓 to be independent of surface 
coverage when they measured deoxyribonucleic acid (DNA) polysaccharides, 
a none globular molecule. As −∆𝑓 is a measure of the density of the adsorbed 
surface-bound molecules it was used to analyse how the measurement of the 
∆𝐷/−∆𝑓 ratio changed as a function of HA surface coverage. Therefore, the 
expectation was the ratio of ∆𝐷/−∆𝑓 would either decrease or remain 
unchanged as a function of −∆𝑓. 
There is a clear trend observed between increased HA size and an increase 
in the ∆𝐷/−∆𝑓 ratio (Figure 43). Interestingly, there was no clear trend 
observed between increased surface coverage and the ratio of ∆𝐷/−∆𝑓. To 
analyse this further the ratio of ∆𝐷/−∆𝑓 was measured by 3 different 
methodologies. The first method aimed to measure the HA films at low surface 
coverage towards the start of the incubation process, therefore the ratio of 
∆𝐷/−∆𝑓 was measured between −∆𝑓 values of 4 and 5 Hz. The range 
between −∆𝑓 values of 0 to 3 Hz could not be used due to the tendencies for 
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outliers affecting the measurements of the ∆𝐷/−∆𝑓 ratio, as small changes in 
both ∆𝑓 and ∆𝐷 in this range have a large effect on the ratio, that stabilised 
around 4 Hz. The second methodology aimed to measure the HA films at high 
surface coverage, towards the end of the incubation process, therefore the 
ratio of ∆𝐷/−∆𝑓 was measured for values of −∆𝑓 within 1 Hz of the final 
equilibrium measurement. The third methodology averaged all measurements 
of the ∆𝐷/−∆𝑓 ratio throughout the binding process, excluding values 
between −∆𝑓 values of 0 to 3 Hz range.  
 
 
Figure 43. Representative plots of the relationship between the ratio of ∆𝑫/−∆𝒇 
and −∆𝒇 throughout the binding process.  
Each colour represents an individual experiment using one of the HA samples: 
HA_dp15 (cyan), HA50 (blue), HA250 (grey), HA500 (red), HA1000 (black). All 
datapoints recorded throughout the binding process are included to create the scatter 
plots for each sample. 
 
The three methodologies all produced the same trend, as the ratio of ∆𝐷/−∆𝑓 
increased as a function of increased Mw,GAG (Figure 44). However, there were 
differences in the values of ∆𝐷/−∆𝑓 measured for HA_dp15 and HA250 
samples, as at low surface coverage the values differed significantly from the 
other two methodologies. To emphasise the different effect of surface 
coverage on the ratio of ∆𝐷/−∆𝑓 for different HA sizes, the differences 
between the 4 to 5 Hz and the final equilibrium measurements (low and high 
surface coverage respectively) were compared (Figure 44B). For HA50 (0.00 
± 0.02 × 10-6/Hz)  and HA500 (0.01 ± 0.01 × 10-6/Hz) there was little change 
as a function of surface coverage. As surface coverage increased there was 
a small decrease in the ∆𝐷/−∆𝑓 ratio for both HA_dp15 (−0.06 ± 0.01 × 10-
6/Hz) and HA1000 (−0.09 ± 0.02 × 10-6/Hz).  The increase in the ratio of 
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∆𝐷/−∆𝑓 as a function of surface coverage for HA250 (0.15 ± 0.02 × 10-6/Hz) 
was a surprising observation, as the ratio of ∆𝐷/−∆𝑓 increasing as a function 
of surface coverage has rarely been reported, though has been observed 
previously (Tellechea et al., 2009). Perhaps the configuration of the HA chains 
on the surface form a particular coiled effect that produces an increase in 
∆𝐷/−∆𝑓, however this would require further measurements to understand this 
relationship further. 
The results from the maximal coverage measurements and the average 
measurements were in agreement, with no significant differences found 
between the measurements for any of the HA samples. Therefore, either 
methodologies could have been used for the following quantitative analysis, 
without impacting the trend produced in any major way. The methodology 
taken forward was the average ∆𝐷/−∆𝑓, as this standardised the differences 
in the ∆𝐷/−∆𝑓 ratio observed with changing surface coverage.  
 
    A                                                            B 
 
Figure 44. Comparison of different methods for analysing the ratio of ∆𝑫/−	∆𝒇 
for HA chains. 
A Comparison of mean values of the ratio of ∆𝐷/−	∆𝑓 for HA chains. The error bars 
represent the standard deviation (n = 3). The lines above the graph represent statistical 
significance:  p ≤ 0.005 (**), p ≤ 0.0005 (***). B The change in the ∆𝐷/−∆𝑓 value 
throughout the binding process. The maximal coverage ∆𝐷/−∆𝑓 ratio value was 
compared with the ∆𝐷/−∆𝑓 value at the start of the binding process. A positive result 
reflects an increase in ∆𝐷/−∆𝑓 ratio throughout the binding process. The error bars 
represent the standard deviation The data is provided in Appendix 5.   
 
5.3.2.3 The relationship between HA size and the ratio of ∆𝐷/−∆𝑓 
The average ∆𝐷/−∆𝑓 ratios between the different HA samples were all 
significantly different from each other, with the exception of the difference 
between the HA500 and HA1000 (Table 6). HA_dp15 (0.14 ± 0.01 × 10-6/Hz) 
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HA250 (0.85 ± 0.02 × 10-6/Hz). For HA500 (1.33 ± 0.18 × 10-6/Hz) and 
HA1000 (1.17 ± 0.23 × 10-6/Hz) the values of ∆𝐷/−∆𝑓 were not significantly 
different from each other (Figure 44: purple bars).   
 
Table 6. The p values measuring the differences between the ratio of ∆𝑫/−∆𝒇 
for different HA sizes. 
 HA_dp15 HA50 HA250 HA500 HA1000 
HA_dp15  
    
HA50 0.022     
HA250 0 0    
HA500 0 0 0.001   
HA1000 0 0 0.013 0.451   
 
It is important to note the sensitivity for the ratio of ∆𝐷/−∆𝑓 is determined by 
the ability of the shear-acoustic wave to propagate throughout the HA film (δ~ 
250 nm; described in detail in chapter 2). Therefore, if the HA films formed are 
over 250 nm, the methodology won’t be able to measure the ∆𝐷/−∆𝑓 ratio as 
effectively. Previous work has measured the persistence length (Lp) of HA to 
be ~4 nm, therefore HA chains over 4 nm are likely to coil (Bano et al., 2016). 
The contour length (Lc) is a measure of the maximum size of a polymer chain 
at full extension. For HA_dp15 (Lc ~7.5 nm) and HA50 (Lc ~145 nm) Lc < 250 
nm therefore even at maximum extension the surfaces would be under this 
maximum.  
For HA250 (Lc ~700 nm), HA500 (Lc ~1300 nm)  and HA1000 (Lc ~2092.5 
nm) Lc > 250 nm the polymer chains are likely to be coiled, making the 
respective size of the HA films  far smaller than Lc. Previously, the film 
thickness of HA50 and HA1000 were found to be 140 ± 10 nm and 530 ± 20 
nm respectively using colloidal probe reflection interference contrast 
microscopy (Richter et al., 2007). Without a complimentary method to 
measure film thickness HA250 and HA500 film thickness is currently 
unknown. If HA1000 is thicker than the sensitivity of the shear acoustic wave, 
it may partially explain why the ratio of ∆𝐷/−∆𝑓 did not differ significantly from 
HA500.  
 
5.3.2.4 Quantitative description of the trend between ∆𝐷/−∆𝑓and Mw,GAG 
As there was a clear trend observed between HA size and ∆𝐷/−∆𝑓, the aim 
was quantitatively describe this relationship, to establish a standard curve that 
can be used to size unknown GAG chains using the ∆𝐷/−∆𝑓 ratio. Thakar et 
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al (2014) have previously reported QCM-D data for films of size-defined HA 
and HS oligosaccharides. In their experiments, the GAG chains were 
immobilised in the same way as reported here (i.e. via biotin moieties at the 
reducing end to streptavidin monolayers). These data are complementary as 
they cover a GAG size range not explored in the present study. The ∆𝐷 versus 
∆𝑓 plots reported by Thakar et al (2014) showed a linear relationship to a good 
approximation. Thus, the ratio of ∆𝐷/−∆𝑓 could readily be extracted as the 
slope in these graphs and the results are presented in Figure 45. 
Thakar et al (2014) previously reported identical values of the ∆𝐷/−∆𝑓 ratio 
for HA_dp8 and HS_dp8 GAGs. These molecules had the same length, yet 
different molecular masses, which suggested that the ∆𝐷/−∆𝑓 ratio is 
dependent on the contour length (number of disaccharides). Therefore the 
number of disaccharides was used for as the unit of size in this analysis. 
Mw,GAG of Nds = 1 is 400 Da to a good approximation, therefore this conversion 
was used to convert company estimations of HA Mw,GAG to Nds using the ratio 
1 kDa (Mw,GAG) : Nds = 2.5. 
There was a clear trend for all GAG sizes that the ratio of ∆𝐷/−∆𝑓 increased 
as function of Nds (Figure 45). However, the increase in the ratio of ∆𝐷/−∆𝑓 
as a function of Nds was different at 2 distinct size ranges. Between Nds = 3 
and Nds = 7.5 the increase in ∆𝐷/−∆𝑓 as a function of Nds was sharper than 
the increase between Nds = 7.5 and Nds = 2092.5. Therefore, 2 functions were 
required to describe the relationship between Nds and ∆𝐷/−∆𝑓, as no fit could 
be found that reproduced all the data well. Equally, neither of the two identified 
functions adequately reproduced all the data well, as is emphasised in Figure 
45C.  
To describe the trend between Nds = 3 and Nds = 7.5 non-linear regression 
analysis with the equation ∆𝐷 −∆𝑓⁄ = 𝐴 − 𝐵 × 𝐶}~ was used to model the 
data (R2 = 0.9800), with A = (0.1746 ± 0.0219) × 10-6 / Hz, B = (0.3758 ± 
0.0620) × 10-6 / Hz and C = 0.7102 ± 0.0695 for the adjustable parameters 
(Figure 45B). This equation reproduced the data well with a small number of 
adjustable parameters. This equation can be rewritten as a function of 𝑁 as: 
 




Hz ` ÷ −0.3758
10I
Hz  ÷ 𝑙𝑛
(0.7102)	 (17)	
 
Non-linear regression analysis also modelled the trend between Nds = 7.5 and 
Nds = 2092.5 most appropriately (R2 = 0.9996) and could be described by the 
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equation ∆𝐷 −∆𝑓⁄ = 𝐴 − 𝐵 × 𝐶}~ with A = 1.1169 ± 0.0288 × 10-6 / Hz, B = 
0.9897 ± 0.0266 × 10-6 / Hz and C = 0.9976 ± 0.0013 for the adjustable 
parameters (Figure 45A). This equation reproduced the data well with a small 
number of adjustable parameters. This equation was also rewritten as a 
function of 𝑁 as:  
 




Hz ` ÷ −0.9897
10I
Hz  ÷ 𝑙𝑛
(0.9976)		 (18)	
 
By using Equations 17 & 18 estimates of GAG chain size can be made if the 
ratio of ∆𝐷 −∆𝑓⁄  is known. However, between Nds = 7.5 and Nds = 145 the 2 
models differ, which is emphasised in Figure 45C. Without further datapoints 
to plot within this ‘region of uncertainty’ it is unclear which relationship 
describes the relationship most appropriately. An explanation for the 2 
different trends that result in this ‘region of uncertainty’ may be explained in 
terms of the persistence length (Lp) and contour length (Lc) of HA. 
 Previously, Lp of HA has been measured to be ~4 nm which converts to Nds 
~4 (Bano et al., 2016). It is a measure of polymer chain structural rigidity that 
is commonly defined in 3 regimes in context of Lc  as: rigid (Lp ≫ Lc), semi-
flexible (Lp ≈ Lc) and flexible (Lp ≪ Lc) (Manning, 1986; Grosberg and 
Khokhlov, 1994; Nelson, 2004). Therefore, between Nds = 3 and Nds = 7.5 the 
HA chains are in the semi-flexible regime while between Nds = 7.5 and Nds = 
2092.5 the HA chains are in the flexible regime. The region of uncertainty is 
likely caused by the transition from the semi-flexible (flexible rod) regime to 
the flexible (random coil) regime. Future work is planned to produce HA 
standards in this size range to further resolve this region and define the 
transition point more accurately. Specifically, HA chain sizes of 20 
disaccharides (10 kDa) and 60 disaccharides (30 kDa) are currently in the 
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5.3.2.5 Interpolating the ratios of ∆𝐷/−∆𝑓 to estimate the size of CS GAG 
chains.  
So far samples of known Nds have been used to establish the trend between 
Nds and the ratio of ∆𝐷/−∆𝑓. To validate the model the same CS samples 
used in the PAGE analysis were compared using QCM-D measurements. 
Goodenough (2018) had previously reported the ratio of ∆𝐷/−∆𝑓 for films of 
CS using the same protocol as reported in this chapter. The values of the 
∆𝐷/−∆𝑓 ratio were interpolated using Equations 3 and converted from Nds to 
      A                                                                          B 
 
                                           C 
 
Figure 45. The ratio of ∆𝑫/−	∆𝒇	 as a function of HA Nds.  
A The relationship between the Nds and the ratio of ∆𝐷/−	∆𝑓 for HA chains between 
Nds = 7.5 (3 kDa) and  Nds =  2092.5 (837 kDa). The standard curve (R2= 0.9996) is 
defined by ∆𝐷 −∆𝑓⁄ = 𝐴 − 𝐵 × 𝐶}~. B The relationship between the Nds and the ratio 
of ∆𝐷/−	∆𝑓 for HA and HS chains between  Nds =  3 and  Nds = 7.5. The standard curve 
(R2= 0.9800) is defined by ∆𝐷 −∆𝑓⁄ = 𝐴 − 𝐵 × 𝐶}~. See main text for results of the 
best-fit values. C The two standard curves superimposed onto the same graph. The 
differences between the 2 trends are emphasised in this plot. The region in blue, 
defined as the region of uncertainty is the size range for which GAGs currently cannot 
be sized due to discrepancies between the models. For all graphs the red line 
represents the standard curve, with the black symbols (HA) and red symbols (HS) 
representing experimental data (mean ± S.D.). The red bands on either side of the 
standard curve represent the 95% confidence intervals. 
Region of uncertainty
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Mw,GAG (Table 7). As  ∆𝐷/−∆𝑓 > 0.18 × 10-6/Hz Equation 2 could not be used. 
When the interpolated results were compared, CS-A and CS-B had the lowest 
Mw,GAG, then CS-D, CS-C and CS-E. Of note, all of the results were measured 
in the region of uncertainty.   
 
Table 7. The values of ∆𝑫/−∆𝒇 for CS chains used to validate the model.  
Nds, as well as molecular weight were interpolated using Equation 3. 
CS ∆𝑫/−∆𝒇 
(10-6/Hz) 
Nds Molecular weight 
[Nds × 0.45 ± 0.05a] (kDa) 
CS-A 0.22 41 ~ 18 ± 2 
CS-B 0.23 46 ~ 21 ± 2 
CS-C 0.32 90 ~ 41 ± 5 
CS-D 0.29 75 ~ 34 ± 4 
CS-E 0.37 117 ~ 53 ± 6 
 
a) Molecular weight of CS was converted from disaccharides to kDa by assuming 
that the molecular weight of HA and CS are similar. An HA disaccharide (including a 
sodium counterion) is 400 Da to a good approximation. However, the value for CS is 
likely to be higher and dependent on the degree of sulfation. For this reason, 0.45 ± 
0.05 was chosen to account for this uncertainty. 
 
5.3.3 Validating QCM-D and PAGE CS sample estimates  
So far values of CS Mw,GAG have been measured using PAGE and QCM-D. 
To validate the methods, the results were compared with the estimated Mw,GAG 
provided by the company datasheets (Figure 46).  
Both PAGE and QCM-D results measured the CS samples in the same order 
of size. The ordering was in agreement with the ordering using the company 
datasheet estimates. The company estimate of CS-B and CS-D do not contain 
any error margins, therefore although the company estimates predict them to 
be of the same Mw,GAG it is not unexpected that the actual values would be 
different.  
For CS-A, CS-B, CS-C and CS-D, PAGE Mw,GAG  values were smaller than 
the company estimates. Furthermore, comparatively the values of Mw,GAG 
using PAGE were smaller than the values measured using QCM-D (excluding 
CS-E). This may reflect an underestimation of Mw,GAG using PAGE. This 
underestimation may be accounted for by the assumption that HA and CS 
migrate at equal rates being invalid. The underestimation of CS Mw,GAG may 
reflect the faster migration rate of CS, caused by the presence of the 
negatively charged sulfate group, when compared with HA. This would lead 
to a larger dmig that would consequently produce a smaller Mw,GAG value.  
When the QCM-D values of Mw,GAG were compared with the company values, 
CS-C, CS-D and CS-E fell within the company range. CS-B and CS-A were 
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close to the predicted sizes provided by the company (though lacking margin 
of error information by the company).  
In comparison with PAGE, QCM-D was able to more accurately replicate the 
results predicted by the company estimates. The results of the CS 
measurements by QCM-D reported here are partially validated by the 
comparison with the company Mw,GAG, suggesting that the QCM-D technique 





CS Company Mw 
(kDa) 
PAGE Mw 
Median [lower – upper 
estimates] kDa 
QCM-D Mw 
(kDa ± sd) 
CS-A 16 6 [5 – 12] ~ 18 ± 2 
CS-B 30 7 [6 – 16] ~ 21 ± 2 
CS-C 60 ± 20 37 [11 – 52]  ~ 41 ± 5 
CS-D 30 22 [13 – 34] ~ 34 ± 4 
CS-E 62.5 ± 12.5 106 [47 – 230] ~ 53 ± 6 
 
 
Figure 46. Comparison of CS Mw estimates using PAGE, QCM-D and company 
estimates.  
A Comparison of the relative values of CS chain size using PAGE (green), QCM-D 
(lilac) and estimates provided by the company (beige). The error bars reflect the 
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5.4 Discussion  
HA of known sizes have been used to successfully establish two new 
methodologies for measuring GAG chains using PAGE and QCM-D 
methodologies. A ratio describing the different migration rates of HA and 
protein standards using PAGE was established that will enable the sizing of 
unknown GAG chains by comparing them with protein standards. The second 
methodology established a relationship between HA size and ∆𝐷 −∆𝑓⁄  that 
was defined using 2 individual standard curves: one to define GAG chains 
between 3 and 7.5 disaccharides, the second to define GAG chains between 
7.5 and 2092.5 disaccharides.  
 
5.4.1 Sizing GAG chains using PAGE 
By comparing the migration distance (dmig) of the HA50 (58 kDa) sample with 
the dmig of the protein standards, the HA sample migrated at a slower rate, 
which could be defined by the ratio 1 kDa (protein) : 1.7 kDa (GAG). As the 
proteins are in an unfolded, disordered state, the migration rate is largely 
dictated by the attachment of sodium dodecyl sulfate (SDS) which is highly 
negatively charged, to an extent that it far outweighs the charge imparted by 
the protein. Although HA is a linear polysaccharide chain, therefore should be 
conformationally similar in shape to the disordered protein, HA does not 
interact with SDS. As an approximation, the results here suggest that the HA 
chains are less negatively charged than SDS-bound protein at a ratio of 1 : 
1.7. It has currently not been established if the migration rate scales with 
charge for GAGs, therefore an assumption is being made that the relationship 
scales similarly to that of proteins. Previously, the sizing of HA using PAGE 
has been established by comparing HA samples with specific HA ladders 
(Select-HATM LoLadder and Select-HATM HiLadder) (Cowman et al., 2011; 
Bhilocha et al., 2011). Between them, the HA ladders have a range between 
30 and 1510 kDa. However, there is only 1 HA standard below 100 kDa (30 
kDa), making the sizing of GAGs smaller than 100 kDa difficult using the 
current HA standards available. By defining the ratio of GAG migration rate 
with protein migration rate the range of size markers available for sizing GAGs 
at lower molecular weights has been expanded. 
As HA250, HA500 and HA1000 migrated less than the largest Mw protein 
standard they could not be measured using this method. For this reason the 
current upper limit on GAG sizes that can be estimated using this specific 4 – 
12% bis-Tris gel using PAGE is 271 kDa (460 kDa protein standard divided 
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by 1.7). Thus, larger pore sized gels and larger protein standards would be 
required to increase dmig for larger GAG chains and expand the size range.  
The large range of CS Mw,GAG reflected the large range of GAG chain sizes in 
the samples that could be observed by the presence of the smear in the CS 
lanes. In contrast, HA samples were synthesised in vitro with a 
stoichiometrically controlled polymerization process using Pasteurella 
multocida HAS specifically to have small size variability (Jing and DeAngelis, 
2004). The quantitative analysis of the PAGE gel was able to reflect these 
differences and suggest a method for quantitively assessing the differences 
in the range of Mw,GAG between samples using PAGE.  
In conclusion, the ratio between migration rates of protein and HA were 
defined for the first time using PAGE. This method could be used to expand 
the range of standards that can be used to size GAG chains, especially at 
lower molecular weights. The PAGE measurements were also able to 
comparatively analyse CS samples in order of size, with the results reflecting 
the large range of GAG chain sizes in each sample. 
  
5.4.2 QCM-D sizing method 
The ratio of ∆𝐷/−∆𝑓 increased as GAG size increased (Figure 43 and Figure 
45). This relationship was also previously observed for GAG oligosaccharides, 
and DNA molecules (Tsortos, Papadakis and Gizeli, 2008; Papadakis et al., 
2010; Thakar et al., 2014). The trend of increased values of ∆𝐷/−∆𝑓 with 
increased size was true from GAG measurements of a few disaccharides, to 
GAG lengths larger than 500 kDa. The large size range for which this trend 
was observed suggests the technique is robust enough to measure samples 
with a large range of GAG sizes. The technique may also be applicable to 
measure other GAG types as the methodology was able to estimate CS 
samples mean Mw,GAG within the company estimates. This is particularly 
interesting considering Equation 18 was produced exclusively with HA 
samples yet was able to predict the size of CS chains.  
Previously, the results measured by Thakar et al (2014) suggested a function 
could be ascertained to describe the relationship between the ratio of ∆𝐷/−∆𝑓 
and Mw,GAG of HA and HS oligosaccharides. When HA_dp15 was added to the 
same dataset the trend was not well described by a linear relationship (R2= 
0.91), with Equation 17 describing the relationship more accurately. This is 
likely a reflection on the transition beginning to occur between the different 
size regimes of HA chains, as it is interesting that the datapoint added to the 
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previous oligosaccharide data was the largest GAG chain size in the dataset. 
With the addition of further datapoints using HA chain sizes in the ‘region of 
uncertainty’, the description of the 2 trends will be further refined.   
The trend between Mw,GAG and the ratio of ∆𝐷/−∆𝑓 was successfully defined 
and used to develop a measuring technique to size Mw,GAG. The advantage of 
using the ∆𝐷/−∆𝑓 ratio here is that it can be readily extracted from QCM-D 
data to provide a simple, relative measure of film softness without the 
requirement for further measuring techniques. Therefore, although methods 
exist for measuring film  softness more accurately using a form of nonlinear 
regression analysis (also referred to as ‘viscoelastic modelling’) ∆𝐷/−∆𝑓 was 
selected as it did not require any further measurements to model the data 
(Reviakine et al., 2011; Eisele et al., 2012).  
Previously, the ratio of ∆𝐷/−∆𝑓 has been measured for other polymer chains, 
though no attempt was made to measure the polymer chains using the ratio. 
As the ratio is affected by the shape of the polymer chains the methodology 
described in this chapter is unlikely to be a good predictor of the Mw for other 
polymer chains with different biomechanical properties. To emphasise this 
point when comparing the ratio of ∆𝐷/−∆𝑓 for similar sized polymer chains of 
HA and double stranded DNA, the results were not equal (0.4 10-6/Hz and 0.2 
10-6/Hz respectively for a ~58 nm polymer chain) (Papadakis et al., 2010). 
This result is not unexpected, as DNA polymer chains have a larger 
persistence length (50 – 80  nm for DNA) than HA (~4 nm)  reflecting their 
more rigid polymer structure (Levicky et al., 1998; Lu et al., 2002; Bano et al., 
2016). Therefore, the use of the technique described in this chapter is only 
likely to be applicable to polymers with a similar persistence length. However, 
as the ratio of ∆𝐷/−∆𝑓 also increased with the size of DNA polymers it makes 
it possible to conduct a similar analysis as described in this chapter to produce 
a separate trend for DNA polymers that could predict DNA chain size based 
off ∆𝐷/−∆𝑓 measurements.  
This protocol benefits from the ability to measure GAG Mw in real-time, while 
creating functional surfaces that can then be used in further experimental 
protocols. Therefore, the process could act as a validation step to check the 
molecules for intra-sample variability and reproducibility, before further testing 
the surfaces afterwards. This is especially useful when considering the 
methodology used in chapter 4 where the reproducibility of HA films is vital to 
the experimental protocol. 
Previous work has used QCM-D as a detection method for determining 
whether DNA is present in complex samples that have not been purified where 
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the DNA was in low amounts (Papadakis et al., 2017). It is plausible that the 
protocol described in this chapter could also be adapted for use as a detection 
system for determining the presence of GAGs in complex samples, providing 
that the oxime ligation of the biotin moiety does not occur on other 
biomolecules. Therefore, not only could the presence of GAG samples be 
determined, but an average size could then be interpolated from the data to 
provide extra insight into the GAG population present in the sample.  
5.4.3 Conclusion 
There is a growing need both scientifically and commercially for accurate 
methodologies for measuring Mw,GAG. This chapter has established 2 new 
methodologies for measuring Mw,GAG using PAGE and QCM-D techniques. 
The former expands on previous PAGE methodologies by defining the 
relationship between HA and protein standard migration rates, thus expanding 
the range of standards that can be used to measure HA chains to include 
protein standards. The latter successfully established a relationship between 
Mw,GAG and the ratio of ∆𝐷/−∆𝑓 of HA films. These were used to establish 2 
functions that measured Mw,GAG between different size ranges. The method 
was then validated by correctly estimating the Mw,GAG of heterogenous CS size 
samples by comparing them with company estimates.  
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Chapter 6: General discussion & future perspectives 
This thesis has identified molecular heterogeneity in the distribution of PNN 
components throughout the CNS that could have significant implications for 
the organisation of PNNs. Furthermore, this thesis has established a 
methodology for measuring the size of HA, an essential component of PNNs, 
that can be combined with a further methodology for analysing the molecular 
interactions that underpin the formation of the supramolecular PNN structure 
in vitro.   
PNNs are macromolecular pericellular structures that surround sub-
populations of neurons in the CNS (Kwok et al., 2011; Wang and Fawcett, 
2012). Various molecular components have been identified as important in the 
formation of PNNs, with other molecules identified as associating with the 
PNN structure (Carulli et al., 2006; Deepa et al., 2006; Galtrey et al., 2008). 
Together this already presents the potential for producing highly 
heterogenous PNN structures. CSPGs particularly from the lectican family 
(Acan, Ncan, Vcan and Bcan) and Pcan have been well documented as 
important to PNN formation, and all have numerous splice variants, multimeric 
variants caused by proteolytic cleavage and can be glycosylated to varying 
degrees, presenting a variety of possible molecular components that could be 
present in PNNs (Ruoslahti, 1996; Yamaguchi, 2000; Bandtlow and 
Zimmermann, 2000; Rauch et al., 2004; Carulli et al., 2006; Deepa et al., 
2006; Galtrey et al., 2008; Zimmermann and Dours-Zimmermann, 2008; Kwok 
et al., 2011; Wang and Fawcett, 2012; Giamanco and Matthews, 2012). This 
heterogeneity is likely to be highly relevant to the function of PNNs, as 
numerous studies have singled out individual molecules within the PNNs for 
further investigation (John et al., 2006; Giamanco et al., 2010; Bekku et al., 
2012; Favuzzi et al., 2017). However, to date there has been limited 
investigation of how the biochemical composition of PNNs affect the 
macromolecular structure itself. The assembly of the macromolecular 
structure of PNNs on cell surfaces is likely to change the biochemical and 
biomechanical properties of the cell surface that could then be detected via 
mechanosensing by the surrounding cells. Therefore, the aim of the project 
was to investigate the potential biochemical heterogeneity of PNN 
components, including their splice variants, then investigate how the PNN-
associated molecules interacted to self-organise into the macromolecular 
PNN structure.  
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6.1 Heterogeneity in the distribution of PNN components 
This project has highlighted the heterogeneity in distribution of PNN-
associated molecular components observed throughout the CNS. Specifically, 
the characterisation of a large array molecular species of individual CSPGs, 
demonstrated that the structure of PNNs could be even more heterogenous 
than was previously thought. Not only are there 5 distinct CSPGs known to be 
associated with PNNs, but there are a number of CSPG sub-types that may 
also be present. How the distinct CSPG sub-types are regulated is currently 
unknown. It is also unknown if these sub-types are correlated with certain 
neuropathology’s, however it may provide a new insight into the regulation 
and formation of PNNs. One mechanism for the regulation of these CSPG 
splice-variants is through post-transcriptional modulation of the CSPG 
molecules. A second possible mechanism for regulating the CSPG sub-types 
could be through the regulation of enzymes that cleave the core proteins. For 
example, the Acan core protein is known to be cleaved by a number of 
enzymes called aggrecanases (Yamaguchi, 2000; Kiani et al., 2002; 
Morawski et al., 2012). Future work looking into the potential role of these 2 
mechanisms may provide further insight into the distribution of these PNN-
associated molecules within the CNS.  
Furthermore, the observation that CSPGs are also differentially glycosylated 
provides further potential for heterogenous components. The regulation of 
glycosylation may occur during the synthesis of the molecules, or through 
enzymatic degradation post-translationally by chondroitinases (Yamaguchi, 
2000; Kiani et al., 2002; Morawski et al., 2012). Future work aimed at 
understanding the mechanisms responsible for the production of the splice 
variants may offer unique insights into how to potentially biochemically 
manipulate PNN composition. 
The varied distribution of PNN molecular components suggested that PNNs 
in different CNS regions may be biochemically distinct. Unfortunately, it was 
not possible to investigate the specific molecules found within PNNs using the 
method described by Kwok et al (2014), due to methodological constraints on 
sensitivity. Therefore, by increasing the amount of starting tissue to increase 
the sensitivity of the assay, future work may focus on demonstrating if all of 
the molecular heterogeneity observed in this project is found within the 
structures of PNNs. Furthermore, it would be interesting to compare whether 
the biochemical composition of the whole CNS lysate (ECM + PNN) mirrors 
the biochemical composition of the PNN material alone, or if there are 
significant differences between them. 
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The lack of correlation between the two morphological phenotypes observed 
in the cortical and hippocampal regions, in comparison with the cerebellar and 
cSC regions suggest that the regulation of these morphological phenotypes 
may not be due to the presence of varied biochemical components. When 
combined with the observations from chapter 4 demonstrating how the density 
of PNN components can influence the assembly of PNNs it implies that the 
relative density of the components is likely to be an important factor that may 
be responsible producing these phenotypes. This is further supported by the 
size of HA, as well as the spacing of HA molecules on the surface having an 
influence on the assembly of PNNs and the biomechanical properties of the 
films produced. Therefore, the heterogeneity in components is likely to be an 
important factor in the structural properties of PNNs, however alone it is not 
enough to explain the presence of the morphologically distinct PNN 
phenotypes described in section 1.5.3.  
 
6.2 Important factors in the assembly of PNNs 
This project has provided unique insights into the processes underpinning the 
self-organisation of PNN components into the supramolecular PNN structure. 
Both Hapln1 and Acan were found to be able to interact with HA films. This is 
in agreement with previous observations measuring the relationship of Hapln1 
and Acan with HA (Shi et al., 2004; Attili and Richter, 2013). Although the films 
produced were biomechanically distinct, both Acan and Hapln1 were able to 
interact independently with HA films of varying HA density. Hapln1 was able 
to interact stably without the presence of Acan, though Acan required the 
presence of Hapln1 to interact stably with HA surfaces.  
The importance of Haplns in the stabilisation of the macromolecular structure 
implied that it may be the essential molecular trigger for PNN formation to 
occur. This mechanism is reliant on the presence of CSPGs in the pericellular 
space that are close in proximity to the surface bound HA on the cellular 
surface. The results from chapter 3 suggest that within the ECM in the CNS, 
many CSPGs are present, supporting this mechanistic hypothesis. This 
mechanism is not reliant on Hapln1 being presented in a particular order, as 
the results from chapter 4 highlighted that Hapln1 was able to stably interact 
with HA and Acan, irrespective of the order of incubation. Therefore, the 
introduction of Hapln1 would provide two important functions to PNN 
assembly. First, it would bind CSPGs already present within the HA films 
stably to the forming PNN surface. Secondly, any future CSPGs that interact 
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with the forming PNN will then be stably bound to the surface, allowing for an 
accumulation of CSPGs to occur over time. This gradual aggregation 
hypothesis suggests that this accumulation would then lead to the stable 
assembly of the PNN structure. Experiments aimed at testing this hypothesis 
in cell cultures by varying the availability of Acan and Hapln1 are required in 
the future. This hypothesis also provides a potential mechanism for temporally 
regulating the formation of PNNs by varying the amount of Hapln1 present 
within the PNN surface. Future work aimed at observing if the other Haplns 
(Hapln2 and Hapln4) and CSPGs (Bcan, Ncan, Vcan and Pcan) interact 
similarly with HA surfaces would provide greater insights into how the stable 
formation of PNNs is assembled. Future work could also analyse whether the 
upregulation of PNNs is correlated with the upregulation of Haplns.   
A unique insight provided by chapter 4 was the observation that the density of 
surface-bound HA films affected the interaction of both Hapln1 and Acan. It 
particularly highlighted the potential for steric hinderance playing an important 
factor in the ability for Acan to interact with the surface. For Acan to be 
incorporated into HA films HA molecules were required to be spaced far 
enough apart to allow Acan to interact within the HA film. If HA films were too 
dense then the interaction of Acan was hindered, observed by the reduced 
effect on the ratio of ∆𝐷/−∆𝑓. Interestingly, when combined with the 
observations in chapter 3 that a number of the CSPG molecules in the CNS 
are present in a cleaved, truncated form, it remains unknown if the cleaved 
CSPGs variants would be more likely to be incorporated into the PNN 
structure. Future work analysing how the different splice variants are affected 
by HA density would provide unique insights into how PNNs assemble.  
Two PNN-associating molecules Sema3a and Tn-R have previously been 
identified as being mechanistically linked to a role in cross-linking the PNN 
structure (Aspberg, 1995; Lundell et al., 2004; Morawski et al., 2014; Djerbal 
et al., 2019). The density of CS-E units may be of particular importance, as 
Sema3a is known to specifically cross-link GAG chains (Dick et al., 2013; Vo 
et al., 2013; Djerbal et al., 2019). CS-E units have previously been analysed 
within PNNs and were found to make up approximately 2.1% of the total GAG 
composition (Deepa et al., 2006). The density of CSPGs and the respective 
distribution of their G3 domains is likely to be of importance for Tn-R cross-
linking. Both these mechanisms imply that the abundance of CSPGs 
(particularly their G3 domain) and the degree of CSPG glycosylation could 
influence the ability of Sema3a and Tn-R to cross-link PNNs. Furthermore, the 
relative abundance of Sema3a and Tn-R may also influence the degree of 
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cross-linking. In this project, the abundance of Tn-R was observed to remain 
relatively consistent throughout the different CNS regions investigated (cortex, 
hippocampus, cerebellum and cSC), though interestingly the relative 
proportions of CSPGs were differentially distributed. Specifically, in chapter 3 
it was observed that a large proportion of CSPG species existed in a truncated 
form, implying that many CSPG splice variants would be present without a G3 
domain. Furthermore, the distribution of glycosylated CSPGs species were 
also differentially distributed, suggesting that the relative proportions of GAGs 
within PNNs may also be regulated. This suggested that a combination of 
post-transcriptional and post-translational modification during CSPG 
synthesis, as well enzymatic cleavage are responsible for these variants. In 
this project the relative abundance of G3 domains and CS-E were not 
specifically, therefore although this research highlights potential future 
research perspectives, it cannot be concluded that these mechanisms have 
been observed in this project. Though the observation in chapter 4 that Tn-R 
was unable to interact with HA / Hapln1 / Acan films suggested that the 
abundance of Acan G3 domains may be responsible for the lack of Tn-R 
interacting with the films. Though again, this result was not conclusive. Future 
work analysing the abundance of G3 domains and CS-E present within PNNs 
may provide a mechanistic insight into how PNNs may be biomechanically 
regulated through cross-linking by Tn-R and Sema3a.  
Future work is also required to further validate the structural properties of the 
PNN surfaces formed. The use of combinatorial techniques such as pairing 
QCM-D measurements with an optical measurement of density such as 
spectroscopic ellipsometry would allow for more a rigorous understanding of 
the density of molecules present within the forming films. Further 
methodologies could also be used to understand the topographical nature of 
the surface, such as the use of AFM. This would provide key information on 
how the supramolecular structures are assembling.   
 
6.3 Potential mechanisms for biomechanical signalling 
Biomechanical signalling mechanisms have been well documented in the 
CNS (Flanagan et al., 2002; Georges et al., 2006; Jiang et al., 2008; 
Moshayedi et al., 2010; Koch et al., 2012; Franze et al., 2013; Moshayedi et 
al., 2014; Bollmann et al., 2015; Koser et al., 2016; Moeendarbary et al., 
2017). Therefore, cells within the CNS have the ability to identify changes to 
the biomechanical properties of surfaces. What remains currently unknown is 
  - 127 -  
what the biomechanical properties of the PNN surfaces are and what factors 
are important in defining the biomechanical properties of the surface.  
 
6.3.1 Mechanisms for altering the biomechanical properties of PNNs 
By altering the size of HA alone, the biomechanical properties of films are 
affected, as observed in chapter 5. Increased HA size correlated with softer 
films, suggesting a potential mechanism for regulating the compliance of 
PNNs via HAS synthesis of HA on the cell surface. In chapter 3 a wide 
variation of HA sizes in the CNS was observed, therefore it is possible that 
these varying sizes partially act to change the biomechanical properties of 
PNNs. It is important to note that the observations in chapter 3 were not PNN-
specific, therefore this project indicated that HA size may be important to the 
structure of PNNs but is not conclusive. Manipulating HA size also contributes 
to other biological processes including the function of cell surface receptors, 
such as CD44, where the mechanism of superselectivity has been proposed 
(English et al., 1998; Lesley et al., 2000; Wolny et al., 2010; Dubacheva et al., 
2015). Therefore, to further understand the role of varying HA size within 
PNNs it is important to establish the range of HA sizes found within PNNs. 
One potential study could involve a combinatorial approach using the method 
of isolating components described by Kwok et al (2014) with the QCM-D 
measuring method described in chapter 5. Through understanding the size of 
HA in PNNs it would allow the initial compliance of the HA film that provides 
the foundation for PNN assembly to be better characterised. Furthermore, it 
would be interesting to observe if differing HA sizes are correlated with 
morphologically distinct PNN structures. Therefore, this project highlights the 
potential for HA size to be an important factor in manipulating the 
biomechanical properties of PNNs.   
Interestingly, it was also observed that altering the density of HA on the 
surface of PNNs contributed to changes to the properties of PNNs. In chapter 
5 the effect of HA density on the compliance of HA films was different for 
different sized HA chains. Although it was not possible to define a simple 
relationship, it indicated that the biomechanical properties of HA films are 
formed by a combination of both density and size of HA molecules on the cell 
surface. Therefore, the knowledge of both parameters is important to 
understanding the surface properties of the film. This provides a further reason 
for the need to determine the size of HA found within PNN structures. 
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Furthermore, altering the density of HA films also influenced the 
supramolecular assembly of PNN-associated molecules with the HA films. 
The observation in chapter 4 that Acan interaction had a larger influence on 
the biomechanical properties of sparse HA films in comparison with dense HA 
films indicated steric hindrance may be an important factor to consider during 
PNN formation. Previous work has also observed that the interaction of Acan 
with HA films caused the surfaces to become more compliant (Attili and 
Richter, 2013). Interestingly, when the idea of steric hinderance is applied to 
the results observed in chapter 3, where a variety of smaller CSPG splice 
variants were identified it suggests that a combination of both the size of the 
CSPG molecules as well as the density of HA surfaces is likely to influence 
the assembly of the supramolecular PNN structure and thus the 
biomechanical properties of the surface. Future work aimed at analysing how 
the splice variants interact with the sparse and dense HA surfaces defined in 
chapter 5 would provide unique insights into how these different CSPG splice-
variants may be incorporated into PNNs and affect the biomechanical 
properties of the surface. Also, future work aimed at analysing the density of 
HA surfaces present on the surface of PNN-producing cells is recommended. 
This could potentially be achieved by observing the relative distances between 
HAS molecules on the cell surfaces using histochemical and fluorescent 
imaging techniques.  
In chapter 4 it was observed that it was possible to change the biomechanical 
properties of HA surfaces by changing the density of Hapln1 associating with 
HA films. A larger density of Hapln1 correlated with a decrease in surface 
compliance, suggesting that the surfaces become more rigid. Interestingly, in 
chapter 3 the relative abundance of Hapln1 in the cortical region was 
increased in comparison with other CNS regions. It currently remains 
unknown if this increase in relative abundance correlates with more rigid 
PNNs in the cortical region. Furthermore, the physiological density of Hapln1 
within PNNs remains an important future research question, as this will have 
direct implications on the formation of PNNs, as well as the biomechanical 
properties of the surface. Taken together the results suggest a possible 
mechanism for changing the biomechanical properties of the surface, 
alongside results that suggest that Hapln1 abundance displays CNS regional 
variations.  
Therefore, taken together this project has provided multiple potential 
mechanisms by which the biomechanical properties of PNNs may be 
regulated. The likelihood is that all of these mechanisms act together to 
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influence the biomechanical properties of PNNs and produce the PNN 
structure. This may partially explain why the distinct PNN morphologies 
observed in the different CNS regions could not be characterised through the 
biochemical analysis alone. The morphologically distinct PNN structures are 
likely to be a reflection of a combination of a number of the biomechanical 
parameters described above.  
 
6.3.2 Potential mechanisms for biomechanical signalling 
Having identified a number of potential mechanisms for regulating the 
biomechanical properties of PNNs, particularly in manipulating the compliance 
of the surface, it is important to consider how this may influence biological 
processes in the CNS. One of the most obvious ways that the change in 
compliance could regulate cell behaviour, is if these changes to the surface 
could be detected by neuronal cells, specifically the axonal growth cones and 
glial cells via a biomechanical signalling mechanism. Both cell bodies and 
growth cones are known to actively mechanosense via stress-sensitive ion 
channels and integrin mediated pathways to measure the stiffness of 
substrates (Bray, 1979; Harris et al., 1980; Betz et al., 2011; Koch et al., 2012; 
Schwarz and Gardel, 2012). Therefore, it is possible that the changes to 
compliance observed through changing the biochemical properties of PNNs 
could be detected by cells in the CNS causing them to change their behaviour. 
Glial cells have been observed to increase in area in response to stiffer 
surfaces (Georges et al., 2006; Cullen et al., 2007; Jiang et al., 2008; 
Moshayedi et al., 2010; Moshayedi et al., 2014). Also, neurons have been 
observed to change their behaviour in response to changing biomechanical 
properties (Flanagan et al., 2002; Kostic et al., 2007; Jiang et al., 2008; Jiang 
et al., 2010; Previtera et al., 2010; Stabenfeldt and Laplaca, 2011). Though 
this project has identified that it is possible for a biomechanical signalling 
mechanism to be present and offers various possible methods for altering the 
biomechanical properties of PNNs, this project has not measured the 
biomechanical properties of PNNs surrounding cells. Future research aimed 
at providing measurements of compliance and surface thickness, as well as 
detecting the surface topology of PNNs, potentially using AFM would be 
recommended as it would provide a unique insight into precisely how the 
PNNs change the surface properties of neurons they surround.    
Another potential way that PNNs effect mechanosensing is by acting as a 
barrier that limits the ability for the cell bodies and dendrites of neurons they 
surround to detect the biomechanical properties of their surroundings. 
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Neurons have been observed to respond to dynamic mechanical stimuli 
(LaPlaca et al., 2005; Cullen and LaPlaca, 2006; Jiang et al., 2010; Franze et 
al., 2013). Currently, what remains unknown is if the biomechanical properties 
of PNNs differs from the biomechanical properties of the loose ECM. Although 
direct measurements have not been taken in this project, the observation in 
chapter 4 that increasing the density of molecules caused changes to the 
compliance of surfaces indicates that the increased presence of PNN-
associated molecules in PNNs in comparison with the loose ECM is likely to  
change the biomechanical properties of the PNN environment. It would be 
interesting to observe if the cells ensheathed by PNNs can detect their own 
PNN via mechanosensing and if that influences their behaviour. Furthermore, 
it would be interesting to observe if the PNN surface influences the cells ability 
to respond to dynamic mechanical stimuli.  
PNNs may also provide insulation and neuroprotection to the cells they 
surround. The observation in chapter 4 that Acan appeared to be sterically 
hindered from interacting within the HA film when the HA molecules were 
densely packed indicated that it is possible for PNN-like surface to impede the 
movement of molecules. Considering that Hapln1 density caused the surface 
to become less compliant, and also affected the interaction of Acan further 
suggests that the composition of the surface can influence molecular 
movement into the film. What remains unknown is if this limits the diffusion of 
molecules through the surface, which may provide a mechanism for both 
neuroprotection as well as controlling biochemical signalling. It would be 
interesting for future research to observe if the changes to the biomechanical 
properties of the film can actively regulate the diffusion of molecules through 
the film.   
 
6.4 The successful establishment of methodologies for 
analysing PNNs  
An important aspect of this project was the establishment of a method for 
measuring the formation of PNN-like surfaces in vitro. This method will provide 
a useful tool for further identifying how the contributions of further PNN-
associating molecules affect the overall formation of PNN structures. By 
establishing a method that can both investigate the formation of PNNs, while 
simultaneously measuring the biomechanical properties of PNNs it has the 
potential to interrogate questions that were previously difficult to analyse. For 
example, both Sema3a and Tn-R are hypothesised to cross-link PNNs, 
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however it is currently unknown if they cause a conformational change to PNN 
structure, therefore using this methodology will aid in understanding how they 
alter the assembly of PNNs.  
Furthermore, in chapter 4 this project established a method for creating a 
PNN-like surface in vitro. Stable HA / Acan / Hapln1 films were produced that 
recreated the molecular interactions that underpin the supramolecular 
assembly of PNNs. Future experiments that tweak and alter the methodology 
using other PNN-associated components will be able to create even more 
biochemically accurate PNN-like surfaces in the future. Furthermore, the 
abundance of each molecule present within PNNs still remains poorly 
characterised and remains the main challenge in developing this methodology 
in the future. However, the methodology in its current form still provide a useful 
tool that could then be scaled commercially to investigate how molecular 
interactions of potential CNS drug candidates affect the properties of PNNs. 
As PNNs have been correlated with many neurological diseases, methods for 
analysing PNNs will provide useful insights into disease pathologies. 
Secondly, this project has established two methodologies in chapter 5 for 
measuring the molecular weight of GAG chains. As there are limited 
methodologies available for measuring the molecular weight of GAGs the 
establishment of these methodologies will provide a useful tool for further 
analysing and understanding GAGs in future experiments. Combining PAGE 
with protein standards provides a quick, methodology that increases the 
standards size ranges that can be used for establishing GAG size. The second 
methodology, using the measurement technique QCM-D established a 
technique for analysing the size of GAGs that are tethered to surfaces. As well 
as measuring HA, it could also be used to size other GAGs, such as CS, that 
is also abundant within PNNs. Currently, the size of CS chains found within 
PNNs is not known, yet the size and density of these GAG chains offers a 
further potential mechanism for altering the biomechanical properties of PNN 
surfaces. The establishment of a methodology for measuring the size of GAG 
chains described in this project will help gain measurements of GAG chain 
lengths found in PNNs in the future experiments.  
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Chapter 7: Conclusions 
To gain insights into how the biochemical properties of PNNs influence the 
biomechanical properties of PNNs the distribution of PNN associating 
molecules was first analysed. Through the analysis of 4 distinct CNS regions 
(cortex, hippocampus, cerebellum and spinal cord) the heterogenous 
distribution of PNN-associated molecules throughout the different regions was 
observed. Furthermore, the CSPG variants observed in the different CNS 
regions were characterised. Taken together the large degree of biochemical 
heterogeneity observed within the 4 regions identified that PNNs may be more 
biochemically heterogeneous than previously thought. Also, the identification 
that CNS Acan is smaller than cartilage Acan, presents a potentially notable 
difference that could have significant implications for PNN organisation and 
phase separation.  
To investigate how the individual biochemical PNN components influence the 
formation and biomechanical properties of PNNs a new methodology was 
established that allowed for artificial PNNs to be produced in a cell-free in vitro 
system using QCM-D. This method provided unique insights into the formation 
of PNN structures, as Hapln1 was able to stabilise the interaction of HA and 
Acan irrespective of the order of incubation. This implicated Hapln1 as being 
the potential molecular trigger that is responsible for the formation of PNNs.  
Through manipulating the density of surface-bound HA the ability of Hapln1 
and Acan to interact with the surface and alter its biomechanical properties 
was affected. Furthermore, the biomechanical properties of HA films could 
also be affected by altering the density of Hapln1. By increasing Hapln1 
abundance HA films became less compliant.  
A new methodology for measuring the size of GAG chains was optimised and 
established. A consequence of the establishment of this technique was the 
observation that as GAG size increased, HA films became more compliant. 
Therefore, it highlighted the potential for the biomechanical properties of 
PNNs to be altered by varying the size of HA chains synthesised at the cell 
surface.   
Taken together this thesis suggests numerous potential mechanisms through 
which altering the biochemical composition of the PNN surface could influence 
the biomechanical properties of PNNs.  
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Chapter 9: Appendices 
Appendix 1: Quantitative analysis of film rigidity  
 ∆𝐷/(−∆𝑓 𝑛⁄ ) ≪ 4 × 10IJHzIM 
For dense HA50 films: 
∆𝑓 = 	−35	𝐻𝑧 
∆𝐷 = 14 × 10I 
𝑛 = 5 
Therefore: 
14 × 10I/(−−35 5⁄ ) ≪ 4 × 10IJHzIM 
2 × 10I ≪ 4 × 10IJHzIM 
This statement is not true, therefore the film is classified as soft.  
For sparse HA50 films: 
∆𝑓 = 	−5	𝐻𝑧 
∆𝐷 = 2 × 10I 
𝑛 = 5 
Therefore: 
2 × 10I/(−−5 5⁄ ) ≪ 4 × 10IJHzIM 
2 × 10I ≪ 4 × 10IJHzIM 
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Appendix 2: Lipid datasheets for DOPC : DOPE-cap-biotin 
liposomes [95 : 5] and DOPC : DODA-tris-NTA [99.5 : 0.5] 
 
DOPC : DOPE-cap-biotin 
- stock spec  C (g/L) Mw (g/mol) 
lipid DOPC 26.2 786.15 
lipid DOPE-cap-biotin 26.2 1105.47 
solvent CHCl3    
 
Desired conc. 
(mg/mL)  µmol 
Sample mix (mol ratio) 
          DOPC   DOPE-cap-biotin 
     Amount sample (µmol) 
 DOPC        DOPE-cap-biotin 
2.00 2.40 95.0 5.0 2.28 0.12 
 
             Mass sample (mg)        Volume stock (µL) 
 
Volume buffer (mL) 
DOPC DOPE-cap-biotin sum DOPC DOPE-cap-biotin 
 
1.79 0.13 1.93 68.41 5.06 0.96 
 
DOPC : DODA-tris-NTA 
. stock spec  C (g/l) Mw (g/mol) 
lipid DODA-Tris-NTA 2.29 786.15 





(mg/mL)  µmol 
Sample mix (mol ratio) 
          DOPC   DODA-tris-NTA 
     Amount sample (µmol) 
 DOPC        DODA-tris-NTA 
2.00 2.40 99.5 0.5 2.39 0.01 
 
             Mass sample (mg)        Volume stock (µL) 
 
Volume buffer (mL) 
DOPC DODA-tris-NTA sum DOPC DODA-tris-NTA 
 
1.88 0.01 1.89 71.65 5.79 0.95 
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Appendix 3: Analysis process and tables of results for HA and 
CS used in the PAGE analysis 
 
Figure 47. An example of how dmig, dmin and dmax were measured is represented 
in the image below.  
The white line across the top indicates the top of the gel. The yellow line running down 
the image is an example of the line used to measure the value of pixel intensity. The 
Graph to the right of the image reflects the relationship between distance travelled and 
pixel intensity. The discrete steps in intensity reflect the quality of the image taken, as 
the image was not as high in resolution as was intended.  
 
Table 8. HA and CS migration distance values (normalised).  
dmig dmax dmin 
HA 0.29 0.25 0.32 
CS-A 0.93 0.85 1.00 
CS-B 0.92 0.79 1.00 
CS-C 0.47 0.31 0.79 
CS-D 0.67 0.49 0.85 
CS-E 0.16 0.08 0.37 
 
Table 9. Mw,protein values for HA50 and CS samples.  
For dmig For dmax For dmin 
HA 93 110 86 
CS-A 11 22 10 
CS-B 12 28 10 
CS-C 63 89 18 
CS-D 38 59 22 
CS-E 180 390 79  
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Table 10. Mw,GAG values for CS samples.  
mean mean - half max mean + half max 
CS-A 6 13 6 
CS-B 7 16 6 
CS-C 37 52 11 
CS-D 22 35 13 
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Appendix 4: Tables of migration distances for the protein 
standards, HA and CS used in the PAGE analysis 
 
dtotal = 477 pixels (measure of the maximum gel distance). 
 
Table 11. Protein standard results. 
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Appendix 5: Values for measuring HA ∆𝑫/−	∆𝒇 using different 
methods 
 
Table 12. Values for measuring HA ∆𝑫/−	∆𝒇 using different methods. 
Sample -4 to -5 Hz Maximal coverage Average 
HA_dp15 0.19 ± 0.01 0.13 ± 0.01 0.14 ± 0.01 
HA50 0.37 ± 0.03 0.36 ± 0.01 0.37 ± 0.01 
HA250 0.72 ± 0.03 0.88 ± 0.01 0.85 ± 0.02 
HA500 1.33 ± 0.18 1.34 ± 0.20 1.15 ± 0.34 
HA1000 1.07 ± 0.02 1.10 ± 0.22 1.17 ± 0.24 
    
 
